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ABSTRACT SUMMARY 
 
Background: Non-invasive cardiac imaging provides important diagnostic and prognostic 
information in cardiovascular disease. Assessment of ventricular function remains the 
fundamental imaging request in clinical practice. Cardiac magnetic resonance (CMR) is 
now the recognised reference standard for quantification of left and right ventricular 
systolic function, but not diastolic filling. Due to cost and limited availability of CMR, 
echocardiography remains the first line imaging modality for assessing ventricular function 
in most cases.  Several echocardiographic methods are available for quantifying global 
ventricular function however despite significant advances in cardiac imaging techniques, 
visual assessment of ventricular systolic function remains the standard by which ventricular 
function is reported in many centres. This method is subjective and introduces inter-
observer bias. In an era of multi-modal imaging, accurate, reproducible and widely 
available methods for quantifying ventricular function, which exhibit good inter-modal 
inter-technique concordance, are desirable. The overall aim of this thesis was to examine 
the accuracy and reproducibility of several new echocardiographic imaging techniques for 
quantifying left and right ventricular systolic function, indexed against CMR reference 
standards, and to examine a novel CMR technique for assessing diastolic function, indexed 
against current reference standards  (invasive catheter recording of left ventricular end 
diastolic filling pressure (LVEDP)), in a heterogeneous cohort of patients as seen in clinical 
practice. 
Methods: All imaging modalities were performed within three hours of each other.  
Study 1 was designed to compare the accuracy of speckle tracking strain echocardiography 
for quantifying LV systolic function against biplane Simpson’s  rule (SR) and 3D-
echocardiography, using CMR LV ejection fraction (LVEF) as the reference standard.   
Study 2 was designed to investigate the accuracy of a novel modified regional wall motion 
scoring index (RWMSI) for calculating LVEF, and compare its accuracy against SR and 
CMR LVEF. 
Study 3 was designed to explore the clinical utility of velocity encoded (VEC) CMR for 
diagnosing LV diastolic dysfunction. VEC CMR E/Em velocity ratio was compared to 
LVEDP recorded during left heart catheterisation.  
Study 4 was a head-to-head comparison of 10 echocardiographic non-volumetric indices of 
right ventricular systolic function, based on current European Association of 
Echocardiography recommendations, indexed against CMR RVEF as the reference 
standard. 
Results: In study 1 we demonstrate that speckle tracking strain may be superior to SR for 
quantifying LV systolic function. In study 2 we suggest that, when specialist imaging 
software is unavailable, a modified RWMSI may be superior to SR for calculating LVEF. 
In study 3, we demonstrate a significant correlation between VEC-CMR E/Em ratios and 
LVEDP, and conclude that VEC-CMR may be a useful tool to diagnose diastolic 
dysfunction, especially in patients with preserved LVEF. In study 4, we demonstrate that 
RV free wall strain has a closer correlation to CMR-RVEF than nine alternative 
echocardiographic indices of RV function, and may be the method of choice for assessing 
RV systolic function by 2D-echocardiography in the future. 
Conclusions: This series of studies has confirmed that novel non-invasive cardiac imaging 
techniques may be used to accurately quantify cardiac ventricular function, and may confer 
significant advantage over current methods.  
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 1 
SYNOPSIS 
 
The mechanical pump action of the heart makes this organ unique within the thoraco-
abdominal viscera.  The continual pumping motion of the heart has for years also made it 
one of the most difficult organs to image accurately.  Invasive recordings of changes in 
intra-cardiac pressures throughout the cardiac cycle convey indirect information about 
cardiac pump function but are subject to changes in preload and afterload.  Fluoroscopic 
left ventriculography during cardiac catheterisation provided the first images of the moving 
heart together with information on regional wall motion abnormalities (RWMAs) within 
the anterior wall, inferior wall and apex of the left ventricle (LV).1,2 However, the use of 
left ventriculography for calculation of left ventricular ejection fraction (LVEF), the 
ubiquitous measure for quantifying LV systolic function, is at best crude. 
 
The application of sonar ultrasound to imaging cardiac structures by Edler and Hertz in the 
1950’s signalled the birth of echocardiography.3 Since then advances in cardiac ultrasound 
have been considerable. Two-dimensional echocardiography today remains the first line 
investigation for the assessment of cardiac structure and quantification of LV function.  In 
recent years advances in diagnostic ultrasound techniques now enable visualisation of 
cardiac structures in three-dimensions in real time and new imaging software permits the 
calculation of LVEF from reconstructed three dimensional (3D) left ventricular volumes.   
 
Alternative non-invasive imaging modalities also play increasingly important roles in 
diagnostic cardiology.  Nuclear single-photon emission computed tomography (SPECT) 
scanning is used regularly in some cardiac centres for identification of individuals with 
infarcted myocardium and/or the presence of inducible ischaemia. The use of multi-detector 
computed tomography angiography (MDCTA) is gaining popularity for the non-invasive 
assessment of coronary artery disease. Most recently, cardiac magnetic resonance imaging 
(CMR) is being increasingly used to enhance cardiac diagnoses. The excellent spatial 
resolution of CMR makes it ideal for the accurate anatomical assessment of congenital 
cardiac anomalies and intra-cardiac masses. In specialist centres CMR is now being used to 
assess post–infarct myocardial viability using delayed enhancement gadolinium CMR and 
to identify inducible cardiac ischaemia in patients with chest pain syndromes using 
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adenosine stress-perfusion CMR or dobutamine stress CMR.  The ability of CMR to image 
the heart in multiple planes and to enable highly reproducible 3D volumetric 
reconstructions from contiguous slice imaging throughout the ventricles mean it has now 
become widely accepted as the new reference standard for the quantification of baseline left 
ventricular and right ventricular systolic function.   
 
As several device and pharmacological therapies within cardiology and other medical 
specialties require accurate quantification of LVEF and serial monitoring of left ventricular 
systolic function as a prerequisite for treatment, it is important that available techniques for 
assessing left ventricular systolic function are sensitive, safe, accurate and reproducible.  
They also need to be standardized and widely available across institutions.  In this respect 
CT and nuclear SPECT have limited application due to repeated patient exposure to 
ionising radiation.  Although CMR and three dimensional echocardiography (3DE) have 
superior spatial resolution to conventional two-dimensional (2D) echocardiographic 
imaging techniques, at present due to high costs and limited availability of CMR and 3DE, 
these imaging modalities are not widely available outside specialist centres and 2D 
echocardiography (2DE) remains the first line non-invasive imaging modality for 
quantifying left ventricular systolic function.  To retain its clinical utility, it is therefore 
important that 2DE techniques for quantifying left ventricular systolic function improve in 
line with other non-invasive imaging modalities as 2DE technology advances. 
 
Cardiac diastole is a complex process and left ventricular diastolic dysfunction is difficult 
to quantify non-invasively.  Traditional echocardiographic assessments of diastolic function 
are semi-quantitative and load-dependent.  Recently much work has been done using tissue 
Doppler echocardiography E/Em ratio as an estimate of left ventricular filling pressure.4-13 
Revised American and European echocardiographic guidelines now recommend the use of 
tissue Doppler E/Em to assess LV diastolic function, despite recent research questioning 
the accuracy of this technique in certain patient cohorts.14-19  CMR is already being used in 
selective centres, including the Royal Adelaide Hospital, as the superior imaging modality 
for the detection of cardiac structural anomalies, perfusion defects and accurate assessment 
of systolic function. At present, however, it is difficult to routinely assess and diagnose 
diastolic dysfunction with current clinical CMR scan protocols. It has recently become 
possible however, using a phase contrast cardiac MRI sequence, to record and encode 
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velocity profiles of both myocardial tissue motion during diastole and blood as it passes 
through the mitral valve.20,21  From the reconstructed velocity versus time curves of LV 
filling, it should theoretically be possible to estimate left ventricular end diastolic filling 
pressure (LVEDP) using velocity encoded cine CMR (VEC-CMR) E/Em imaging in 
similar manner to tissue Doppler echocardiography (TDE). 
 
For many years the right ventricle has largely been the “forgotten” ventricle. As the 
understanding of cardiac contractile function has improved so too has the understanding of 
the important role of right ventricular contractility in the normal heart and across a range of 
cardiac and pulmonary disorders. The excellent spatial resolution of CMR, and its ability to 
image the heart in any plane enables accurate assessment of right ventricular volumes.22-36 
In specialist centres, CMR is increasingly being used to quantify right ventricular ejection 
fraction (RVEF) and has become the widely accepted non-invasive reference standard for 
doing so.  However, due to the current limited access to CMR, the majority of institutions 
rely on 2DE assessment of the RV. The complex geometry of the RV, and limited 
echocardiographic imaging windows precludes accurate volumetric quantification of RV 
systolic function by 2DE.  For this reason, several 2DE non-volumetric indices of RV 
systolic function have been developed. In response to increasing research in this field, the 
American Society of Echocardiography, in association with the European Association of 
Echocardiography and Canadian Society of Echocardiography, have recently published 
revised guidelines on the 2DE assessment of the right heart.37  The guidelines review all the 
available non-volumetric measures of RV function, the evidence behind the use of these 
indices, and where appropriate have published lower normative cut-off values based on a 
meta-analysis of the published literature. The guidelines conclude that at least one non-
volumetric quantitative index of RV function should be measured in addition to a visual 
assessment of RV function, and should be incorporated into every routine transthoracic 
echocardiography report. At the time of writing, there have been no head-to-head studies 
comparing the accuracy and reproducibility of all these non-volumetric indices of RV 
function, and the guidelines are unable to draw conclusions as to which of the available 
non-volumetric quantitative indices of RV function is superior in accuracy and 
reproducibility to the others and should therefore be the method of choice. 
 
 4 
In an era of increasing multi-modal imaging, it is important that current techniques are 
comparable in accuracy and reproducibility. The overall objective of this thesis was to 
assess the accuracy and reproducibility of novel non-invasive imaging indices of LV 
systolic function, LV diastolic function and RV systolic function, by indexing them against 
the respective reference standards. The study aim was to assess firstly, the diagnostic 
accuracy of identifying and quantifying ventricular dysfunction and secondly inter-
modality concordance between different imaging techniques. 
 
 The first objective of this thesis was to examine the potential of novel 2DE myocardial 
deformation imaging software to establish if this software was comparable to CMR and 
3DE for quantifying left ventricular systolic function. 
 
The second objective of this thesis was to utilise a widely available regional wall motion 
scoring system in a novel way to assess global left ventricular systolic function. The 
accuracy of this novel method was compared against CMR and current recommended 2DE 
assessment of LVEF. 
 
The third objective of this thesis was to explore the utility of VEC-CMR imaging as a 
method of quantifying left ventricular diastolic function by comparing it to TDE 
assessments and invasive catheter recordings of LVEDP. 
 
The final objective of this thesis was to perform a head-to-head comparison study of ten 
different 2DE non-volumetric measures of RV systolic function, indexed against CMR-
derived RVEF as the reference standard. The aim was to establish which method was 
superior in accuracy, reproducibility and clinical applicability, compared to the others, and 
should therefore be the quantitative index of choice for assessing RV systolic function by 
2DE in routine clinical practice. 
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CHAPTER 1 
 
 
 
INTRODUCTION 
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CHAPTER 1: INTRODUCTION 
 
1.1   CARDIOVASCULAR DEMOGRAPHICS AND THE EVOLVING ROLE OF 
 NON-INVASIVE CARDIAC IMAGING   
 
As the incidence of cardiovascular disease continues to rise, the demand for prompt, 
accurate non-invasive cardiac imaging for early diagnosis, monitoring and prognosis, 
across all aspects of cardiovascular disease becomes more important.  As more treatment 
options become available, and conversely as the importance of preventative strategies are 
increasingly realised, there is an increasing demand for sensitive non-invasive cardiac 
imaging methods that can reliably detect cardiovascular disease processes at a sub-clinical 
level enabling the cardiologist to implement early disease modification strategies to enable 
reduction in morbidity and mortality from the condition. 
 
THE LEFT VENTRICLE 
 
1.2   ANATOMY OF THE NORMAL LEFT VENTRICLE 
 
The LV is the systemic ventricle and its normal geometry is that of a prolate ellipse.  For 
imaging purposes the boundaries of the left ventricular cavity are divided into six walls – 
four free walls; the anterior, lateral, posterior and inferior walls of the LV, and the 
interventricular septum, which for imaging purposes is conventionally subdivided into the 
anteroseptum, and the inferoseptum (often simply referred to as the septum). For 
descriptive purposes the left ventricle is subdivided into 16 or 17 regional myocardial 
segments according to the American Heart Association model and is described in more 
detail in section 1.11.4 (Figure 1.20).38 
 
Left ventricular size and mass vary according to the body surface area of individuals.  
Normal ranges for left ventricular mass, as determined by CMR,22,24 and for left ventricular 
wall thickness, cavity dimensions and volumes, as agreed by joint American Society of 
Echocardiography/European Association of Echocardiography and British Society of 
Echocardiography Guidelines, are shown in Table 1.1.38 
Comment [DZ1]: Do we really need a 
6th form biology lesson at this level? 
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Index Females Females/BSA Males Males/BSA 
 
LV mass 
 
LV wall 
thickness 
 
LVEDD 
 
LVEDV 
 
LVESV 
 
LVEF 
 
 
 
 
0.6-1.2 cm 
 
 
3.9-5.3 cm 
 
56-104ml 
 
19-49ml 
 
≥55% 
 
31-79 g/ m2 
 
 
 
 
2.4-3.2 cm/m2 
 
35-75 ml/ m2 
 
12-30 ml/ m2 
 
 
 
0.6-1.2 cm 
 
 
4.2-5.9cm 
 
67-155ml 
 
22-58ml 
 
≥55% 
 
45-81 g/ m2 
 
 
 
 
2.2-3.1 cm/m2 
 
35-75ml/ m2 
 
12-30 ml/ m2 
 
Table 1.1. The Left Ventricle – Normal Ranges22,24,38  
BSA, body surface area; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter; LVEDV, 
left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular 
end-systolic volume 
 
The alignment of myofibres within the ventricular wall appears to be unique to the heart.39 
The angulation of the long axis of the fibres relative to the equatorial axis of the left 
ventricle changes within the level of the left ventricle from base to apex (Figure 1.1).39  The 
myofibres in the immediate subendocardial and subepicardial parts of the ventricular wall 
are aligned in a longitudinal fashion in relation to the ventricular equator, with changing 
angulations when measured on a radial axis.  At the base of the left ventricle there is a 
distinct collection of circular fibres aligned parallel to the ventricular equator.39 It is this 
complex fibre orientation in all three planes of the heart: radial, longitudinal and 
circumferential, that is believed to account for the unique “twisting” motion of the left 
ventricle during cardiac systole witnessed by cardiothoracic surgeons during operative 
procedures.   An understanding of this complex myofibre orientation of the left ventricle is 
important from an imaging perspective, as different disease processes can affect myocardial 
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deformation in the longitudinal, radial and circumferential planes of the LV to differing 
extents. Our understanding of the relationship between the complex myofibre architecture 
of the LV and LV systolic contractile function in the different axes of the heart has been 
greatly enhanced in recent years by myocardial deformation imaging in the form of tissue 
Doppler strain and speckle tracking strain echocardiography and grid-tagged CMR cardiac 
magnetic resonance imaging. 
 
       
Figure 1.1. Myocardial fibre orientation within the normal heart.39  
(A) Blunt dissection of the normal heart reveals varying myocardial fibre orientation 
in relation to the ventricular plane from base to apex (B) Schematic diagram 
highlights the complex myofibre alignment within the left ventricle. 
 
 
1.3  ANATOMICAL RELATIONSHIP OF THE CORONARY CIRCULATION TO   
THE LEFT VENTRICLE AND ITS IMPORTANCE IN ASSESSING 
REGIONAL LV FUNCTION 
 
To understand the origin of abnormalities in regional left ventricular function due to 
ischaemia or infarction, it is important to appreciate the arterial territories of the heart. The 
coronary circulation consists of the left and right coronary arteries, the ostia of which arise 
immediately superior to the left and right coronary cusps of the aortic valve. The coronary 
vasculature, unlike the rest of the arterial tree is perfused during diastole, when not 
occluded by the valve cusps or squeezed during cardiac systole. The right coronary artery 
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arises from the right coronary sinus and descends through the right side of the 
atrioventricular groove giving off branches that supply the right atrium and right ventricle. 
The right coronary artery supplies the sinus node and the AV node in about 60% and 90% 
of individuals respectively.40  If the right coronary artery is dominant, it gives off the 
posterior left ventricular branches then continues as the posterior descending artery which 
runs in the posterior interventricular groove and supplies the basal inferoseptum and 
inferior left ventricular wall.  The left coronary system arises from the left coronary sinus 
and continues as the left main stem before it branches, usually within 2.5 cm from its 
origin, into the left anterior descending artery and left circumflex artery.  The left anterior 
descending artery runs in the anterior interventricular groove and supplies the anteroseptum 
and anterior left ventricular wall.  The left circumflex artery travels along the left 
atrioventricular groove and gives off branches to the left atrium and lateral and posterior 
walls of the left ventricle. If the left circumflex artery is dominant, then it gives rise to the 
posterior descending artery.40  Figures 1.2 and 1.3 show schematic and fluoroscopic images 
of the normal coronary anatomy. Figure 1.4 demonstrates the arterial territories of the left 
ventricle, a relationship that is important to understand when assessing patients with left 
ventricular dysfunction secondary to regional wall motion abnormalities. 
 
 
Figure 1.2.  Schematic diagram of normal coronary artery anatomy41 
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Figure 1.3. Coronary angiography images of the normal coronary 
circulation.40 (A) Dominant left coronary arterial system and (B) non-dominant 
right coronary artery from the same patient 
 
 
 
 
 
Figure 1.4.  Relationship of coronary blood supply to left ventricular regional 
wall segments38 
Cx, left circumflex artery; LAD, left anterior descending artery; RCA, right coronary artery 
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1.4   PHYSIOLOGY OF THE NORMAL LEFT VENTRICLE 
 
The cardiac cycle refers to the physiological events that occur from the beginning of one 
heart beat to the commencement of the following heart beat. The cardiac cycle consists of a 
period of ventricular contraction (systole) and ventricular relaxation and filling (diastole). 
 
1.4.1 Left ventricular systole 
 
The onset of systole occurs when the left ventricular pressure exceeds that of the atrial 
pressure and approximates with the closure time of the mitral valve.  As more and more 
myofibres enter the contracted state, the pressure generated within the left ventricle 
continues to rise until it exceeds the aortic pressure. This first phase of systole is known as 
isovolumic contraction because the volume within the left ventricle is fixed as both the 
mitral and aortic valves are closed. Once the left ventricular pressure exceeds the aortic 
pressure, the aortic valve opens and the systolic ejection phase occurs. The rate of ejection 
of blood through the aortic valve is determined by the pressure gradient across the valve 
and also by the elastic properties of the aorta and the arterial tree.  The volume of blood that 
is ejected through the aortic valve during cardiac systole expressed as a percentage of the 
total volume of blood present in the left ventricular cavity at the end of ventricular filling 
(diastole) is called the ejection fraction.  The volume of blood that is ejected by the LV 
during each heat beat is called the stroke volume. Changes in the stroke volume are 
dependent on both the myocardial contractility of the LV and the cardiac loading 
conditions. The overall cardiac output of the heart is the product of the stroke volume and 
the heart rate (Equation 1.1). Normal LV haemodynamics are shown in Table 1.2. 
 
Equation 1.1: 
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Haemodynamic Index Normal Range 
LV velocity-time integral (cm) 
Stroke Volume (ml/m2) 
Cardiac Output (l/min) 
Cardiac Index (l/min/m2) 
                             15-35 
75-100 
4.0-8.0 
2.5-4.0 
 
Table 1.2. Normal resting haemodynamic indices of left ventricular function 
(95% confidence interval)42,43 
 
 
Currently used non-invasive imaging methods for quantifying global LV systolic 
performance can be divided into haemodynamic and volumetric assessments of the LV. 
Haemodynamic assessment of LV systolic function includes the non-invasive 
quantification of stroke volume and dp/dt. Volumetric assessment of LV systolic function is 
performed non-invasively by calculating the ejection fraction of the LV. LVEF 
quantification is the most common measure of left ventricular systolic function and can be 
assessed using several different methods.38 LVEF is the most commonly requested 
quantitative index on a diagnostic imaging scan request, and is also used to monitor disease 
progression.44,45 LVEF has also been shown to be a reliable indicator of prognosis in 
cardiovascular disease.46-50  Differing degrees of LV systolic impairment according to 
LVEF are shown in Table 1.3. 
 
 
LV Systolic Function 
 
LVEF range 
 
                Normal 
 
≥ 55% 
 
                Mildly impaired 
 
45-54% 
 
                Moderately impaired 
 
36-44% 
 
                Severely impaired 
 
≤ 35% 
 
Table 1.3.  Degrees of LV dysfunction according to left ventricular ejection 
fraction.38 
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Current non-invasive imaging guidelines for assessing LV systolic function by 
haemodynamic and volumetric means are described in section 1.11. 
 
1.4.2  Left ventricular diastole 
 
Diastole has four phases: 
1) Isovolumic relaxation  
2) Early passive left ventricular filling 
3) Diastasis 
4) Late active left ventricular filling associated with atrial contraction  
 
Phase 1:  Isovolumic relaxation 
 
Isovolumic relaxation is an active energy dependent process during which the myocytes 
return to their presystolic length and tension.  This event occurs early in diastole and starts 
with the closure of aortic valve which occurs when the left ventricular pressure falls below 
the aortic pressure.  As the left ventricle actively relaxes, the left ventricular pressure falls 
without a change in left ventricular volume.  Once the left ventricular pressure falls below 
that of the left atrial pressure, the mitral valve opens, signalling the end of the isovolumic 
relaxation phase.42 The isovolumic period lasts 50-100ms (approximately 15-20% of 
cardiac diastole), during which time the ventricular pressure drops to 85% of its diastolic 
value.51 The rapidity with which left ventricular pressure declines during phase 1 diastole 
cannot adequately be explained by the isovolumic relaxation of the myocardium alone.  
Buckberg and colleagues have nicely demonstrated using sonomicrometer crystals in a pig 
model, that contraction of subendocardial fibres in the LV anterior wall ceases at end-
systole, but contraction of sub-epicardial fibres persists 92±20ms longer.  This dissociation 
between the end of sub-endocardial and sub-epicardial contraction corresponds with the 
isovolumic relaxation period, suggesting the presence of an active “suction” mechanism 
contributing to the rapid left ventricular pressure decent seen during phase 1 diastole.51 
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Phase 2:  Early passive ventricular filling  
 
After the mitral valve opens the early passive left ventricular filling phase starts.  Early 
diastolic filling depends on the magnitude of the pressure gradient between the left atrium 
(LA) and left ventricle which propels blood into the left ventricular cavity.  The rate at 
which the LA:LV pressure gradient declines is dependant on 1) the elastic recoil of the left 
ventricle, 2) chamber compliance and 3) left atrial pressure.  Normally the rate of left 
ventricular filling and left atrial emptying is rapid and approximately 80% of left 
ventricular filling occurs during this phase.42 
 
Phase 3:  Diastasis  
 
Diastasis occurs due to equalization of the pressures across the mitral valve. Despite the 
equilibrium of pressures reduced blood flow can continue through the mitral valve due to 
inertia.  The duration of diastasis is determined by the heart rate, being longer during 
bradycardia and shorter during tachycardia. 
 
Phase 4:  Late active ventricular filling   
 
During diastasis, the left atrial and left ventricular pressures are at equilibrium.  To enable 
further left atrial emptying and left ventricular filling, atrial contraction occurs. This 
increases left atrial pressure and enables a further volume of blood to be propelled into the 
left ventricular cavity.  This final phase of diastole accounts for approximately 20% of left 
ventricular filling.42  
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Figure 1.5. Intracardiac pressure changes during the cardiac cycle in the 
normal left ventricle 
S1; Systole Phase 1: isovolumic contraction 
S2; Systole Phase 2: systolic ejection phase 
D1; Diastole Phase 1: isovolumic relaxation 
D2; Diastole Phase 2: early passive filling 
D3; Diastole Phase 3: diastasis 
D4; Diastole Phase 4: late active filling associated with atrial contraction  
 
 
LV diastole is a complex multi-stage process. This makes a quantitative non-invasive 
assessment of global diastolic function difficult. For many years, the diastolic relaxation of 
the heart has been assessed by Doppler echocardiography by studying mitral inflow and 
pulmonary vein flow patterns. Unfortunately these indices are only semi-quantitative at 
best, and are load dependent. In recent years, with the development of tissue Doppler 
echocardiography (TDE) techniques, there has been an increasing move to assess diastolic 
function by non-invasively estimating LV filling pressures. This physiology behind this 
technique is described in detail in section 1.10.3. CMR may provide useful in assessing LV 
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diastolic function in the future, but at the time of writing has no clinical application in this 
field. 
 
1.4.3  Systolic and diastolic interdependence 
 
Currently left ventricular systolic failure is diagnosed in the presence of a reduced LVEF. 
Diastolic heart failure is traditionally defined as heart failure symptoms in the presence of 
preserved LVEF.  In reality, this classification is an over-simplification. It seems unlikely 
that systolic and diastolic heart failure are two distinct entities as systole and diastole are 
intrinsically linked within the cardiac contractile cycle. Diastolic filling patterns and filling 
pressures are often abnormal in patients with systolic dysfunction.52-56  Furthermore, recent 
insights from myocardial deformation imaging studies by our research group57 and others58 
have suggested the presence of reduced long axis systolic contractility in patients with 
elevated diastolic filling pressures, abnormal diastolic filling patterns and preserved LVEF. 
Despite this overlap, distinguishing between predominantly systolic dysfunction and 
predominantly diastolic dysfunction is important for prognostic reasons. Furthermore, the 
correct diagnosis of diastolic heart failure as a cause of dyspnoea is important for 
prognostic reasons. In the Framington Heart study, patients with symptoms of congestive 
heart failure and impaired LV systolic function had an annual mortality of 18.9%.59  By 
comparison, symptomatic heart failure due to diastolic dysfunction with preserved ejection 
fraction has a more benign prognosis with an annual mortality rate of 8.7%.60,61 
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THE RIGHT VENTRICLE 
 
1.5   ANATOMY OF THE NORMAL RIGHT VENTRICLE 
 
“Thus the right ventricle may be said to be for the sake of transmitting 
blood through the lungs, not for nourishing them” 
- Sir William Harvey, De Motu Cordis 161662 
 
Despite the insight of Sir Harvey into the function of the right ventricle (RV), the RV was 
historically viewed by most as a passive conduit connecting the venous circulation to the 
pulmonary circulation.  The RV was not considered nearly as important as the left ventricle 
in maintaining normal cardiovascular haemodynamics, and as such study of the RV has 
been largely neglected in favour of research into LV physiology.  It is not until recent years 
that the importance of this “forgotten” ventricle in cardiovascular pathophysiology is 
finally being appreciated, and it is now recognised that the RV and LV are interdependent 
and have similar vitally important functions. 
 
In the normal heart, the RV is the most anteriorly situated chamber and lies immediately 
behind the sternum. The normal RV is delimited by the tricuspid valve annulus at the inlet 
and the pulmonary valve at the outlet.  Because the RV operates as a lower pressure system 
than the left heart, it is a thin walled and more compliant structure than the LV by the law 
of LaPlace, and its septal contour is indented by the dominant LV. As a result the RV is a 
complex shape that appears triangular when viewed side on, and a crescent when viewed in 
cross-section.   This complex geometry of the right ventricle and its relation to the left 
ventricle within the thorax renders two-dimensional volumetric assessment of RV function 
inaccurate.  
 
Morphologically the RV is distinguished from the LV by having coarser trabeculae, a 
moderator band and lack of fibrous continuity between the inlet and outflow valves.63  
Anatomically the RV can be subdivided into three component parts – 1) the inlet, which 
consists of the tricuspid valve, chordae tendinae and papillary muscles, 2) the trabeculated 
apical myocardium and 3) the infundibulum or conus which corresponds with the smooth 
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walled outflow region of the RV which lies immediately below the pulmonary valve 
(Figure 1.6).  Three prominent muscular bands are present in the RV: the moderator band, 
the septomarginal band and the parietal band.   The septomarginal band extends inferiorly 
and becomes continuous with the moderator band which attaches to the anterior papillary 
muscle.  The parietal band and the infundibular septum together make up the crista 
supraventricularis.64 
 
 
 
 
 
Figure 1.6. (A) Anatomy & (B) geometry of the normal right ventricle64 
 
 
(A) Schematic diagram 
demonstrating the anatomy 
of the normal right ventricle 
from the anterior aspect. 
Note the heavily 
trabeculated RV 
endocardial surface and RV 
moderator band. 
 
     
    
      
    
    
(B) Geometric 
illustration of the normal 
right ventricle. The 
complex crescentric 
shape of the RV 
prevents accurate 
volumetric assessment 
of RV function by 2D 
echocardiography 
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The myofibre architecture of the RV differs from that of the LV. The RV has transverse 
and longitudinally orientated fibres and but lacks the middle constrictor fibre layer of the 
LV (Figure 1.7). The RV therefore must rely more heavily on longitudinal shortening 
during systole to maintain ejection fraction.63  
 
 
Figure 1.7. Schematic of RV myocardial fibre orientation64,65 
The RV wall is mainly composed of superficial and deep muscle layers. (A) The 
fibres of the superficial layer are arranged transversely in a direction that is parallel 
to the atrioventricular groove. (B) The deep muscle fibres are longitudinally aligned 
from base to apex adjacent to the trabeculated endocardial surface of the RV. 
Ao, aorta; LV, left ventricle; PT, pulmonary trunk; RV, right ventricle 
 
 
1.6  ANATOMICAL RELATIONSHIP OF THE CORONARY  CIRCULATION TO   
       THE RIGHT VENTRICLE 
 
The blood supply to the right ventricle depends on the anatomy of the coronary tree.  
Approximately 80% of the population have a dominant right coronary system, in which 
case the right coronary artery (RCA) supplies most of the right ventricle.  The lateral wall 
of the RV is supplied by the marginal branches of the RCA.  The posterior wall and 
inferoseptum are supplied by the posterior descending artery.  The infundibulum or conus is 
supplied by the conal artery, which has a separate ostial origin to the RCA in up to 30% of 
individuals.  The anteroseptum and anterior wall of the RV are perfused by branches of the 
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left anterior descending artery.63,66  However, as the degree of RV dysfunction post 
myocardial infarction is often out of keeping with the findings on coronary angiography, a 
segmental model cannot be applied to the RV in the same manner as the AHA segmental 
model used to describe regional wall motion abnormalities of the LV.66,67 
 
1.7 PHYSIOLOGY OF THE NORMAL RIGHT VENTRICLE 
 
The primary function of the RV is to receive systemic venous return and pump it to the 
pulmonary system. Under normal circumstances the RV is connected in series with the LV 
and so is required to pump the same stroke volume as the LV.  However compared to the 
systemic circulation, the pulmonary circulation has a much lower vascular resistance and 
greater pulmonary artery distensibility.  Right-sided intracardiac pressures are therefore 
much lower than left sided pressures, giving the RV its unique physiology.   
 
Due to the anatomy and myofibre orientation of the RV, the RV contracts by three different 
mechanisms; 1) inward movement of the RV free wall (which produces a bellows effect) 2) 
contraction of the longitudinal fibres (long axis shortening), and 3) traction on the free wall 
at the points of attachment secondary to LV contraction.64,68 RV contraction is greater 
longitudinally than radially.63 Also, due to the higher surface-to-volume ratio of the RV, a 
smaller inward motion is required to eject the same stroke volume.  Understanding these 
fundamental differences between the physiology of RV and LV systole are important when 
developing and comparing different methods for quantitative assessment of RV function. 
 
1.7.1   Contribution of the interventricular septum to right ventricular contractility 
 
The role of the septum in ventricular-ventricular interactions is incompletely understood.  
The oblique fibre orientation of the LV enables ventricular torsion which helps to create the 
high pressures required to eject blood into high systemic vascular resistance. By contrast, 
under normal conditions the pulmonary vascular resistance is approximately one sixth of 
systemic resistance, and so the transverse constriction (bellows effect) and longitudinal 
shortening of the RV free wall is satisfactory to eject blood into the lower pressure 
pulmonary tree. In situations where septal akinesis is present, and RV free wall function is 
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preserved, RV haemodynamics may remain normal as long as pulmonary vascular 
resistance is low.65  However, the contribution of septal contraction to RV systole becomes 
increasingly important in situations of increased pulmonary vascular resistance, where the 
oblique fibre orientation of the septum and subsequent septal twisting becomes a vital 
mechanism for the RV to maintain output against increased pulmonary vascular 
resistance.65  
 
Recent advances in TDE have enabled preliminary research into the functional 
contributions of the interventricular septum to left and right ventricular contraction 
respectively showed that differences in thickening and radial strain could be observed 
between the two sides of the septum, which were not present in the longitudinal axis.69  
Knowledge of fibre architecture with an abrupt change in the middle of the septum together 
with the above study suggests the septum to be a morphologically and functionally bilayerd 
structure.63 
 
1.7.2  Right Ventricular Haemodynamics 
 
Under normal conditions, unlike the LV, the right ventricle is an energy efficient pump. 
The RV produces approximately the same stroke volume as the LV, but at 25% of the 
stroke work. However this efficiency is largely predicated by the low hydraulic impedance 
of the pulmonary vascular bed. That coupled with the highly compliant nature of the RV 
wall means the contractile properties of the RV are significantly influenced by changes in 
cardiac loading conditions. 
 
Preload 
 
Preload is the load present on the right ventricle in end-diastole, prior to systolic 
contraction, and is a reflection of the venous filling pressure. Within physiological limits an 
increase in RV preload improves myocardial contractility as per the Frank-Starling 
relationship (Figure 1.8).  Due to the increased compliance of the RV free wall, the RV 
may tolerate volume overloaded states well for a long time without a significant decrease in 
RVEF.63  However beyond a certain point, excessive RV volume loading can alter septal 
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geometry, compress the LV and impair global ventricular function due to the mechanism of 
ventricular interdependence (Figure 1.9). 
 
 
 
 
 
Figure 1.8. The Frank-Starling Curve.  
The Frank-Starling curve demonstrates the effect of altered filling pressures on 
ventricular performance in the normal, failing and sympathetically stimulated 
ventricle. 
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Figure 1.9. RV volume overload and “D” shaped flattening of the 
interventricular septum affecting LV filling. (A) parasternal short axis 
echocardiography view of the volume overloaded RV (left) causing D-shaped 
flattening of the interventricular septum and reversal of the transeptal gradient with 
resultant underfilling of the LV cavity (right). (B) Corresponding steady state free 
precession short axis cine CMR image demonstrating the same pathophysiology. 
 
Myocardial contractility 
 
Myocardial contractility is the inherent capacity of the myocardium to perform work 
independent of changes on preload or afterload.  RV myocardial contractility differs to that 
of the LV due to the different myofibre orientation, however there is also limited evidence 
to suggest that the RV myocardium is intrinsically different with a faster twitch velocity in 
RV muscle bundles than those of the LV.70-72 
 
Afterload 
 
As the RV is “coupled” to its low impedance pulmonary vascular bed, acute changes in 
afterload lead to major changes in RV pressure-volume relationships (see Figure 1.10).  
Compared to the LV, the RV is therefore extremely sensitive to changes in afterload, and 
the presence of pressure overloaded states such as acquired pulmonary hypertension often 
leads to RV dilatation and failure. 
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Figure 1.10. Right ventricular pressure-volume loops under different loading 
conditions.64,73 Cardiac loading conditions alter the RV pressure-volume 
relationship as shown above. The slopes of maximum time-varying elastance 
(Emax), maximum pressure-volume ratio (Max PV) and end-ejection 
pressure/volume (EEPV) are displayed on the graph. 
 
 
1.8   VENTRICULAR-VENTRICULAR INTERDEPENDENCE 
 
While it has been traditional to consider left and right ventricular physiology as 
independent of each other, this concept is flawed. The right and left ventricle share the 
constraints of the pericardial cavity and are interconnected via the interventricular septum. 
Ventricular interdependence refers to the concept that the size, shape, compliance and 
function of one ventricle effects the size, shape and pressure-volume relationship of the 
other. It is now well recognised that normal right ventricular function is dependent on 
normal left ventricular function, and conversely abnormalities of the left ventricle are 
important in the pathophysiology of RV failure. 
 
Research suggests systolic ventricular interdependence is mediated predominantly through 
the interventricular septum.  Damiano and colleagues electrically isolated contractility of 
the left and right heart, and demonstrated that LV systole caused pronounced pressure 
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generation in the right ventricle, estimated to account for up to 30% of the contractile 
energy of the RV.74  Furthermore, animal experiments have shown that normal contractility 
of the septum is able to maintain RV pressure generation and circulatory stability when the 
RV free wall is scarred or replaced by a non-contractile patch, as long as the RV itself is 
not dilated.75  
 
Diastolic ventricular interdependence is believed to be mediated through pericardial 
constraints on the dilated heart. In RV overloaded states, the compliant RV dilates. 
Eventually due to the constraint of the pericardial sac, the RV free wall cannot dilate 
outwards any further, and so pressure or volume overload within the right ventricle causes 
the interventricular septum to be displaced leftwards, altering the LV geometry and 
increasing the pericardial constraint on the left heart. The LV diastolic pressure-volume 
curve is displaced upwards.  The reduced LV cavity size impairs diastolic filling and results 
in a reduction in cardiac output. 
 
Systolic septal motion is influenced by the transeptal gradient. Under conditions of severe 
RV free wall dysfunction, paradoxical septal motion reflects the left to right systolic trans-
septal gradient because depressed RV contraction allows unopposed LV septal tension 
development.66,76-80  The compensatory contribution of septal contraction to global RV 
systolic function is highlighted in the presence of septal hypokinesis. Unsurprisingly, 
haemodynamic compromise and morbidity associated with RV ischaemia is exacerbated by 
the presence of septal dysfunction.76 
 
Right ventricular infarction is known to complicate approximately 50% of cases of acute 
inferior myocardial infarction and is a predictor of major complications and mortality.81,82 
However, right ventricular dysfunction following acute inferoposterior myocardial 
infarction may not be fully explained by right ventricular wall ischaemia. The dominant 
right coronary artery supplies the inferior and posterior walls of the left ventricle and acute 
ischaemic LV dysfunction results in elevated filling pressures and increases the afterload 
pressure on the right ventricle.  The right ventricle is sensitive to pressure overloaded states, 
which further exacerbates RV systolic dysfunction.  The fact that significant transient RV 
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systolic dysfunction has been noted in 77% of study subjects within 48 hours after anterior 
myocardial infarction further supports this theory.83 
 
The physiology of the right ventricle is unique, and the early detection and quantification of 
RV systolic dysfunction has important prognostic implications in cases of both primary RV 
failure due to cardiomyopthic processes, or more commonly secondary RV dysfunction in 
response to conditions of increased RV afterload (pressure overloaded RV secondary to 
pulmonary hypertension +/- elevated LV filling pressures), or pre-load (volume overloaded 
RV). 
 
1.9   THE ORIGINS OF DIAGNOSTIC CARDIOLOGY 
 
1.9.1 Invasive catheter studies 
 
The history of diagnostic cardiology can be traced back to 1711 when Stephen Hales placed 
catheters into the left and right ventricles of a living horse.84  More than a century later, the 
first formal studies of cardiac physiology were performed using invasive cardiac 
catheterisation by Claude Bernard in animal models.85  The first clinical cardiac catheter 
procedure on a human was performed by Werner Forssmann in 1929 when he inserted a 
catheter into a vein in his own forearm, guided it fluoroscopically into his right atrium.86  A 
decade later Professor Andre Cournand and colleagues developed the techniques for left 
and right heart catheterisation that we still use today.87 Cardiac catheterisation provides 
valuable well-validated haemodynamic information on intra-cardiac pressures which are 
still used for diagnostic purposes and to guide clinical decision making. Invasive techniques 
however, by their very nature, carry inherent risks and discomfort for the patient. Non-
invasive alternatives for quantifying ventricular systolic and diastolic function and 
measuring haemodynamic indices of contractility, ventricular relaxation and diastolic 
filling are safer and more patient-friendly and should therefore be considered first line 
investigations in diagnostic cardiology, provided the technique itself is robust and 
reproducible. 
 
The currently recommended methods for quantifying ventricular function are well validated 
within the differing imaging modalities. However, current techniques have recognised 
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limitations as subsequently discussed in section 1.11.  In an era of multi-modal imaging, 
intermodality concordance is also important.  There have been major technological 
advances in the field of non-invasive cardiac imaging in recent years, and the objective of 
this thesis is to explore the use of novel imaging methods to quantify resting ventricular 
function.   
 
1.9.2 Echocardiography 
 
The existence of ultrasonic radiation in nature was first demonstrated by Lazzaro 
Spallanzani in the seventeen hundreds during a study of bats.88  Edler (a Swedish 
cardiologist) and Hertz (a physicist) were the first clinical team to successfully utilize 
ultrasound technology to non-invasively image the heart in Europe in 1954.89  Using 
similar principles to the SONAR (sound navigation and ranging) ultrasound system used to 
detect enemy submarines during World War I, Edler and Hertz recorded the first moving 
images of the heart by M-Mode and used this technology to aid the pre-operative selection 
of patients with mitral stenosis for a new closed mitral commissurotomy technique.89  This 
signified the birth of transthoracic echocardiography (TTE). The early progression of 
echocardiography in the 1960’s was largely as a result of the scientific work of Professor 
Harvey Feigenbaum of the Indiana University School of Medicine, Indianapolis, USA.90-93  
Since this time, major advances in TTE have occurred including the development of fast 
Fourier transformation and Doppler colour flow mapping, resulting in TTE becoming the 
“Gold Standard” bedside cardiac imaging modality for the diagnosis of a variety of cardiac 
complaints.  Standard TTE is the most widely available, and often first line, non-invasive 
imaging modality for diagnosing abnormalities of cardiac morphology (using 2D and time-
motion mode measurements), valvular pathologies (combining abnormalities on both 2D 
imaging and spectral Doppler flow patterns) and cardiac contractile dysfunction (resting 
global systolic and diastolic impairment, regional wall motion abnormalities, and the use of 
dobutamine stress/viability protocols for the diagnosis of inducible ischaemia and 
myocardial viability).  The recent development of tissue Doppler echocardiography, 
myocardial deformation imaging and three-dimensional echocardiography has further 
provided new and exciting tools in clinical imaging research and clinical echocardiography. 
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1.9.3 Nuclear Cardiology 
 
The history of nuclear medicine originated in the 1920s.  The first diagnostic application of 
nuclear medicine was in the field of cardiology, when in 1927 Herman Blumgart used 
injectable solutions of radon gas and a Geiger tube to measure the “velocity of the 
circulation” in normal volunteers.94  Clinical nuclear cardiology began in the early 1960’s.  
The production of the scintillation camera and commercial development of radioisotopes 
enabled the imaging of radio-labelled tracers as they circulated through the heart in real-
time.  The first uses of nuclear cardiology included measurement of regional myocardial 
perfusion, regional function and detection of intra-cardiac shunts.95  The 1970’s and 1980’s 
heralded the development of 201-thallium, technetium-99mm and myocardial stress-
perfusion imaging for the detection of inducible myocardial ischaemia.96  This is performed 
today using single-photon emission computed tomography (SPECT).  From the late 1970’s 
onwards first-pass ventriculography and equilibrium ventriculography have become 
available for assessing right and left ventricular function, and quantification of cardiac 
stroke volumes and ejection fractions. 
 
1.9.4 Cardiac Magnetic Resonance 
 
Cardiac magnetic resonance imaging is a new and continually evolving sub-specialty 
within the field of diagnostic cardiology which is at present limited to specialist centres. 
However the origins of magnetic resonance imaging (MRI) can be traced back over one 
hundred years. 
 
The rotating magnetic field was first discovered by Nicola Tesla in 1885.97  The concept of 
nuclear magnetic resonance however was not established until 1946 when Felix Bloch and 
Edward Purcell, independently discovered that certain nuclei placed in a magnetic field 
absorbed energy in the electromagnetic spectrum and re-emitted this energy as a 
radiofrequency pulse when the nuclei transferred to their resting state, with the frequency of 
the radiofrequency pulse being proportional to the strength of the magnetic field.98,99  This 
finding eventually led to the production of the first magnetic resonance images some 30 
years later by Lauterbur and Mansfield. Paul Lauterbur in New York, USA and Peter 
Mansfield from Nottingham, UK, independently described the use of magnetic field 
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gradients to enable spatial localisation of nuclear magnetic resonance signals.100,101  The 
first published magnetic resonance image of a living creature, a clam, in 1974 was 
produced by Lauterbur and colleagues.102  The first in vivo human MRI image, the cross 
section of a finger, was published by Mansfield in colleagues in 1977.102  Lauterbur and 
Mansfield were jointly awarded the Nobel prize in 2003 for inventing magnetic resonance 
imaging.103  
 
Goldman and colleagues from Harvard Medical School were the first to describe the future 
potential of MRI in diagnostic cardiology in 1980.104  A year later Hawkes and colleagues 
in Nottingham, UK described what is believed to be the first recorded cardiac magnetic 
resonance image,105 followed by the first ECG gated moving cardiac image by Lauterbur’s 
group in 1983.106 Since this time advances in MRI imaging of the heart have been 
considerable, and include the development of delayed enhancement CMR for assessing 
myocardial viability, steady state free precession CMR for assessing cardiac anatomy and 
chamber quantification, adenosine stress-perfusion CMR and dobutamine stress CMR for 
detecting inducible myocardial ischaemia, velocity encoded CMR for calculating valvular 
haemodynamics and grid-tagging to assess regional myocardial deformation.  CMR is 
emerging as its own distinct sub-specialty within the field of diagnostic cardiology. The 
clinical research for this thesis was performed during a research fellowship at the 
Cardiovascular Research Centre, Royal Adelaide Hospital, South Australia. During the 
writing of this thesis, the Department of Cardiology at the Royal Adelaide Hospital became 
the first cardiology centre in Australasia to set up a dedicated clinical cardiac MRI service 
under the leadership of Prof Stephen Worthley and Dr Karen Teo. 
 
1.9.5 Cardiac Computed Tomography 
 
British engineer, Godfrey Hounsfield, a former employee of UK record company EMI, and 
American physicist Allan M Cormack invented computed tomography (CT) in 1972 by 
combining computer technology with X-ray technology, for which they received the Nobel 
prize in medicine.107 Two years later the first commercially available CT system was 
produced by Siemens Medical Systems.108  Multiplanar reformatting became available in 
1984, and the development of slip-ring technology in 1988 enabled the production of the 
first spiral CT scanner. The first CT angiogram was performed in 1997 from a single-slice 
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spiral CT reconstruction. However it was not until 2002 that cardiac CT progressed from 
research dream to reality with the development of 16-slice multi-detector CT (MDCT) for 
imaging the coronary arteries.  Since this time we have seen the development of 64-slice 
MDCT in 2004, the dual source scanner in 2006, and 128-, 256- and 320-slice MDCT in 
2007-2008.107   Gantry rotation speeds and collimeter slice thickness have decreased with 
each generation of CT scanner, and it is now possible to image the whole heart in seconds 
with high spatial and reasonable temporal resolution.107 
 
1.10  MULTI-MODAL IMAGING FOR THE ASSESSMENT OF VENTRICULAR 
         FUNCTION 
 
1.10.1 Assessment of resting ventricular function 
 
Historically 2D-echocardiography has been the imaging modality of choice for the 
assessment of resting LV and RV global systolic function, LV diastolic function and 
regional myocardial function.  Radionuclide ventriculography has also been used to 
quantify right and left ventricular ejection fractions, but has fallen out of favour with the 
development of newer imaging modalities and techniques.  The development of 3D-
echocardiography has improved accuracy of cardiac volume quantification, however the 
most exciting development in cardiac ventricular functional imaging is CMR.  The superior 
spatial resolution of CMR compared to echocardiography and nuclear techniques, and its 
ability to image the heart in any plane, now makes it the generally accepted reference 
standard for quantification of right and left ventricular ejection fraction. At the present 
time, CMR is not the recommended standard for assessing diastolic function.  Cardiac CT 
also has excellent spatial resolution.  Although the major current clinical application for 
cardiac CT is for the non-invasive imaging of the coronary arteries, a recent study by 
Brodoefel and colleagues has demonstrated the feasibility of CT for quantifying LV 
systolic function with excellent inter-technique correlation in both ventricular volume 
quantification (LVEDV: R=0.98; LVESV: R=0.99) and LVEF calculation (R=0.95), when 
compared to CMR.109 
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1.10.2 Assessment of dynamic ventricular function: Stress-perfusion imaging 
 
A major application of cardiac functional imaging is in the diagnosis, assessment and risk 
stratification of patients with known or suspected coronary artery disease.  Nuclear SPECT, 
dobutamine stress echocardiography, dobutamine stress CMR and adenosine stress-
perfusion CMR can all be used to assess areas of regional ventricular infarction and 
inducible ischaemia.  Low-dose dobutamine viability stress echocardiography and delayed 
enhancement gadolinium CMR imaging protocols are also used to differentiate between 
viable and non-viable ventricular myocardium.  Each imaging modality has its advantages 
and limitations, the further discussion of which is out-with the scope of this thesis. 
 
1.10.3 Safety issues 
 
The quantification of resting ventricular function is the most common imaging request in 
diagnostic cardiology.  Furthermore, ejection fraction quantification is often used serially as 
a monitoring tool to aid clinical decision-making in both cardiac and non-cardiac 
pathologies. The safety of a diagnostic imaging test, which will be used to assess many 
millions of patients world-wide, often serially, is therefore of paramount importance. 
Currently no adverse biological effects have been observed in humans at diagnostic 
ultrasound intensity levels.  Similarly, excluding patients with ferromagnetic implants and 
implanted device therapies, CMR performed in a 1.5T scanner, is believed to be safe. 
 
The UK department of Health’s Administration of Radioactive Substances Advisory 
Committee (ARSAC) limit for a single administered dose of radioactive-thallium is 
80Mbq.110  The effective dose equivalent is 0.23mSv/Mbq giving a total dose of 17-18mSv 
radiation exposure during a thallium-SPECT scan and the 8.6-10.7mSv radiation exposure 
during a technetium-labelled SPECT scan depending on the protocol used.111  The radiation 
dose to patient during radionuclide ventriculography is in the region of 800 Mbq giving a 
dose equivalent of approximately 7mSv.112  For a 64-slice MDCT scan the radiation 
exposure for a retrospectively ECG gated scan is 13-15mSv for a man and 18-21mSv for a 
woman, although these doses may be less in newer generation scanners.111 
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Due to repeated exposure to ionising radiation, we believe nuclear cardiology and cardiac 
CT are not suitable or justifiable imaging modalities for assessing resting ventricular 
function in patients that require serial monitoring, when safer alternatives are available.  
For this reason the investigation of potential novel methods to improve the diagnosis of 
cardiac dysfunction within this thesis will concentrate on the use of new echocardiographic 
and CMR imaging techniques. 
 
1.11  THE NON-INVASIVE ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC  
   FUNCTION 
 
Traditionally and currently, the first line non-invasive imaging modality for the assessment 
of left ventricular systolic function remains 2D echocardiography. Left ventricular systolic 
function is assessed globally (overall ventricular performance) and regionally (for the 
presence of regional wall motion abnormalities indicating the site and extent of previous 
myocardial infarct). 
 
1.11.1 Haemodynamic assessments of global left ventricular function 
 
Echocardiographic quantification of global left ventricular systolic function is traditionally 
assessed using either haemodynamic or volumetric measurements. 
 
Stroke distance, Stroke volume and Cardiac Output 
 
Haemodynamic assessments of left ventricular function are measured using spectral 
Doppler indices. The stroke distance is equivalent to the left ventricular systolic velocity 
time integral (LV VTI) and is easily measured from a pulsed wave Doppler trace recorded 
in the left ventricular outflow tract (LVOT).113  From the stroke distance, both the stroke 
volume (the volume of blood ejected from the heart during each systolic contraction) and 
the cardiac output (the volume of blood pumped out by the heart per minute) can be 
calculated as shown in Equations 1.2 and 1.3. 
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Equation 1.2:  
 
SV = π(LVOT D/2)2 x LV VTI                  where: SV = stroke volume 
                                                                          LVOT D = LV out flow tract diameter 
                                                                          LV VTI  = LV velocity time integral 
 
Equation 1.3: 
 
CO = SV x HR                                           where: CO = cardiac output 
                                                                                SV = stroke volume 
                                                                                HR = heart rate 
 
The normal ranges for LV VTI (stroke distance), stroke volume and cardiac output are as 
previously shown in Table 1.2. 
 
Limitations of the technique 
 
Doppler assessment of LV VTI and SV are influenced by cardiac loading conditions, 
dysrhythmias and ectopy. Further more, any errors in LVOT diameter measurements are 
magnified during cross-sectional area calculations. 
 
Left ventricular pressure-time relationship (dP/dT) 
 
An alternative non-invasive haemodynamic estimate of LV systolic function can be 
determined from the LV pressure-time relationship (dP/dT).  Doppler indices obtained 
during the non-ejection phase of the cardiac cycle are less dependent on loading 
conditions.42  DP/dT is a measure of the rate of rise of left ventricular pressure during the 
isovolumic contraction period and is calculated as shown in Equation 1.4.42 
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Equation 1.4: Calculating dP/dT 
 
dP/dT = 32/∆t   where ∆t = time interval           
measured between velocity points  
1 and 3 m/s on the mitral regurgitant 
spectral Doppler envelope. 
 
An example of the echo Doppler measurement of dP/dT is shown in Figure 1.11. 
 
 
Figure 1.11. Measuring dP/dT. 
The time interval between 1 and 3 m/s is 51.76ms as shown. The corresponding 
dP/dT is therefore 620.16mmHg/s indicating severe left ventricular dysfunction. 
 
Reference values for dP/dT are shown in Table 1.4 below. 
 
LV Systolic Function DP/dt values (mmHg/s) Time taken to generate 32mmHg 
 
Normal 
 
> 1,200 
 
< 27ms 
 
Mild-Moderate 
dysfunction 
 
800 –1,200 
 
27-40ms 
 
Severe dysfunction 
 
< 800 
 
> 40ms 
 
Table 1.4.  Reference values for dP/dT.42 
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To minimise error during this measure, care must be taken to ensure correct Doppler 
alignment and to optimise gain and filter settings. The velocity scale and sweep speed 
should be set consistently – for example, 0-4m/s with a sweep speed of 100mm/s. This 
technique is dependant on the presence of a well-defined mitral regurgitant Doppler 
envelope. 
 
1.11.2 Volumetric assessments of global left ventricular systolic function 
 
Diagnostic and prognostic importance of left ventricular ejection fraction 
 
Due to geometric assumptions and load dependent nature of haemodynamic estimations of 
LV systolic function, calculation of LVEF by volumetric methods is the universally 
accepted measure of LV systolic function in clinical practice.  LVEF is one of the basic 
quantitative indices of any cardiac imaging study and is diagnostically important in 
identifying patients with LV systolic dysfunction and heart failure. The LVEF is the total 
blood volume ejected from the LV during each cardiac cycle, expressed as a percentage of 
the total volume of blood present in the LV at the end of the diastolic filling period.  
Degrees of systolic dysfunction are categorised according to specified ranges of LVEF into 
normal contractile function, mild, moderate and severely impaired function as previously 
shown in Table 1.3.  A LVEF ≥ 55% is considered normal.38 
 
Not only is LVEF important diagnostically, it is arguably the most important index of 
prognosis.  The prognostic value of LVEF is well established.46-50  Patients with 
symptomatic heart failure have a significantly increasing 12 month mortality per 10% 
reduction in LVEF.114  Furthermore, quantification of LVEF aids clinical decision making 
when forming medical management plans for patients with a variety of cardiac and non-
cardiac pathologies alike. 
 
Patients with impaired LVEF due to ischaemic and non-ischaemic cardiomyopathies have 
been shown to prognostically benefit from pharmacological therapies such as angiotension 
converting enzyme inhibitors,115-120 beta-blockers121-124 and aldosterone antagonists.125,126  
The monitoring of left ventricular dimensions and LVEF is important in patients with 
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valvular heart disease and guides the optimal timing of surgical interventions.127  Cardiac 
resynchronisation therapy (CRT) has been shown to improve both morbidity and mortality 
in heart failure patients with New York Heart Association functional class III-IV 
symptoms, a broad QRS on ECG and severe left ventricular dysfunction in several 
multicentre trials.128-135  The presence of a LVEF≤35% is a prerequisite for consideration of 
CRT under current National Institute of Clinical Excellence (NICE) (2007) UK 
Guidelines.136  Similarly AVID,137 MADIT II138 and COMPANION134 clinical trials 
demonstrated significant survival benefit with the implantation of internal cardioverter 
defibrillator (ICD) device therapies for the  prevention of sudden arrhythmia-induced 
cardiac death in patients with severe left ventricular dysfunction of ischaemic origin, who 
had no evidence of untreated ischaemia.  Again accurate quantification of LVEF is a 
prerequisite for consideration of ICD device therapy according to NICE Guidance number 
95.139 
 
The importance of LVEF quantification in the management of patients with non-cardiac 
disorders and diseases should not be underestimated either.  Quantification of LVEF in 
patients prior to non-cardiac surgery is increasingly common and aids surgeons and 
anaesthetists in risk stratification of their patients pre-operatively.  Initial quantification of 
LVEF and subsequent monitoring of LV systolic function is also important during the 
treatment of oncology patients to ensure the avoidance of chemotherapy induced 
cardiomyopathy due to the potentially cardiotoxic nature of these agents.140 
 
Two-dimensional echocardiography assessments of left ventricular ejection fraction 
 
Despite the clear importance of accurately calculating LVEF in clinical practice, it is a 
measure that is often performed sub-optimally.  Although accurate quantification of LVEF 
is one of the fundamental indications for performing a non-invasive cardiac imaging study, 
the accuracy and reproducibility of this measurement is modality, method and operator 
dependent.  Traditionally, 2D transthoracic echocardiography has been the imaging 
modality used to quantify LVEF and a variety of different methods for calculating LVEF 
have been developed.  Each of these methods has advantages and limitations which are 
summarised in Table 1.5. 
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Dimensions/volumes 
 
Use/advantages Limitations 
Linear 
M-Mode 
(Teicholtz) 
 
 
 
 
 
 
2D Guided 
 
 
 
Volumetric 
Simpson’s Biplane 
 
 
 
 
 
 
 
Area-length 
 
 
Mass 
M-Mode or 2D guided 
 
 
 
 
 
 
 
 
Area-length 
 
 
Truncated ellipsoid 
 
       -     Reproducible 
- High frame rates 
- Wealth of accumulated 
data 
- Most representative in 
normally shaped 
ventricles 
 
- Assures orientation 
perpendicular to 
ventricular long axis 
 
 
- Corrects for shape 
distortion 
- Minimises mathematical 
assumption 
 
 
 
 
- Partial correction for 
shape distortion 
 
 
- Wealth of accumulated 
data 
 
 
 
 
 
 
 
- Allows for contribution 
of papillary muscles 
 
- More sensitive to 
distortions in ventricular  
Shape 
 
 
- Beam orientation 
frequently off axis 
- Single dimension may 
not be representative in 
distorted ventricles 
- Inaccurate in ventricles 
with RWMAs 
 
- Lower frame rates than 
M-Mode 
- Single dimension only 
 
 
- Apex frequently 
foreshortened 
-     Endocardial dropout 
- Relies on only two  
      planes 
-     Few accumulated data on         
      normal population 
 
- Based on mathematical   
       assumptions 
- Few accumulated data 
 
- Inaccurate in ventricles  
with RWMAs   
- Beam orientation (M-
mode) 
- Small errors magnified 
- Overestimated LV mass 
- Insensitive to distortion 
in ventricular shape 
 
- Based on a number of 
mathematic assumptions 
 
- Minimal normal data 
 
 
Table 1.5. Left ventricular quantification methods: Use, advantages & limitations38  
2D, two dimensional; RWMAs, regional wall motion abnormalities 
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Due to the inherent problems of the Teicholtz and Area-Length methods for quantifying LV 
systolic function, both the American Society of Echocardiography and the European 
Association of Echocardiography guidelines favour the use of the biplane method of discs 
(modified Simpson’s rule) as the 2D echocardiographic standard for calculating LVEF, 
despite the recognised limitations of this technique.38 
 
The principle underlying this method is that the total left ventricular volume is calculated 
from a stack of elliptical discs, the calculated volume of which is derived from left 
ventricular cavity measurements recorded in the apical four chamber and apical two 
chamber views in end diastole (EDV) and end systole (ESV) (Figure 1.12).141 
 
 
Figure 1.12 & Equation 1.5.  Calculating left ventricular volumes using 
Simpson’s Biplane Method of Discs.42 
The left ventricle is divided into a series of 20 discs along its length (L).   The total 
volume of the left ventricle is then calculated from the above equation where a = 
area of disc in plane 1 (cm2), b = area of disc in plane 2 (cm2) and L = length (cm). 
 
LVEF is then calculated as follows: 
 
Equation 1.6. Calculating left ventricular ejection fraction 
 
LVEF (%) = EDV-ESV 
  EDV 
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Limitations of Biplane Simpson’s Rule 
 
The modified Simpson’s biplane method of discs, which is not a true Simpson’s, relies on 
imaging in only two planes and therefore makes geometric assumptions. This technique 
requires both the presence of good endocardial definition and the absence of apical 
foreshortening during image acquisition.  In echogenic subjects and with the introduction of 
second harmonic imaging in the absence of contrast enhancement, interobserver errors are 
still significant.  Thompson et al showed that the interobserver variability in calculating the 
LV end diastolic volume (LVEDV), LV end systolic volume (LVESV) and LVEF are 13%, 
17% and 18% respectively.142  Even with the use of both second harmonic imaging and 
contrast enhancement, which requires intravenous cannulation and medical supervision and 
is therefore not practical for routine use in a busy clinical echocardiography laboratory, 
interobserver variability for LVEDV, LVESV and LVEF are 8%, 15% and 6% 
respectively.142 
 
Three-dimensional echocardiography  
 
The recent development of three-dimensional echocardiography (3DE) largely overcomes 
the geometrical limitations of standard 2DE.  A 3D acquisition of the LV is performed from 
the apical window, from data gathered over 4-5 cardiac cycles.  Using semi-automated 
endocardial border detection, the LVEDV and LVESV are measured from the resulting 
three-dimensional left ventricular volume (see Chapter 3, Section 3.5). The LVEF is then 
calculated from the LV volumes as described previously. The changes in regional volumes 
between end-diastole and end-systole are also displayed by the software (Figure 1.13).  
Jacobs et al have shown 3DE to have significantly better reproducibility than standard 2D 
TTE, with 3DE interobserver variabilities of 10%, 11%, 5% for LVEDV, LVESV and 
LVEF respectively.143  Volumetric calculations using 3DE correlate well with cardiac MRI 
derived measurements,144-146 although 3DE significantly underestimates ventricular 
volumes when compared to CMR.147,148  However, due to cost and limited availability of 
3DE, routine use of this technology is limited to specialist centres.  
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Figure 1.13. Change in American Heart Association 17 segment regional LV 
volumes over time with 3DE 
 
Cardiac magnetic resonance imaging 
 
As technology has advanced, a variety of alternative cardiac imaging modalities can be 
used to quantify LVEF – most notably nuclear SPECT and cardiac magnetic resonance 
imaging.  Unfortunately, LVEF calculated by these different imaging modalities are often 
used interchangeably when close intertechnique agreement has not been established.149  
Two dimensional volumetric assessments of LV function have been previously shown to 
have a sub-optimal correlation with CMR,150,151 and nuclear techniques tend to 
underestimate LVEF compared to 2DE.149  Quantification of global LV systolic function by 
3DE has a closer correlation with CMR, but significantly underestimates left ventricular 
volumes.144,148 
 
Nuclear imaging is limited by the fact it exposes patients to ionising radiation. In an era 
where safer alternative imaging modalities are available, diagnosis and monitoring of LV 
dysfunction by SPECT scanning is no longer justifiable. Nuclear imaging is therefore out 
with the scope of this thesis and will not be discussed further.  
 
CMR has superior spatial resolution to both 2D and 3D echocardiography and the 
advantage of being able to image the heart in any plane, unlike echocardiography which is 
limited to standardised transthoracic windows.  Furthermore, the ability of CMR to acquire 
sequential short axis steady state free precession (SSFP) imaging sequences in a contiguous 
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manner through the heart from the left ventricular base to apex (Figure 1.14a), enables a 
geometrically accurate 3D volumetric reconstruction of the left ventricular cavity.  
Proprietary analysis software allows endocardial border tracing in end diastole and end 
systole for each imaging sequence within the left ventricular short axis stack (Figure 
1.14b). Indeed, by applying Simpson’s method of discs to a CMR SSFP breath hold cine 
LV short axis series, multiple slice by slice LV volumes are actually measured and 
summated, resulting in fewer mathematical assumptions and a high reproducibility with an 
interobserver variability for LVEDV, LVESV and LVEF of 8%, 4% and 5% respectively152 
– a significant improvement on standard TTE techniques. For these reasons it is now 
generally accepted that CMR is the reference standard for assessing resting global LV 
systolic function.  
  
 
Figure 1.14. Calculating LVEF by cardiac magnetic resonance. 
(A) Acquisition of retrospectively gated steady state free precession short-axis cine images 
from left ventricular base to apex. Subsequent manual endocardial border tracing in end-
diastole (B) and end-systole (not shown) for each LV short axis slice enables multiple slice 
by slice LV volumes to be measured and summed. LVEF is therefore calculated by CMR 
using a true Simpson’s method of discs with minimal mathematical assumptions – in 
contrast with the Biplane Simpson’s method used in 2D echocardiography 
 
 
Cardiac magnetic resonance imaging for assessing left ventricular dysfunction in heart 
failure however, has several potential limitations.  A full cardiac magnetic resonance study, 
depending on the clinical indication, can take from 40-70 minutes to complete. During this 
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time, the patient needs to be supine within the magnet.  Dyspnoea is a common symptom of 
heart failure, often exacerbated in the supine position and therefore lying flat may be 
difficult.  Furthermore, most steady state free precession imaging sequences are acquired as 
breath-hold sequences over several cardiac cycles which again can be difficult for the 
dyspnoeic patient.  Cardiac magnetic resonance imaging is ECG-gated and in most routine 
imaging sequences the resultant 2D image is a reconstruction of data acquired over several 
heartbeats.  Variation in the R-R interval of the ECG, as occurs in the presence of atrial 
fibrillation and ventricular ectopy, therefore has adverse effects on image quality.  The 
prevalence of atrial dyssrhythmias and ventricular ectopy are significantly higher in 
patients with left ventricular dysfunction than those without.153-155  In the in-patient setting, 
patients requiring left ventricular functional assessment are often acutely unwell.  
Transferring an unstable patient from ITU or CCU to the MRI scanner for the purpose of 
ventricular assessment is not justifiable when a bedside echocardiogram is an available 
alternative.  Cardiac magnetic resonance imaging is contra-indicated in patients with 
ferromagnetic metallic implants.  The prevalence of device therapies in patients with 
impaired left ventricular function is rising.156  Although this may be set to change in the 
future, at the time of writing, most pacemakers, CRT and ICD devices currently implanted 
are not MRI compatible, thus prohibiting the use of CMR imaging in this (growing) patient 
population.  Finally, although widely accepted as the reference standard technology for 
assessing left ventricular systolic function, the considerable cost and expertise required for 
CMR imaging means access to a dedicated clinical CMR programme is at present limited to 
specialist centres.  Until this changes, or until 3DE becomes routinely available, 2DE will 
remain the standard by which most clinicians will quantify left ventricular function and 
subsequently base clinical decisions. 
 
For the reasons above, and due to the portable nature and wide availability of 
echocardiography, the 2D echocardiogram will continue to play an important role in 
cardiovascular diagnostics. Due to the recognised limitations of current 2D 
echocardiographic assessments of LVEF, it is important that clinical research seeks to 
improve 2DE methods for quantifying global LV systolic function.  A 2DE technique that 
is quick to perform, reproducible, recognises contractile information from all six walls of 
the left ventricle and makes minimal geometric assumptions is desirable. Furthermore, as 
the clinical availability of CMR grows, it will become increasingly common to use both 
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imaging technologies in parallel.  For this reason, it is important that CMR and 
echocardiographic methods used to assess ventricular systolic function have good inter-
technique agreement.  
 
1.11.3  New 2DE assessments of left ventricular systolic function 
 
Tissue Doppler Echocardiography (TDE) 
 
Ultrasonic imaging utilizes a physical phenomenon first recognised by Christian Johann 
Doppler in 1842.157  The Doppler principle states that when a transmitted ultrasound beam 
hits a moving object (for example red blood cells) the ultrasound beam is reflected back at 
an altered, or “shifted’ frequency.113 The magnitude of this Doppler shift frequency is 
proportional to the velocity and direction in which the moving object is travelling.  By 
ensuring the Doppler beam is directly in line with the direction of myocardial blood flow, 
the blood flow velocity can be calculated using the Doppler Shift equation (Equation 1.7). 
 
Equation 1.7. The Doppler Shift Equation113 
 
V =      ∆F.c____                    where:   ∆F = Doppler shift frequency 
2F0. Cos θ                                F0  = transducer frequency 
                                                                    c  = velocity of sound in tissue (1540m/s) 
    θ = angle of incidence (assumed to be 00                        
                                                                    if Doppler alignment correct) 
 
Myocardial tissue movement occurs at an amplitude of forty decibels higher and a velocity 
ten times slower than myocardial blood flow.158  By applying standard autocorrelation 
processing but reversing low amplitude and high velocity filters it is possible to obtain 
images of tissue Doppler motions of high temporal resolution without significant artefact 
originating from the blood pool.158,159  This is the basis underlying tissue Doppler 
echocardiography (TDE) techniques. 
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By employing the above gain/filter settings regional myocardial tissue velocities, strain and 
strain rates can be recorded throughout the whole of the cardiac cycle with excellent 
temporal resolutions. 
 
Tissue velocity imaging 
 
Tissue velocity imaging (TVI) allows accurate recording of regional velocity profiles 
within the myocardium. Using either pulsed-wave TVI or colour TVI with post processing, 
myocardial velocity profiles can be generated throughout the whole of the cardiac cycle for 
the basal and mid segments of all LV walls.  Ensuring a Doppler angle error of <20 degrees 
in the apical views, the resultant velocity profiles equate to the velocity profiles of 
myocardial contraction and relaxation in the longitudinal plane of the heart. The velocity 
information can be displayed in real-time as colour-coded data superimposed on the two-
dimensional grey scale image. With post-processing techniques this data can be displayed 
as tissue velocity waveforms of mean myocardial velocities. The main disadvantage is the 
time consuming nature of the offline analysis. Alternatively, online pulsed-wave TVI 
permits measurement of tissue velocities, within the pre-determined sample volume, over 
time. This method quantifies peak rather than mean myocardial velocities. It is limited 
however, in its inability to record data from more than one site at a time, meaning direct 
comparisons in regional wall motion must be made using different cardiac cycles.  
 
It is important to note with both these techniques, as with all Doppler measurements, 
correct Doppler alignment is of paramount importance to minimise error. The heart 
contracts in three directions: radially, longitudinally and circumferentially.  Due to Doppler 
angle dependence, it is only possible to simultaneously assess longitudinal contraction of 
the basal and mid myocardial segments of the left ventricle using colour tissue Doppler 
imaging techniques. In the normal heart, the velocities at the base are higher than those at 
the apex and the velocities in the right ventricle are higher than those in the left.  Normal 
tissue velocity profiles using pulsed-wave tissue velocity imaging and colour-coded tissue 
velocity imaging with post processing are shown below in Figure 1.15 and Figure 1.16 
respectively. 
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         Figure 1.15.  Pulsed-wave tissue velocity trace in a normal subject. 
          S1 = myocardial velocity associated with isovolumic contraction 
          Sm = peak systolic shortening velocity 
          Em = peak early diastolic myocardial relaxation velocity 
          Am = late diastolic myocardial velocity associated with atrial contraction. 
 
 
       Figure 1.16. Colour coded tissue velocity trace in a normal subject. 
        S1 = myocardial velocity associated with isovolumic contraction 
        Sm = maximal systolic shortening velocity 
        Em = maximal early diastolic myocardial relaxation velocity 
        Am = late diastolic myocardial velocity associated with atrial contraction 
        MVC = mitral valve closure 
        AVO = aortic valve opening 
        AVC = aortic valve closure 
        MVO = mitral valve opening 
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The peak systolic velocities of the basal walls of the LV in a normal heart are as shown in 
Table 1.6. 
 
PW sample position Peak systolic myocardial tissue velocity (cm/sec) 
Basal septum 7.5 ± 1.3 
Basal lateral wall 10.3 ± 1.9 
Basal anterior wall 10.3 ± 1.6 
Basal inferior wall 9.6 ± 0.9 
Basal posterior wall 9.9 ± 1.3 
 
Table 1.6.  Pulsed-wave tissue Doppler systolic myocardial velocities of the 
normal left ventricle.160 
 
Tissue Doppler strain and strain rate imaging 
 
One of the drawbacks of tissue velocity imaging is that it cannot distinguish between active 
and passive movement.  It is unclear if the velocity profile recorded for a severely 
hypokinetic/akinetic myocardial segment actually represents the velocity of contraction for 
that segment or if the segment is being passively dragged inwards by pulling forces from 
adjacent contracting myocardium.   
 
Lagrangian strain is the degree of myocardial deformation, at a given time point within the 
cardiac cycle, in relation to end-diastole as the reference point.161  Strain analysis enables 
calculation of the instantaneous velocity gradient between two sample points at a pre-
defined distance.  This velocity gradient is then divided by the sample distance to yield the 
temporal changes of deformation known as myocardial strain rate.  The potential 
advantages of myocardial strain and strain rate over current assessments of LV systolic 
function are four fold: 1) they allow sensitive assessment of regional myocardial function at 
high temporal resolutions, far excelling those of the naked eye; 2) the resultant strain 
graphs are both objective and quantifiable; 3) Strain assesses myocardial deformation not 
myocardial velocity and so distinguishes between active contraction and passive inward 
motion of akinetic myocardium being “dragged” inwards by pulling forces from adjacent 
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contracting myocardium, 4) strain enables assessment of systolic contraction in two cardiac 
contractile planes; radial and longitudinal, compared to standard methods which assess 
contraction in the radial plane only.  Change in systolic strain can be documented over 
time, and is a more sensitive measure of changes in systolic contractile function thant 
calculated ejection fraction.162  An example of a tissue Doppler longitudinal strain profile is 
shown in Figure 1.17. 
 
In relation to end-diastole as the reference point, Lagrangian strain is positive in the radial 
direction, reflecting systolic wall thickening (Figure 1.18) and negative in the longitudinal 
direction, reflecting myocardial fibre shortening during systole (Figures 1.17 & 1.19).  
 
 
Figure 1.17. Tissue Doppler longitudinal strain profile. Longitudinal strain is 
represented as a negative value reflecting the shortening of myocardial fibres from 
base to apex during systolic contraction. The arrow indicates peak systolic strain. 
 
Due to the angle dependency of tissue Doppler techniques, radial strain can only be 
measured in the anterior and posterior walls of the left ventricle in the parasternal short axis 
view.  Furthermore, longitudinal tissue Doppler strain imaging appears to be more angle 
sensitive that tissue velocity imaging and hence more prone to artefact and distortion.159,163  
The resultant measurements are highly operator dependant.  The high angle dependency of 
strain imaging can make direct comparison of opposing left ventricular walls in a large 
globular heart difficult.163  For reliable and robust strain recordings, different left 
ventricular regions need to be examined in separate recordings.163,164  This makes analysis 
times extremely long and at present not practical for routine clinical application.   Inter-
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observer and intra-observer variability in tissue Doppler strain analysis are high, in the 
region of >16% compared to ≤ 5% for tissue velocity imaging analysis.159 
 
While undoubtedly CMR has superior spatial resolution to echocardiography, TDE has the 
advantage over CMR, by virtue of the fact that it is a real time technique, and unlike CMR 
is not dependant on frame (phase) averaging. High frame rates with TDE (≥ 100fr/sec) are 
readily achievable and so although the spatial resolution is not as good as CMR, the 
temporal resolution is superior.   
 
Myocardial deformation imaging – 2D Speckle tracking Strain  
 
As previously described, tissue Doppler derived strain imaging is a measure of myocardial 
deformation. Longitudinal strain, measured from the apical views of the heart, enable 
quantification of myocardial fibre shortening and therefore, in theory, a very accurate and 
sensitive representation of regional myocardial systolic function in the longitudinal plane of 
the heart.  As strain imaging can detect differences between active and passive motion, it 
may be superior to tissue velocity imaging for assessment of left ventricular systolic 
function. In reality, tissue Doppler strain is prone to both “drift” and “noise” artefact. Due 
to the angle dependency of tissue Doppler derived strain imaging and the globular nature of 
the dilated heart, there are further problems with the accuracy of this technique. 
Furthermore, it is not possible to accurately measure strain values in the apical regions of 
the heart due to the unacceptable Doppler angles or therefore combine the segmental 
systolic strain readings to calculate a global strain score for the heart as a whole when 
measuring myocardial deformation using tissue Doppler methods.  The development of 2D 
speckle-tracking strain imaging has largely overcome these problems.  Speckle tracking 
strain is a Doppler independent measure of myocardial deformation. Speckle tracking strain 
utilizes a speckle tracking software program which ‘recognizes’ the unique “speckle’ 
patterns within the left ventricular myocardium and tracks their movement throughout the 
cardiac cycle in an automated manner. As speckle tracking strain is relatively angle 
independent it overcomes the problem of reproducibility and enables a segmental strain 
score to be applied to each of the 16 AHA myocardial segments of the left ventricle. 
Speckle tracking strain also enables the calculation of strain in the radial plane of the heart. 
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Although speckle tracking strain has several advantages over tissue Doppler techniques as 
described above, it also has some limitations.  The temporal resolution of 2D speckle 
tracking strain is inferior to tissue Doppler strain, with achievable frame rates in the region 
of 50fr/sec in comparison to >100fr/sec with tissue Doppler techniques. While this 
temporal resolution is still clinically acceptable, and indeed remains superior to CMR, the 
temporal resolution with newer 3D and 4D speckle tracking software is degraded further, 
resulting in potential underestimation of true peak myocardial deformation. At present, 
there are no published normative values for speckle tracking derived strain indices, and this 
is partly due to the fact that inter-technique concordance between speckle tracking strain 
software produced by different manufacturers has not been established. Finally, strain 
imaging, although relatively load independent, is heart rate dependent, thus limiting the 
clinical usefulness of strain imaging in individuals undergoing dobutamine stress 
echocardiography.  
 
 
An example of a radial speckle tracking strain recording taken from the parasternal short-
axis view is illustrated in Figure 1.18. An example of a longitudinal speckle tracking strain 
recording taken from the apical four-chamber (A4C) view is illustrated in Figure 1.19. The 
normal reference ranges for longitudinal and radial strain are shown in Table 1.7. 
 
 
 
Figure 1.18. Two-dimensional radial strain recording in the apical 4-chamber 
view of the heart of a subject with normal left ventricular systolic function. 
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Radial strain is represented as a positive value reflecting the myocardial wall 
thickening in the radial plane of the LV during systole. 
 
 
Figure 1.19. Two-dimensional longitudinal strain recording in the apical 4-
chamber view of the heart of a subject with normal left ventricular systolic 
function. A segmental strain score is applied to each AHA myocardial segment. 
An overall strain score for that apical view is then automatically calculated (circled). 
 
Strain Imaging Plane Normal Peak Systolic Strain values 
Radial strain165 + 41.0   +/- 17.0% 
Longitudinal strain166 - 18.7    +/- 3.7% 
Table 1.7. Reference ranges for longitudinal and radial strain in left ventricle. 
 
 
1.11.4 The assessment of regional left ventricular systolic function 
 
The assessment of regional left ventricular function is particularly important in patients 
with ischaemic heart disease due to the nature of the coronary artery blood supply to the left 
ventricle (as previously highlighted in Figure 1.4). The detection of areas of regional 
infarction (by low dose viability dobutamine stress echocardiography, nuclear SPECT or 
delayed enhancement gadolinium magnetic resonance imaging) or inducible ischaemia 
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using stress-perfusion techniques (such as dobutamine stress echocardiography, nuclear 
SPECT, adenosine stress-perfusion magnetic resonance imaging and dobutamine stress 
magnetic resonance imaging) confers important information about the presence and extent 
of myocardial scar tissue and presence of haemodynamically significant coronary stenoses. 
In addition to this, viability and stress-perfusion imaging also confer important information 
on the coronary territory involved and the likely culprit coronary artery, thus in turn giving 
diagnostically and prognostically useful information to aid decision making for targeting 
coronary revascularisation procedures. 
 
At a more basic level in patients with known or suspected ischaemic heart disease a 
standard 2D echocardiogram, as a first line investigation can provide much information on 
regional myocardial function.  Regional wall motion abnormalities in the anterior wall and 
apex of the left ventricle following chest pain for example, indicates myocardial infarction 
in the left anterior descending artery territory of the heart. The echocardiographic 
measurement of the diameter of each myocardial segment in end-diastole has been shown 
to provide a relatively sensitive measure of myocardial viability. An end diastolic wall 
thickness (EDWT) >0.6cm diagnoses the presence of viability in severely 
hypokinetic/akinetic segments with a sensitivity, specificity and negative predictive value 
of 80%, 51% and 80% respectively.167 
 
The American Heart Association 16- and 17-segment models of the left ventricle 
 
To enable a universally standardised description of regional wall motion abnormalities 
(RWMA), the American Heart Association (AHA) have subdivided the left ventricle into 
16 or 17 myocardial segments.  The AHA 16 and 17 myocardial segment models of the left 
ventricle are essentially identical, with the exception of the addition of an apical cap in the 
17-segment model.  Both models have been endorsed by the American Society of 
Echocardiography (ASE) and European Association of Echocardiography (EAE) for use in 
clinical practice.38  The 17-segment model is more commonly used in myocardial stress-
perfusion studies and the 16-segment model for the description of resting LV regional wall 
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motion abnormalities. Figure 1.20 is a schematic representation of the AHA 17-segment 
model of the left ventricle. 
 
Figure  1.20.  The American Heart Association 16- & 17-myocardial segment 
models of the left ventricle. The schematic below represents the AHA 17-
segment model which is often used in stress-perfusion studies. The 16-segment 
model is more commonly used to assess resting regional wall motion 
abnormalities, and is essentially the same as the 17-segment model with the 
exception of the apical cap.38 
 
Regional Wall Motion Scoring 
 
Regional wall motion scoring refers to the regional assessment of systolic function of each 
of the myocardial segments of the left ventricle.  The radial contraction of each myocardial 
segment is visually assessed by the cardiac sonographer and a score is applied.   A score of 
0 = hyperkinesis, 1 = visually normal contraction; 2 = hypokinesis; 3 = akinesis; 4 = 
dyskinesis and 5 = aneurysmal.  An overall regional wall motion score index of 1.00 is 
indicative of normal global left ventricular systolic function. A wall motion score index 
approaching 3.00 is consistent with severely impaired radial contraction within the left 
ventricle as a whole. Figure 1.21 highlights the use of regional wall motion scoring to 
assess regional left ventricular function in a patient with ischaemic cardiomyopathy.  
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Figure 1.21. Assessing regional left ventricular systolic function: Regional 
wall motion scoring. This patient has ischaemic cardiomyopathy. Akinesis of the 
inferoposterior LV walls is in keeping with the previously known inferior myocardial 
infarction and right coronary artery occlusion. There are also wall motion 
abnormalities in the anterolateral regions of the left ventricle. 
LAX, parasternal long axis view; SAX, parasternal short axis view; WMSI, wall motion score index; 
4C, apical four-chamber view; 2C, apical two-chamber view. 
 
New assessments of regional left ventricular function 
 
Strain imaging has the advantage over tissue velocity imaging due to the fact that it records 
myocardial deformation during systolic contraction therefore differentiating between active 
contraction and passive inward motion of akinetic myocardial segments due to tethering 
and drag effects from adjacent viable myocardium.  The clinical application of tissue 
Doppler strain is limited due to its high signal to noise ratio, moderately poor 
reproducibility and angle dependency as previously discussed.  Due to the angle 
dependency of tissue Doppler techniques, radial strain can only be measured in the anterior 
and posterior walls of the left ventricle in the parasternal short axis view.  Longitudinal 
strain can be assessed in the basal-mid segments of all left ventricular walls in the apical 
views.  The increased angle of incidence between the tissue Doppler beam and apex of the 
heart means that opposing apical myocardial segments of the left ventricle cannot be 
assessed from the same cardiac cycle by tissue Doppler strain.  The need for manual 
myocardial tracking throughout systole and long analysis times severely limits the clinical 
application of this technique for assessing regional myocardial function. 
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Speckle tracking strain by contrast has semi-automated border tracking and tracks unique 
myocardial “speckle” patterns through-out systole in an automated and angle independent 
fashion. The automated nature of this technique makes it potentially highly reproducible 
and easy to use.  Further more, the angle independent nature of the 2D speckle tracking 
software means that all 16 segments of the AHA model can be analysed, thus giving 
speckle tracking strain the potential to assess global as well as regional myocardial 
function. General Electric Automated Functional imaging (AFI) software enables 
automated quantification of the mean myocardial deformation recorded within each of the 
16 AHA LV myocardial segments, using speckle tracking techniques. Speckle tracking AFI 
imaging therefore provides an alternative sensitive quantitative method for assessing 
regional (and global) myocardial function of the LV, in addition to current visual 
assessments of regional LV function. 
 
1.11.5 Concept behind Study 1: Creating a Global Strain Score using regional 
myocardial deformation imaging to quantify global left ventricular systolic 
function 
The hypothesis behind both Study 1 and Study 2 of this thesis was that methods for 
analysing regional cardiac function, that encompass a comprehensive assessment of all LV 
myocardial segments of the AHA-segment model, could potentially be used to quantify 
global as well as regional systolic function.  Further more, mathematical equations could be 
derived to convert the sum of the regional LV myocardial segment scores into a global 
LVEF-equivalent score. 
 
Volumetric assessments of global LV function are load dependent. Furthermore biplane 
Simpson’s rule makes geometric assumptions as previously discussed. Strain imaging 
assesses myocardial deformation, therefore should not be subject to changes in loading 
conditions, and can differentiate between active and passive movement. Longitudinal strain 
is affected early in cardiomyopathic disease processes and impaired longitudinal strain is 
therefore an early sensitive marker of left ventricular systolic dysfunction. Two 
dimensional speckle tracking strain imaging has several advantages over tissue Doppler 
strain imaging techniques as previously discussed.  Currently longitudinal strain speckle 
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tracking software enables semi-automated quantification of mean longitudinal strain for 
each of the AHA-16 myocardial segments within the left ventricle. We hypothesised that 
current speckle tracking software could be utilised to calculate a global strain score for the 
left ventricle, and that this global strain score would correlate more closely to CMR derived 
LVEF than biplane Simpson’s rule.  Furthermore, we believed that the results of this study 
would enable derivation of a regression equation that would enable the global strain score 
to be converted in to more easily recognisable LVEF-equivalent score.  Finally, due to the 
semi-automated nature of the speckle tracking, we hypothesised that our new technique 
would be more reproducible than the currently used biplane Simpson’s method. 
 
1.11.6 Concept behind Study 2: Regional wall motion scoring for calculating global   
left ventricular systolic function 
 
The regional wall motion score index (RWMSI) is a basic but well validated method for 
quantifying regional radial contraction.  By taking the principle of the regional wall motion 
scoring system and restructuring it to give hyperkinesis a score of 3, normal radial 
contraction a score of 2, hypokinesis a score of 1, akinesis a score of 0 and dyskinesis a 
score of -1, we hypothesised that the regional wall motion scoring system could be used to 
calculate a LVEF-equivalent score by using the equation: 
 
LVEF(%) = Σ(16segRWMS)/16 x30 
 
Furthermore, we believe there is a significant difference between myocardial segments that 
are mildly hypokinetic and those that are severely hypokinetic, which are not currently 
differentiated between in the ASE/EAE endorsed regional wall motion score index. We 
believed that sub-classifying hypokinetic segments as mild-moderately hypokinetic, and 
moderately-severely hypokinetic and applying a score of 1.25 and 0.75 respectfully would 
improve the accuracy of the resultant LVEF calculation. 
 
We hypothesised that this new LVEF index may have a closer correlation and better inter-
technique agreement with CMR-derived LVEF (as the reference standard) than 2DE 
biplane Simpson’s rule.  The main advantage of this new method for assessing global LV 
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function is 1) it is quick and easy to perform in clinical practice and 2) it does not require 
the application of specialist software therefore it can be performed on any echo machine, in 
any situation by any experienced sonographer anywhere in the world. 
 
1.12 THE NON-INVASIVE ASSESSMENT OF LEFT VENTRICULAR 
DIASTOLIC FUNCTION 
 
1.12.1  Importance of accurately diagnosing left ventricular diastolic dysfunction 
 
Diastolic heart failure accounts for approximately 50% of all cases of heart failure.168-169   
Originally believed to be a relatively benign condition, it is only in recent years that the true 
prognostic implications of diastolic heart failure have been recognised.170-173  Furthermore, 
diastolic dysfunction has now become recognised as the primary mechanism responsible 
for dyspnoea and exercise intolerance in patients with systolic heart failure irrespective of 
the severity of the systolic dysfunction.14,174-176  Diastolic dysfunction is an independent 
indicator of adverse prognosis in patients with left ventricular systolic impairment.53,177-180 
For these reasons, the importance of accurate diagnosis of diastolic dysfunction is now 
recognised by the cardiology community as clinically important. Unfortunately, as diastole 
is a complex process, the accurate diagnosis and quantification of diastolic impairment is 
difficult. 
 
1.12.2  Traditional assessments of left ventricular diastolic function 
 
Diastolic dysfunction contributes to symptoms of heart failure due to the elevation of the 
left ventricular filling pressure.181,182  This is associated with a rise in left atrial pressure 
which promotes pulmonary oedema and dyspnoea. Left ventricular filling pressures are 
measured invasively during cardiac catheterisation and are directly associated with 
functional capacity and prognosis in patients with heart failure.16,183-185  Because of patient 
discomfort and the potential complications involved with invasive procedures, the routine 
use of invasive catheterisation procedures for assessing diastology has decreased 
significantly over recent years.186  Over the last two decades, the non-invasive evaluation of 
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LV diastolic function has been based on echocardiography spectral Doppler LV filling 
patterns. 
 
Diastole is a complex process that depends on both relaxation of the left ventricle (an active 
and energy dependent process) and compliance of the left ventricle, which is defined as the 
volume related pressure changes that occur during diastole.187  In diastolic dysfunction, 
relaxation abnormalities occur first, followed by abnormalities of ventricular compliance.42  
Since diastole is a complex four-stage process, accurate assessment of diastolic dysfunction 
cannot be traditionally measured echocardiographically from a single diastolic index 
instead the diagnosis of diastolic dysfunction is based upon a combination of diastolic 
measurements including mitral inflow patterns, mitral E and A wave deceleration times, 
abnormal E:A ratios, abnormal pulmonary vein flow patterns and prolonged isovolumic 
relaxation times (Figure 1.22).  
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Figure 1.22. Normal diastolic pressure/flow patterns recorded during (A) 
cardiac catheterisation; (B) mitral inflow Doppler trace during TTE; (C) 
pulmonary vein flow during TTE.42 1: IVRT, 2: Early passive LV filling, 3: 
Diastasis,  4: Late LV filling associated with atrial contraction.  
AV, aortic valve; DT, deceleration time; IVRT, isovolumic relaxation time; MV, mitral valve; LVEDP, 
left ventricular end diastolic pressure 
 
 
Each of the four phases of cardiac diastole can be depicted on the mitral inflow spectral 
Doppler profile and on the tissue Doppler profile as shown (Figure 1.23). Measurements of 
these distinct phases are used in the traditional combined assessment of diastolic function 
as described below. 
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Figure 1.23. The Four Phases of Diastole shown on a (a) Spectral Doppler 
trace of mitral inflow (b) Tissue velocity trace of mitral annular motion. (1) 
Isovolumic relaxation (2) Early passive filling (3) Diastasis (4) Late active filling 
associated with atrial contraction. 
 
 
 
Phase 1:  Isovolumic relaxation time 
 
Isovolumic relaxation is an active energy dependent process during which the myocytes 
return to their presystolic length and tension.  This event occurs early in diastole and starts 
with the closure of aortic valve.  As the left ventricle actively relaxes, the left ventricular 
pressure falls without a change in left ventricular volume.  Once the left ventricular 
pressure falls below that of the left atrial pressure, the mitral valve opens, signalling the end 
of the isovolumic relaxation phase.42 
 
The duration of the isovolumic relaxation period can be measured as the interval between 
aortic valve closure and mitral valve opening.  This is known as the isovolumic relaxation 
time (IVRT).42   
 
In conditions causing abnormally slow relaxation of the myocardial fibrils, it takes longer 
for the left ventricular pressure to fall below left atrial pressure, hence mitral valve opening 
is delayed and the IVRT is prolonged.42  In conditions of reduced left ventricular 
compliance, left atrial pressure is high.  Myocardial relaxation is still impaired but the high 
left atrial pressure largely masks the relaxation abnormalities.  In conditions where left 
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atrial pressure is high, the time taken for the left ventricular pressure to fall below the left 
atrial pressure is reduced, and so mitral valve opening occurs early and IVRT is 
short.42 Thus changes in IVRT can be used as a marker of Phase 1 diastolic dysfunction.   
 
IVRT is traditionally measured from spectral Doppler flow patterns obtained in the 
modified apical five-chamber view.  A pulsed-wave Doppler trace is recorded by angling 
the Doppler beam at an intermediate position between mitral inflow and aortic outflow to 
record both velocities simultaneously. IVRT is measured as the time interval from end of 
aortic outflow to start of mitral inflow (Figure 1.24).   
 
 
Figure 1.24. Phase 1 Diastole: Measuring the isovolumic relaxation time. 
The timing interval from end aortic out flow to commencement of mitral inflow is 
measured from the spectral Doppler signal recorded at a sweep speed of 
100mm/s. 
 
Phase 2:  Early passive ventricular filling - Peak mitral E wave velocity and mitral 
deceleration time 
 
After the mitral valve opens, the early passive left ventricular filling phase starts.  Early 
diastolic filling depends on the magnitude of the pressure gradient between the left atrium 
(LA) and left ventricle which propels blood into the left ventricular cavity.  The rate at 
which the LA:LV pressure gradient declines is dependent on 1) the elastic recoil of the left 
ventricle, 2) chamber compliance and 3) left atrial pressure.  Normally the rate of left 
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ventricular filling and left atrial emptying is rapid and approximately 80% of left 
ventricular filling occurs during this phase.42 
In conditions of abnormal left ventricular relaxation, the IVRT is prolonged and delayed 
mitral valve opening occurs.  This causes a reduction in the early transmitral pressure 
gradient and hence the amplitude of the peak mitral E wave is reduced.  As the ventricular 
myocardium continues to relax in an abnormal fashion, equalisation between left atrial 
pressure and left ventricular pressure is delayed and so mitral E wave deceleration time is 
prolonged.  Thus reduced E peak velocity and prolonged mitral deceleration time are phase 
2 diastolic indices of diastolic dysfunction due to abnormal diastolic relaxation.188 
 
In conditions causing abnormal left ventricular compliance, left atrial pressure is high and 
mitral valve opening occurs early.  The early transmitral pressure gradient is larger than 
normal and hence the peak mitral E velocities are abnormally high.  Due to the reduced 
compliance of the ventricle there is rapid equalisation of transmitral pressure resulting in a 
short deceleration time before the start of diastasis which occurs early.  An increased peak 
mitral E wave velocity and a short mitral deceleration time are phase 2 indices of diastolic 
dysfunction due to abnormal left ventricular compliance.188 
 
Mitral inflow patterns are recorded using pulsed-wave Doppler from the apical four-
chamber view with the pulsed-wave sample volume located adjacent to the tips of the 
mitral valve leaflets.113 Peak mitral E wave velocity is measured as the maximal modal 
velocity recorded during early diastole (see Figure 1.25). The mitral deceleration time is 
measured as the interval between the peak mitral E wave velocity and the point of 
deceleration extrapolated to the zero baseline as shown in Figure 1.25.42 
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Figure 1.25. Phase 2 Diastole: Early passive ventricular filling - Measuring 
Peak Mitral E wave and Mitral E wave deceleration time (DT). 
 
Phase 3:  Diastasis  
 
Diastasis occurs due to equalization of the pressures across the mitral valve.  Despite the 
equilibrium of pressures reduced blood flow can continue through the mitral valve due to 
inertia. The duration of diastasis is determined by the heart rate, being longer during 
bradycardia and shorter during tachycardia.  It is therefore not a reliable measure of 
diastolic dysfunction. 
 
Phase 4:  Late active ventricular filling - Peak mitral A wave velocity and E:A ratio 
 
During diastasis, the left atrial and left ventricular pressures are at equilibrium.  To enable 
further left atrial emptying and left ventricular filling, atrial contraction occurs. This 
increases left atrial pressure and enables a further volume of blood to be propelled into the 
left ventricular cavity.  This final phase of diastole accounts for approximately 20% of left 
ventricular filling.42  The peak velocity generated during left ventricular filling secondary to 
left atrial contraction is represented by the peak mitral A wave on the Doppler spectrum.  
 
In conditions of abnormal myocardial relaxation, early passive left ventricular filling is 
reduced and there is a compensatory increase in left ventricular filling due to atrial 
contraction, thus the peak mitral A valve velocity is increased.  This is usually expressed as 
a ratio of peak E:A.  In abnormal diastolic relaxation E:A ratio is reduced. 
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In conditions of abnormal left ventricular compliance, rapid equalisation across the 
transmitral gradient occurs along with elevated LVEDP. As a result of the elevated 
LVEDP, little or no transmitral gradient is re-established during atrial contraction and so 
the peak mitral A wave is reduced in size or absent.  The E:A ratio is increased in 
conditions due to abnormal left ventricular compliance. 
 
Peak mitral A velocities are recorded as part of the mitral inflow pattern in the manner 
described above.  Peak mitral A wave velocity is measured as the maximal modal velocity 
recorded during late diastole as shown in Figure 1.26 and E:A ratio is then calculated. 
 
 
Figure 1.26. Calculating the E:A ratio. In this example the peak E wave and A 
wave velocities were identical at 1.48m/s giving a ratio of 1:1. 
 
Caveat 
 
As myocardial disease progresses there may be a transition from predominantly abnormal 
diastolic relaxation to restrictive physiology (reduced left ventricular compliance and 
elevated left atrial pressure). During this period the transmitral inflow pattern may look 
normal despite the presence of significant diastolic dysfunction.  This is known as 
“pseudonormalisation”.42 In patients exhibiting a pseudonormal inflow pattern, it is 
traditional to perform a Valsalva manoeuvre to unmask the underlying diastolic 
abnormalities.   Abnormal mitral annular velocities confirm the diastolic abnormalities in 
this cohort of heart failure patients as described in section 1.10.3. 
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Abnormalities recorded in traditional echocardiographic indices of diastolic function occur 
in a U-shaped non-linear fashion, depending on whether impaired ventricular relaxation or 
restrictive LV filling predominates (see Table 1.8). Thus traditional indices of diastolic 
function are best used to describe the grade of diastolic function determined by the overall 
LV filling pattern, rather than used as quantitative nominal variables. Diastolic impairment 
is traditionally graded as 1) abnormal relaxation 2) pseudonormal 3) restrictive filling as 
shown in Figure 1.27.  Restrictive left ventricular filling patterns, are associated with 
greater filling pressures and a worse prognosis than left ventricular filling patterns 
consistent with abnormalities predominantly of diastolic relaxation.189  Furthermore, 
although mitral filling patterns have shown to correlate with invasive diastolic pressure 
recordings in patients with dilated cardiomyopathy, traditional mitral inflow indices of 
diastolic function correlate poorly with haemodynamic data in patients with normal or near 
normal LVEF (LVEF>50%).13,14,190-192  
 
 
Diastolic 
Parameter 
Abnormal Range Normal Range Abnormal Range 
Mitral E wave (m/s) <0.4 0.4-1.0 >1.0 
E:A ratio <0.7 0.7-3.1 >3.1 
MV DT (ms) <139 139-219 >219 
IVRT (MS) <54 54-100 >100 
 
Table 1.8. Normal and abnormal ranges of diastolic function (95% Confidence 
Intervals).188 
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Figure 1.27. Left ventricular filling patterns in diastolic dysfunction. 
Mitral inflow and pulmonary vein flow patterns in normal diastolic function through 
to progressively severe diastolic dysfunction as shown42 
 
 
Thus one of the major drawbacks of using IVRT, E/A ratios, mitral deceleration times and 
pulmonary vein flow patterns to assess diastolic function, is that they are only semi-
quantitative, making it difficult to assess absolute improvements in diastolic function in 
response to treatment strategies. A further drawback of these methods, is that the results are 
dependent on the haemodynamic loading conditions of the heart.189 
 
1.12.3 New assessments of left ventricular diastolic function 
 
Echocardiography: Mitral annular peak early diastolic relaxation velocities (Em), E/Em 
and the non-invasive estimation of left ventricular end diastolic filling pressure  
 
Elevated LVEDP occurs when significant diastolic dysfunction is present. In the absence of 
significant mitral valve disease LVEDP approximately equals mean left atrial pressure 
(mLAP), which in turn, approximates pulmonary capillary wedge pressure (PCWP). 
LVEDP and PCWP are measured invasively at the time of left and right heart 
catheterisation respectively (see Figure 1.22 above). In the last decade much work has been 
done looking at peak early diastolic tissue relaxation velocities at the mitral valve annulus 
(Em).  Em, provides an index of left ventricular relaxation that is relatively independent of 
preload.5,193-195  In addition to providing load-independent information, Em can be used to 
differentiate between normal and pseudonormal filling patterns.42  Em velocities have been 
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shown to be  reproducible.193,194,196   They also have the advantage of being quantifiable.  
An Em velocity recorded from the septal side of the mitral valve annulus (Em(s)) of <8cm/s 
has been shown to accurately predict impaired diastolic relaxation with a sensitivity of 73% 
and a specificity of 100%.197  The normal values for Em velocities recorded from the septal, 
lateral, anterior and inferior sides of the mitral valve annulus are shown in Table 1.9. 
 
Mitral Annular Position Em (cm/sec) 
Basal septum 12.3 ± 2.8 
Basal lateral wall 15.8 ± 3.8 
Basal anterior wall 13.7 ± 4.0 
Basal inferior wall 13.6 ± 3.6 
 
Table 1.9. Pulsed-wave tissue Doppler myocardial early relaxation velocities 
of the normal left ventricle 197 
 
The ratio of E/Em (where ‘E’ is peak velocity of mitral inflow during early passive filling 
and Em is the peak tissue velocity of early diastolic relaxation at the mitral valve annulus) 
has been shown to correlate with invasive LVEDP measurements and PCWP 
measurements.4,9  For example, Agricola et al demonstrated E/Em(s) >10 predicts elevated 
left ventricular filling pressure (LVEDP >15) with a sensitivity and specificity of 90% and 
83% respectively.198  Bruch et al demonstrated an E/Em >15 has a sensitivity and 
specificity of 80% and 100% respectively for predicting an LVEDP ≥15.199  Ommen et al 
assessed the clinical utility of E/Em in patients with both normal and impaired LV systolic 
function.  They reported that E/Em correlated better with mean LV diastolic pressure 
measured using micromanometer-tipped catheter than any other traditional 
echocardiographic index of LV diastolic function over a wide range of LVEFs (r=0.64) and 
when confined to a patient cohort with documented coronary artery disease (r=0.65).4  
Furthermore, they reported that their correlations with invasive diastolic pressure 
measurements were consistently equivalent or better when Em was measured at the septal 
side of the mitral annulus, compared to the lateral mitral annulus, or the combination of the 
septal and lateral mitral annulus.  Subsequent studies have noted that in patients with 
normal LVEF, E/Em ratios have the best correlations with LV filling pressures and invasive 
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indices of LV stiffness when Em is recorded from the lateral mitral annulus.6,200  Based on 
these and other studies, an Em(S) >8cm/s and Em(L) >10cm/s reflect normal mitral annular 
early diastolic relaxation velocities.14  E/Em >15 is believed to indicate elevated diastolic 
filling pressures and E/Em ≤8, to indicate normal filling pressures, with E/Em of 8-15 
representing a grey area when Em is measured at the septal mitral annulus.14  When Em is 
measured at the lateral mitral annulus, E/Em >12 indicates elevated diastolic filling 
pressure14,201  An example of a pulsed-wave Em recording is shown in Figure 1.28. and 
examples of E/Em diastolic patterns are shown in Figure 1.29. Using these two methods, 
(Em and E/Em) changes in diastolic function can be recorded quantitatively.  
 
 
Figure 1.28. Example of a pulsed-wave tissue Doppler velocity trace of the 
mitral annulus. The peak mitral annular early diastolic relaxation velocity (Em) 
was recorded as shown. In this example taken from the septal mitral annulus of a 
patient with dilated cardiomyopathy, Em = 5cm/s which is significantly reduced. 
 
The physiology behind E/Em as an estimate of LV diastolic filling pressure 
 
At end systole, cardiac myocytes are in a contracted state, and the elastic properties of the 
LV myocardium are compressed and twisted resulting in stored energy within the 
myocardium.  Relaxation of myocardial contraction results in release of this energy which 
causes LV pressure to fall rapidly during isovolumic relaxation. Under normal conditions 
the rate of relaxation of the LV wall tension is rapid enough to cause the LV pressure to 
continue to decline after mitral valve opening. This fall in LV pressure produces an early 
diastolic pressure gradient from the LA to LV which “sucks” blood from the atria down 
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towards the LV apex. The rate of early LV filling is determined by the size of this LA-LV 
pressure gradient.  The lower the early diastolic LV pressure is, the greater the gradient for 
filling, enabling the LV to fill without requiring an elevated left atrial pressure (LAP).  The 
ability of the normal heart to decrease the early diastolic LV pressure in response to stress 
enables an increase in cardiac stroke volume without much increase in LAP.  Relaxation 
properties of the LV are affected early in myocardial dysfunction, and the ability of the 
heart to increase LV filling without an increase in LAP is reduced or absent in heart 
failure.201-203   Changes in LV filling through progressive grades of diastolic impairment 
can be non-invasively assessed from Doppler measurements of mitral inflow (E and A) and 
measurements of peak early mitral annular myocardial tissue relaxation velocities (Em).  
As the cardiac apex remains fixed throughout the cardiac cycle, Em provides a measure of 
the long-axis lengthening rate of the LV in early diastole. Under normal conditions, Em 
occurs at the same point in diastole as the peak transmitral E wave velocity as a result of the 
symmetrical expansion of the LV during early diastolic filling. In Grade 1 diastolic 
dysfunction, diastolic relaxation of the LV is impaired but without a significant increase in 
LAP.  This results in a decrease in both E and Em, an increase in the peak transmitral A 
wave velocity reflecting the increased importance of atrial contraction to maintain LV 
filling, and E/A is <1 (Figure 1.29 below). With progressively worsening diastolic 
dysfunction, LVEDP rises closely followed by a rise in LAP, resulting in restoration of the 
early diastolic LA-LV pressure gradient, and pseudonormalisation of the transmitral E 
velocity, despite elevated LV filling pressures (Grade 2 diastolic dysfunction). As LV 
relaxation becomes more impaired Em becomes both reduced and delayed and occurs after 
E, suggesting that in ≥Grade 2 diastolic dysfunction, the LV does not expand in a 
symmetrical manner in diastole, but instead long-axis lengthening and propagation of blood 
to the LV apex occurs after the LV is filled by movement of blood into the LV inflow tract 
across the LA-LV gradient. In the presence of impaired relaxation, Em does not occur 
during the time of the LA-LV pressure gradient, so Em is both delayed and reduced and 
becomes almost independent of LAP.201,204  Em therefore provides a quantitative preload 
independent measure of diastolic function in situations of elevated LAP.201  In addition to 
this, both the peak Em velocity and the delay in Em relative to E, directly correlate with the 
time constant of LV relaxation.205-207  The peak transmitral E wave velocity is altered 
directly by changes in LAP and inversely by changes in the time constant of LV relaxation. 
Dividing E by Em effectively corrects for changes in the time constant of LV relaxation, 
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therefore changes in E/Em ratio should closely reflect changes in LAP giving a non-
invasive estimate of left ventricular filling pressure.  Thus in Grade 2 diastolic function, the 
pseudonormal mitral filling pattern is distinguished from normal by reduced and delayed 
Em, and an elevated E/Em ratio reflecting the rise in LAP. In severe Grade 3 diastolic 
dysfunction, filling is restrictive and LV diastolic filling pressures are very high – this is 
reflected in marked elevation of E/Em ratio (Figure 1.29). 
 
 
              (a)                             (b)                          (c)                             (d) 
 
Figure 1.29. Diastolic dysfunction: Patterns of abnormal mitral inflow 
velocities and mitral annular diastolic relaxation velocities (b) Grade 1 
Diastolic dysfunction, (c) Grade 2 diastolic dysfunction and (d) grade 3 
diastolic dysfunction, compared to normal diastolic function (a).42 
 
 
Not only has E/Em been shown to correlate with elevated diastolic filling pressures, both 
Em and E/Em ratios confer important prognostic information.  Elevated filling pressures are 
associated with increased mortality in heart failure patients. Wang et al have demonstrated 
an incremental survival benefit in heart failure patients with Em >3 and E/Em ≤15 at one 
year follow-up.54  This survival benefit was not only maintained, but cumulatively 
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increased over 5 years (see Figure 4.2.9).54  Subsequent studies have confirmed the 
prognostic importance of E/Em in differing patient cohorts.10,11,208-214 
 
 
 
Figure 1.30. Kaplan-Meier curve demonstrating survival benefit in patients 
with an early peak diastolic mitral annular relaxation velocity ≥3 compared to 
<3 cm/s.54  Cum; cumulative. 
 
 
The assessment of diastolic function by cardiac magnetic resonance imaging 
 
At the time of writing there is no standard CMR method for diagnosing and quantifying left 
ventricular diastolic dysfunction in clinical practice. Small single centre studies have 
explored the potential of using grid-tagged myocardial deformation CMR imaging 
sequences to assess diastolic relaxation.215-219  This has increased our understanding of left 
ventricular torsion and the contribution of diastolic “untwisting” and LV suction to LV 
filling in early diastole.218-220  Diastole however is a multi-stage process and CMR 
myocardial deformation imaging has limited ability to assess late diastolic events due to the 
degradation of the grid-tags in end-diastole.221 Azevedo and colleagues have recently 
developed a method of assessing diastolic strain rate which shows potential but needs to be 
validated in a larger prospective study.222  While myocardial deformation imaging by CMR 
shows potential, it is not yet applicable to clinical practice.  Furthermore, grid-tagging 
analysis software is at present available in only a few specialist centres, further limiting the 
 71 
clinical applicability of this technique. Research studies have demonstrated a relatively 
good correlation between CMR and echocardiography for calculating E/A ratios using 
VEC-CMR sequences, however, the same problems surrounding the load-dependent nature 
of these indices remains.223-225 
 
1.12.4 Current Guidelines for evaluating left ventricular diastolic function 
 
Currently, invasive cardiac catheterisation remains the gold standard for quantifying left 
ventricular diastolic filling pressures (see Table 1.10), with Doppler echocardiography as 
the non-invasive standard by which left ventricular diastolic function is assessed in most 
cases.   
 
 
Catheter derived Pressures Average (mmHg) Range (mmHg) 
 
PCWP (mean) 
 
9 4-12 
LAP  
      - a wave 
- v wave 
- mean 
 
10 
12 
8 
 
4-16 
6-21 
2-12 
 
LVP   
- peak systolic 
- end diastolic 
         
 
130 
8 
 
90-140 
5-12 
 
Table 1.10. Normal Intracardiac Pressures.226 
In the absence of mitral valve disease and pulmonary arterial hypertension, mean 
pulmonary capillary wedge pressure, mean left atrial pressure and left ventricular 
end-diastolic pressure approximate each other. 
PCWP, pulmonary capillary wedge pressure; LAP, left atrial pressure; LVP, left ventricular pressure. 
 
 
Due to the increased prevalence of diastolic heart failure, and recognition of its prognostic 
implications the joint EAE and ASE writing group have recently stated that “the assessment 
of left ventricular diastolic function and filling pressures is of paramount clinical 
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importance”.14  Increasing evidence surrounding the use of tissue Doppler E/Em ratios to 
estimate left ventricular filling pressures has lead the EAE/ASE joint task force to recently 
publish revised guidelines for assessing LV diastolic function (these new guidelines were 
published following recruitment completion of this thesis study population).14  When using 
E/Em calculations, the new EAE/ASE guidelines recommend Em is recorded using pulsed-
wave tissue Doppler with a sweep-speed of 50-100mm/s at end-expiration. For the 
assessment of global diastolic function acquisition, measurement and averaging of tissue 
Doppler signals from a minimum of two sides (the septal and lateral sides) of the mitral 
annulus is recommended, to minimise the effects of regional wall motion abnormalities on 
these velocities.14,227  
 
There are several situations in which E/Em may not provide an accurate representation of 
LV diastolic filling pressure.  Firstly, Em is usually reduced in patients with mitral stenosis, 
significant mitral annular calcification, surgical mitral rings and mitral prostheses. 
Secondly, peak mitral E wave is elevated in patients with moderate to severe primary mitral 
regurgitation and normal LV relaxation, due to increased flow across the regurgitant mitral 
valve. Both these situations may lead to a falsely elevated E/Em ratio.14   Finally, E/Em 
does not increase in patients with constrictive pericarditis despite the presence of elevated 
filling pressures. In constrictive pericarditis annulus paradoxus may occur – whereby E/Em 
becomes inversely proportional to the severity of the constriction and degree of elevation of 
the LVEDP. This is because of an increase in Em which is believed to be due to relative 
preservation of LV longitudinal expansion compensating for the limited lateral and 
anteroposterior diastolic excursion.228  In these situations, E/Em should not be used to 
estimate LV diastolic filling pressure. 
 
A recent paper, published since completion of our study recruitment, suggests E/Em may 
not provide accurate assessment of pulmonary capillary wedge pressure (a surrogate marker 
of LAP and LVEDP) in the structurally normal heart.229  Although in general terms E/Em is 
relatively independent of haemodynamic loading conditions, in the normal heart Em is 
related to preload and responds to changes in LAP.  This was demonstrated by Masutani et 
al in normal experimental animals where E/Em was demonstrated to actually decrease, not 
increase, in response to massive fluid loading.229  A further study by Mullens at al, also 
published since completion of our study recruitment, failed to demonstrate a clear 
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relationship between E/Em and pulmonary capillary wedge pressure in patients with severe 
LV systolic impairment (LVEF≤30%) leading the research group to conclude that tissue 
Doppler E/Em was not reliable in predicting LV filling pressures in advanced systolic heart 
failure.16  These later studies, in conjunction with the exclusion criteria above, now call into 
question the accuracy of echocardiographic E/Em ratios for the quantification of LV 
diastolic filling pressures in routine clinical practice. 
 
Based on a meta-analysis of current research, the new revised EAE/ASE guidelines14 
recommend a differing stepwise approach to assessing diastology in patients with preserved 
and impaired left ventricular systolic function as shown in Figures 1.31 and 1.32. 
 
 
 
Figure 1.31. EAE/ASE diagnostic algorithm for the estimation of left 
ventricular filling pressures in patients with normal LVEFs.14 
A, mitral A wave associated with left atrial contraction; Ar-A, the time difference between the 
pulmonary vein Ar wave duration and the mitral A-wave duration; Av, average; E, peak early mitral 
inflow velocity; e’, mitral annular early diastolic relaxation velocity; IVRT, isovolumic relaxation time; 
LA, left atrial; LAP, left atrial pressure; Lat, lateral; PAS, pulmonary artery systolic pressure; TE-e’, 
the time interval difference between QRS onset and E , and QRS onset and e’. 
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Figure 1.321. EAE/ASE diagnostic algorithm for the estimation of left 
ventricular filling pressures in patients with impaired LVEFs.14 
A, mitral A wave associated with left atrial contraction; Ar-A, the time difference between the 
pulmonary vein Ar wave duration and the mitral A-wave duration;; D, pulmonary venous diastolic 
flow velocity; E, peak early mitral inflow velocity; e’, mitral annular early diastolic relaxation velocity; 
IVRT, isovolumic relaxation time; LA, left atrial; LAP, left atrial pressure; Lat, lateral; PAS, 
pulmonary artery systolic pressure; S, pulmonary venous systolic flow velocity; TE-e’, the time 
interval difference between QRS onset and E , and QRS onset and e’; Vp, flow propagation 
velocity. 
 
 
1.12.5  Concept behind Study 3: VEC-CMR for the estimation of left ventricular end-
diastolic pressure 
 
CMR is now the accepted reference standard for the quantification of left ventricular 
systolic function.  In the future, if CMR is to fulfil it’s potential as a “one-stop” imaging 
modality for anatomical and functional imaging of the heart, an accurate, reproducible and 
clinically applicable method of quantifying left ventricular diastolic function needs to be 
developed. 
 
VEC-CMR imaging sequences are part of all standard clinical CMR imaging packages and 
can be analysed off-line with standard proprietary software. The concept behind Study 3 of 
this thesis was that VEC-CMR could be used to assess left ventricular diastolic function.  
We hypothesized that we could modify the amplitude of the bipolar field gradient used in 
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phase encoded velocity mapping sequences to enable early tissue relaxation velocities of 
the basal left ventricular myocardium (Em) to be recorded and measured in a manner 
analogous to tissue Doppler echocardiography techniques. A standard VEC-CMR sequence 
would then be used to record the early peak mitral inflow velocity (E). The feasibility of 
using VEC-CMR to detect early diastolic relaxation abnormalities would then be assessed 
by comparing CMR-derived Em with Em values recorded using pulsed-wave tissue 
Doppler. The VEC-CMR sequences would then be used to calculate an E/Em ratio which 
will be compared to LVEDP measured during cardiac catheterisation in subjects exhibiting 
a wide range of LVEF’s. We aimed to establish if VEC-CMR E/Em could be used as a 
surrogate measure of LVEDP. The overall aim was to create a novel, accurate and user-
friendly method of assessing left ventricular diastolic function by cardiac magnetic 
resonance imaging. 
 
1.13   THE NON-INVASIVE ASSESSMENT OF RIGHT VENTRICULAR  
          FUNCTION 
 
1.13.1 The prognostic importance of right ventricular function 
 
Prognostic studies have confirmed that RV function is a major determinant of morbidity in 
both heart failure230,231 and pulmonary disease,232,233 with poor outcome in patients with 
impaired RV long axis function and associated vena cavae and right atrial dilation.230,234-236 
Since RV function has been shown to be a sensitive marker of exercise tolerance and 
outcome in a number of cardiac syndromes, identifying the most sensitive markers of RV 
dysfunction is of immense clinical importance.230 
 
1.13.2 Volumetric assessments of global right ventricular systolic function: 
 
By Cardiac Magnetic Resonance imaging 
 
There is no “gold standard” for the quantification of RV systolic function. However, as 
CMR volumetric assessment of the cardiac ventricles is not limited by the anatomy of the 
thorax or subject to geometric limitations, Simpson’s method of discs by CMR for the 
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quantification of RVEF is largely considered to be the non-invasive reference standard for 
accurately assessing RV systolic function.  The two most commonly used RV structure and 
function acquisition protocols, endorsed by the Society for Cardiac Magnetic Resonance 
imaging (SCMR), include steady state free precession cine imaging in the RV short axis 
and trans-axial orientations,237 although other RV image acquisition protocols are 
available.238  
  
By 3D Echocardiography 
 
During the recruitment period of this study, 3DE RV volume and ejection fraction 
quantification software was not commercially available.  Since completion of this project 
3DE software has been developed and pooled data from a few small single centre studies 
and one larger study suggest the assessment of RVEF is feasibley by 3DE, using either the 
3D disc summation or apical rotational methods, with a lower reference limit for RVEF of 
44%.239 Van der Zwaan240 and others241-243 have reported intermodality discordance 
between CMR and 3DE for assessing RV function with RV volumes being underestimated 
by 3DE when compared to CMR.  This is believed to be due to the lack of precise 
endocardial border definition by RT3DE, which in turn is due to a combination of 1) poor 
visualisation of the anterior RV wall segments by RT3DE, 2) the presence of the abundant 
RV trabeculae and 3) the variation in the definition of the RV basal regions and RVOT. 
Furthermore, RV dysfunction is often secondary to pulmonary disease and pulmonary 
hypertension.  Echocardiographic windows, especially RV windows, are often more 
difficult in patients with pulmonary disease. Due to differing 3DE RVEF quantification 
methodologies, limited normative data and a paucity of data for patient cohorts with 
significant RV dilatation and dysfunction, at present the American Society of 
Echocardiography (ASE)/ European Association of Echocardiography (EAE)/ Canadian 
Society of Echocardiography (CSE) 2010 joint guidelines for assessing the right heart, do 
not endorse the use of 3DE for the diagnosis of RV dysfunction in clinical practice.37 
 
By 2D Echocardiography 
 
The complex geometry of the RV and its anatomical relationship to the LV in addition to 
the limited 2DE views obtainable of the RV means it is not possible to accurately measure 
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RV volumes using 2DE. Although biplane Simpson’s rule and area-length methods have 
been used to quantify RVEF in past research studies, due to multiple geometric 
assumptions, these methods are inherently inaccurate. Volumetric assessment of RVEF by 
2DE is therefore not recommended by the ASE, EAE or CSE.37 
 
1.13.3  Non-volumetric assessments of global right ventricular systolic function 
 
Due to the limited availability of CMR, 2DE remains the first line imaging modality for 
assessing RV function. For the reasons described above, volumetric assessment of RV 
systolic function is not recommended. As a result a visual “eyeball” assessment of RV 
function remains the 2DE standard in clinical practice by which the RV is assessed. This 
method is only semi-quantitative.  Furthermore Miller and colleagues have elegantly 
demonstrated the high and disparate inter-observer variation in the visual assessment of the 
RV.244  In an era where complex multi-model imaging technologies are available, and the 
diagnosis and prognostic importance of RV dysfunction is now well recognised, such a 
subjective assessment of RV function is clearly suboptimal. The need for quantitative 2DE 
measures of RV performance, has recently led to the development of several non-
volumetric indices of RV systolic function using M-Mode, Doppler, tissue Doppler and 
myocardial deformation echocardiographic imaging techniques.  A variety of small single 
centre studies have demonstrated correlation of these techniques with alternative cardiac 
imaging modalities including CMR, nuclear ventriculography and right heart 
catheterisation in addition to providing independent prognostic information.243,245-255  In 
response, the ASE, in conjunction with the EAE and CSE, published in 2010, revised 
guidelines for the echocardiographic assessment of the right heart in adults. In this paper, 
they summarize the available non-volumetric indices of RV systolic function from pooled 
data, and recommend that at least one quantitative measure of RV systolic function, for 
which there is normative data available (i.e. fractional area change, tricuspid annular plane 
systolic excursion (TAPSE), peak systolic pulsed wave tissue velocity (PWTDE S’) and 
myocardial performance index (MPI)) be incorporated into the routine echocardiographic 
examination and report in addition to a visual assessment of RV function.37  However, these 
guidelines make no recommendation as to which of these non-volumetric indices of RV 
function should be used. To our knowledge, there have been no head-to-head studies 
comparing these new techniques and currently it remains unclear which technique, if any, is 
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superior to the others and which has the best reproducibility. The differing non-volumetric 
techniques for assessing RV systolic function are discussed below: 
 
 RV Fractional Area Change  
 
The geometric complexity of the RV and its orientation within the thorax prevents accurate 
volumetric quantification of RVEF by 2DE. The percentage change in RV area between 
end systole and end diastole acts as a twoone-dimensional surrogate marker of RVEF. RV 
area is measured in end diastole and end systole from an optimised apical four chamber 
view, by tracing the RV endocardial border along the RV free wall from the lateral 
tricuspid annulus to the apex, from the apex along the interventricular septum to the medial 
tricuspid annulus, and from medial to lateral sides of the tricuspid annulus. The RV 
fractional area change (FAC) is then calculated as:  
 
Equation 1.8. Calculating RV fractional area change37 
 
RV FAC (%) = RV ESA    x 100                     where: ESA=end systolic area 
                           RV EDA                                          EDA=end diastolic area 
 
RV FAC has been shown to correlate with RVEF by CMR, and the ASE/EAE recommend 
a lower normative reference value of 35%.37 
 
RV Myocardial Performance Index 
 
The myocardial performance index (MPI) is a well described Doppler derived index that 
incorporates assessment of systolic and diastolic function and is calculated by the equation: 
MPI= (IVCT + IVRT)/ET.  As myocardial function declines, ejection time is shortened and 
the isovolumic contraction and relaxation periods are lengthened.  MPI is therefore 
inversely proportional to ventricular function.  The use of the MPI as a surrogate marker of 
LV performance is now validated across a range of cardiac conditions.257-265  MPI is 
independent of heart rate and LV geometry.  Furthermore its value as a prognostic indicator 
of cardiac outcome is now recognised.  More recently however, Lavine at al have 
demonstrated that MPI is load dependent and this is seen as a significant limitation to the 
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use of the technique as a prognostic indicator of LV function.266,269  Paradoxically, the 
afterload dependency of the MPI, seen as a limitation in LV studies, may prove 
advantageous when applied to the RV. RV dysfunction is commonly secondary to 
conditions causing pulmonary hypertension.  In practical terms, the echocardiographic 
assessment of RV function should always be accompanied by the non-invasive estimation 
of pulmonary artery systolic pressure (PASP). Currently this is achieved by measuring the 
maximal tricuspid regurgitation (TR) jet velocity and calculating the TR pressure gradient 
using the modified Bernouilli equation.  However, a substantial proportion of individuals 
have insufficient TR to enable TR velocity measurement and hence PASP estimation. It is 
possible that the afterload dependency of the MPI means that when applied to the RV, 
changes in the RV MPI is a reflection of both RV performance and PASP and this warrants 
further investigation. The RV MPI has been shown to have prognostic value in patients 
with pulmonary hypertension and changes in RV MPI correlate with change in clinical 
status in this group.270   
 
The right-sided MPI has now been measured in >1000 normal control subjects across 23 
studies with an upper normative reference limit of 0.40 when measured by pulsed-wave 
spectral Doppler and 0.55 when measured using the tissue Doppler method.37  Although 
RV MPI has been studied in selected patient populations with RV infarction,271 pulmonary 
hypertension,270 hypertrophic cardiomyopathy272 and congenital heart disease,273,274 the use 
of MPI for assessing RV performance in clinical practice in an unselected cohort of patients 
exhibiting a wide range of RVEFs is not well established. A limitation of RV MPI is that it 
is technically more difficult to measure accurately than LV MPI due to shorter RV 
isovolumic relaxation times. Pseudonormalised values may also occur in situations where 
the isovolumic contraction time is shortened due to an acute increase in RV diastolic 
pressure, as occurs in the setting of acute RV myocardial infarction.275 
 
RV MPI can be measured from spectral Doppler patterns of tricuspid inflow and pulmonary 
outflow, or from a pulsed-wave tissue Doppler velocity profile acquired at the lateral 
tricuspid annulus.37  
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RV Strain 
 
The use of myocardial deformation imaging to assess LV systolic function has been 
discussed previously in section 1.11.3.  Global longitudinal strain of the RV and of the RV 
free wall can be measured using 2D speckle tracking software.  Due to the predominant 
long axis contractility of the RV in the normal heart, RV longitudinal strain is greater than 
radial strain.276.277  The use of RV speckle tracking strain to quantify global RV function 
should in theory be highly reproducible due to the semi-automated nature of the analysis 
software, and angle independent.  RV strain has also been shown to be relatively load-
independent.278  In the clinical research setting, myocardial deformation imaging appears 
sensitive enough to discern changes in longitudinal strain values in the right ventricles of 
patients before and after lung transplantation,279 in patients with ischaemic heart 
disease280 and in patients suffering acute pulmonary embolism.281  RV strain analysis may 
therefore be a potentially good method for quantifying RV function in clinical practice. At 
present, due to the lack of normative data, this technique is not recommended by the 
ASE/EAE/CSE for routine clinical use.37 
 
ASSESSMENTS OF TRICUSPID ANNULAR MOTION 
 
Rushmer and Krystal first noted that the RV ejects blood primarily by contraction of the 
walls in the longitudinal axis, drawing the tricuspid annulus towards the cardiac apex.282  In 
healthy adults it has been shown that the tricuspid annulus has the greatest motion along its 
lateral aspect. As a result of these observations several differing measures of tricuspid 
annular motion have been developed as markers of RV systolic function. 
 
Tricuspid annular plane systolic excursion 
 
Tricuspid annular plane systolic excursion (TAPSE) is an M-Mode measure of RV long 
axis function and has been shown to correlate with haemodynamic indices of RV 
function284 and RVEF calculated using radionuclide angiography285 and CMR.286  In a 
study of 900 patients and normal controls a TAPSE ≤1.6 cm had a high specificity, but low 
sensitivity for diagnosing RV systolic dysfunction.287  Furthermore TAPSE has been shown 
to be an independent prognostic indicator in patients with congestive cardiac failure.288  The 
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major advantage of TAPSE is that it is a geometrically independent measure of RV 
function that is quick and easy to perform. Its major limitation is that it is a single plane 
measurement, which like other assessments of tricuspid annular motion may not reflect 
regional changes in RV function.  
 
 
Peak systolic tissue velocity of lateral tricuspid annular motion 
 
Tissue velocity imaging (TVI) is an alternative method of assessing tricuspid annular 
motion.  The peak systolic tissue velocity (S’) of the lateral side of the tricuspid annulus has 
been measured previously with pulsed-wave TVI and shown to correlate with CMR-
derived RVEF.289  A tricuspid annular S’<11.5cm/s has been shown to predict RVEF<45% 
with a sensitivity and specificity of 90% and 85% respectively.290  From pooled data of 
>2000 normal controls across 43 studies the lower reference limit of normal was S’=10cm/s 
for pulsed-wave TVI.37  S’ can also be measured using colour TVI, although the absolute 
value recorded is lower than with pulsed-wave TVI, as colour TVI measures the mean of 
the systolic tissue velocities recorded within the specified region of interest.  Mean annular 
velocities in normal controls average 8.5-10cm/s with lower normative reference limit of 6 
cm/s from pooled studies.37 The main advantages of TVI for assessing RV function include 
the geometric independence of the technique, and the speed and ease with which the TVI 
traces can be acquired. Tissue Doppler velocities of the RV are also relatively independent 
of age.283,291,292  Furthermore S’ of the tricuspid annulus has been shown to be a prognostic 
indicator in patients with congestive heart failure.254,255  In addition to the single plane 
nature of the technique, other limitations of tissue velocity imaging for assessing RV 
function include the Doppler angle dependence of the technique and the fact that tricuspid 
annular tissue velocities may be altered by cardiac loading conditions.293 
 
Tricuspid annular motion during isovolumic contraction: “Isovolumic acceleration” 
 
The three independent physiological components determining the magnitude of RV ejection 
are preload, afterload and myocardial contractility as previously discussed.  Although 
maximal RV elastance is considered the reference standard for measuring RV 
contractility,63 due to the invasive and time-consuming nature of this investigation it is not 
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routinely performed.294  An alternative method for assessing RV contractility is by 
measuring endocardial acceleration by implanting an intracardiac accelerometer into the 
right ventricular wall.295  However, this method too is invasive. Using the principle of 
endocardial acceleration, Vogel and colleagues developed a novel non-invasive technique 
for assessing myocardial acceleration and hence myocardial contractility.246  Isovolumic 
acceleration (IVA) is calculated as the mean of the isovolumic contraction slope on a colour 
tissue Doppler trace recorded from the lateral tricuspid annulus.37  In research studies IVA 
has been shown to be relatively independent of preload and afterload changes within the 
RV, but is heart rate dependent.63,246,293  To date, IVA has been successfully used to assess 
RV function in patients with congenital heart disease and cardiac transplant 
recipients.293,296-298 
 
Tricuspid annular plane systolic excursion by tissue Doppler echocardiography 
 
In addition to velocity and strain information, colour tissue Doppler imaging enables 
assessment of longitudinal myocardial displacement during systole.  Tissue Doppler 
displacement imaging offers a novel method for assessing RV function by assessing 
tricuspid annular excursion in the longitudinal plane during RV systole, i.e. a TDE measure 
of TAPSE. One theorectical advantage of this technique over M-Mode TAPSE is that 
pulmonary valve opening and closure times can be superimposed on the colour TDE 
displacement curve.  This ensures that maximal longitudinal displacement during the 
systolic ejection period is measured in all patients and excludes measurement of post-
systolic motion which does not contribute to RV ejection.  To our knowledge, this potential 
novel method for assessing RV function has not previously been studied. 
 
1.13.4 Concept behind Study 4: Comparison of ten 2DE non-volumetric indices of RV 
systolic function: Correlation with CMR-derived RVEF. 
 
CMR RVEF is the non-invasive reference standard by which RV systolic function is 
measured. CMR enables a true Simpson’s method of discs to be used to quantify RVEF 
from multiple short axis slice sequences without geometric assumptions.  By contrast, 
volumetric assessment of the RV by 2DE is limited by the complex geometry of the RV 
and the limited RV echocardiographic imaging windows.  For this reason, RV FAC, 
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TAPSE, MPI, RV strain, TVI and IVA are being explored for use as new non-geometric 
indices of RV systolic function, to be used in conjunction with visual assessment. Recent 
revised ASE/EAE/CSE guidelines recommend the use of at least one quantitative measure 
of RV systolic function in addition to a visual assessment of RV function to be incorporated 
into routine echocardiographic examination reports.37 However, these guidelines make no 
recommendation as to which non-volumetric index of RV function is superior to the others. 
Although all show promise as adjunctive measures of RV function, direct comparison of all 
these techniques has to date, not been performed in the heterogeneous population of 
patients seen in clinical practice.  Furthermore there is a paucity of data comparing the 
reproducibility of these methods in patients exhibiting a wide range of RV ejection 
fractions.  In addition to M-Mode TAPSE, MPI, RV strain, TVI and IVA, we believe 
TAPSE measured using tissue Doppler displacement imaging, to be a potentially new 
method of assessing RV function which has not been previously described.   
 
The concept behind study four of this thesis was therefore to directly compare the use of 
FAC, M-Mode TAPSE, TDE TAPSE, MPI, 2D strain, TVI and IVA for assessing RV 
function by measuring the correlation of these techniques against CMR-derived RVEF as 
the reference standard. 
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CHAPTER 2: AIMS 
 
2.1  AIMS OF THESIS 
 
The aims of this thesis were: 
1) to explore the use of novel imaging methods to improve non-invasive quantification 
of resting global left and right ventricular function in patients exhibiting a broad 
spectrum of ventricular function and 
2)  where appropriate, to assess intermodality agreement between echocardiography 
and cardiac magnetic resonance imaging techniques. 
 
2.2   SPECIFIC AIMS OF THIS THESIS 
 
2.2.1  Study 1: Left ventricular systolic function – Speckle tracking Strain 
 
• To explore the clinical utility of 2DE speckle tracking strain imaging for 
quantifying global LV systolic function by comparing it to CMR LVEF as the 
reference standard, in a heterogenous cohort of patients as seen in clinical practice. 
• To use regression analysis to compare the accuracy of the 2D strain derived “global 
strain score” (GSS) against 3DE LVEF and 2DE Simpson’s Rule LVEF, indexed 
against CMR LVEF as the reference standard. 
• To compare the reproducibility of the 3 echocardiographic techniques. 
• To develop a regression equation to enable GSS to be converted into a LVEF 
equivalent score. 
• To validate this regression equation in a second cohort of patients. 
 
2.2.2 Study 2: Left ventricular systolic function – Regional Wall Motion Score Index 
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• To explore the clinical utility of using a modified 16-myocardial segment regional 
wall motion scoring index (RWMSI) to calculated LVEF by comparing it to CMR 
LVEF as the reference standard. 
• To use regression analysis to compare the accuracy of RWMSI LVEF against 2DE 
Simpson’s LVEF, indexed against CMR LVEF as the reference standard. 
• To compare the correlation and intermodality concordance of both RWMSI and 
Simpson’s rule against CMR LVEF in patients with normal and impaired LV 
systolic function. 
• To compare the reproducibility of these techniques. 
 
2.2.3 Study 3: Left ventricular diastolic function – VEC CMR for estimating 
LVEDP 
 
• To compare E/A ratios recorded using VEC CMR against Doppler 
echocardiography. 
• To explore the clinical utility of using VEC CMR to record LV myocardial tissue 
velocities, by comparing them to Em velocities recorded by pulsed-wave tissue 
Doppler echocardiography. 
• To explore the clinical utility of using CMR to estimate left ventricular filling 
pressure by comparing VEC CMR E/Em ratio to LVEDP recorded during cardiac 
catheterisation in patients with normal and impaired LV systolic function 
• To establish the reproducibility of this technique. 
 
 Study 4: Right ventricular systolic function – Non-volumetric echo indices of 
RV   
2.2.4       function 
• To perform a head-to-head comparison of ten 2DE non-volumetric indices of global 
RV function, indexed against CMR RVEF as the reference standard in a 
heterogeneous cohort of patients as seen in clinical practice. 
• To assess receiver-operator characteristics and establish normative cut-off values 
for the RV indices which do not have previously published normative values. 
• To assess the reproducibility of the techniques. 
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• To use regression analysis to determine which of the ten 2DE techniques is the most 
accurate when compared to CMR. 
 
 
CHAPTER 3 
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CHAPTER 3: METHODS 
 
3.1   GENERAL 
 
The research studies were approved by the Regional Ethics committee and Wakefield 
Ethics board, South Australia. Study volunteers met with the recruiting cardiologist, Dr 
Duncan, who explained the study protocols to the patients.  Patient information sheets were 
also provided. Written informed consent was obtained. 
 
3.2   STUDY DESIGN 
 
For all ventricular function studies, the aim was to study the clinical usefulness of the new 
imaging methods across a broad-spectrum of ventricular function. This was achieved by 
recruiting patients from cardiac catheterisation lists, cardiology outpatient clinics and 
clinical echocardiography lists. 
 
Study subjects underwent CMR imaging and echocardiography sequentially within two 
hours of each other to ensure similar loading conditions of the heart. Patients undergoing 
cardiac catheterisation, had their CMRs, echocardiograms and cardiac catheter procedures 
performed consecutively within three hours of each other in the fasted state to eliminate 
significant differences in cardiovascular loading conditions during the different 
cardiovascular imaging tests. 
 
Patients were included in the studies if they were in sinus rhythm and had no contra-
indications to CMR. Patients were excluded from the LV systolic function studies if they 
had an atrial dysrhythmia, a contra-indication to CMR or poor endocardial wall definition 
as defined by the inability to assess ≥2 AHA myocardial LV segments. Patients were 
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excluded from the LV diastolic function study if they had an atrial dysrhythmia, a contra-
indication to CMR, moderate-severe mitral valve disease, significant mitral annular 
calcification, a surgical mitral ring, a mitral prosthesis or pericardial constriction. Patients 
were excluded from the RV function studies if they had a contra-indication to CMR, a 
tricuspid valve prosthesis or surgical ring, or poor RV echocardiographic images as 
assessed in the apical 4-chamber view of the heart. 
 
3.3   CARDIAC CATHETERISATION PROTOCOL 
 
3.3.1   Left heart catheterisation 
 
All patients undergoing invasive assessment of left ventricular filling pressures had a 
clinical indication for left heart catheterisation (LHC). Patients were admitted in the fasted 
state and LHC was performed aseptically using the Judkins technique. A fluid-filled 
catheter was placed in the left ventricle after retrogradely crossing the aortic valve. Left 
ventricular filling pressures were then recorded over three or more cardiac cycles in paused 
respiration.  Filling pressures were recorded prior to left ventriculography and coronary 
angiography to ensure non-ionic contrast media did not influence the subsequent pressure 
waveform recordings.  Left ventriculography and coronary angiography then proceeded in 
the standard way.299  
 
LVEDP was defined as the pressure after atrial contraction just before LV systolic pressure 
rise (Figure 3.1).300  This is usual clinical practice, as previously described.  
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         LVEDP 
Figure 3.1.  Recording LVEDP from a fluid-filled catheter trace 
3.3.2  Limitations of the technique 
 
A number of potential errors can occur when intracardiac pressures are measured using a 
fluid-filled catheter system.  Distortion of the output signal can occur as a result of the 
pressure damping characteristics of the system. Another potential source of error can occur 
if the system has not been carefully calibrated against a known pressure to establish a zero 
reference point at the start of the procedure. Other potential sources of error include 
catheter whip artifact and catheter impact artifact. 
 
In this study, the LHC procedures were not performed by the research team, but by the 
clinical cardiologist for clinical indications.  As part of the research protocol, the clinicians 
were asked to take all reasonable measures to minimise pressure damping, ensure correctly 
zeroed transducers and minimise other potential sources of error. 
 
The use of micromanometer catheters can reduce the error in recording invasive left 
ventricular pressure measurements.  These catheters have a pressure transducer mounted at 
their tip, have higher natural frequencies and more optimal damping characteristics because 
the interposing fluid column is eliminated.  The pressure waveform is less distorted and 
they have a decreased incidence of catheter whip artifact.  At the outset of this study we 
aimed to correlate non-invasive estimation of LVEDP recorded using velocity-encoded 
CMR against LV pressure recordings made using a 4F Millar micromanometer-
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tipped catheter system.  The initial aim was to use the micromanometer catheter to measure 
LV pressure, from which its first-time derivative, LV+dP/dtmax, would be determined 
(using the catheterization laboratory polygraph).301 To eliminate the effects of minor 
fluctuations in heart rate on LV+dP/dtmax, patients would be subjected to continuous 
baseline atrial pacing, slightly faster than the spontaneous heart rate, via a bipolar pacing 
electrode inserted either into the high right atrium or the coronary sinus. Cardiac output 
would be determined by the Fick method.301  Mechanical restitution curve construction 
would comprise insertion of an atrial premature stimulus following every eight beats of 
baseline atrial pacing at progressively shorter test pulse intervals (TPI), until atrial/AV 
nodal refractoriness was attained. The LV+dP/dtmax would be determined at each TPI and 
expressed as a percent of that observed at baseline. The TPI would be expressed as a 
percent of baseline atrial pacing cycle length. This is well-validated research technique for 
assessing load independent left ventricular function.301  Unfortunately due to the expense, 
fragility and added procedural times of these micromanometer catheter systems their 
subsequent use for this project was not feasible.  
 
In addition to the above reasons, in clinical practice LVEDP is most commonly recorded 
using fluid-filled catheter systems.  Our aim was to find a clinically applicable non-invasive 
measure of LVEDP using velocity-encoded CMR.  Correlation of non-invasive measures of 
LVEDP against the most common clinically utilised invasive measure of LVEDP was 
therefore more easily applicable and appropriate. 
 
3.4   CARDIAC MAGNETIC RESONANCE IMAGING PROTOCOLS 
 
General imaging methods and the use of standard imaging sequences are described below. 
The specific imaging methodologies used in each study are described in detail in the 
relevant chapters. 
 
3.4.1   Left ventricular systolic function protocol 
 
All CMR studies were performed using a 1.5T MRI scanner (Siemens Sonata, Erlangen, 
Germany) and a phased array surface coil. Long axis reference views were used for 
positioning the perpendicular LV short axis slices from the level of the mitral annulus to the 
 92 
LV apex.  Short axis images were obtained with prospectively ECG-gated TrueFISP (Fast 
Imaging with Steady-State Free Precession) sequences at 6mm slice thickness. Acquisition 
time was 90% of the RR-interval, image matrix 256 X 150, field of view 380 mm, 
repetition time 52.05 ms, echo time 1.74 ms, flip angle 70°, and 12 to 17 heart phases were 
acquired per repetition time interval. All images were acquired during 8 to 10 second 
breathholds and stored digitally for offline analysis of LV function. 
 
Left ventricular analysis was performed off-line using a proprietary software programme 
(Argus software, Siemens Medical Solutions, Germany). Short-axis LV endocardial and 
epicardial contours were manually traced in end-diastole (start of R-wave) and in end-
systole (smallest cavity area) (Figure 3.2).  Papillary muscles and trabeculations were 
excluded from the ventricular volume and were included if contiguous with the myocardial 
mass.  The basal slice was selected as the slice where the blood volume was surrounded by 
>50% of ventricular myocardium. The end-diastolic and end-systolic cavity surface areas 
were then summed and end-diastolic (EDV) and end-systolic (ESV) volumes calculated by 
multiplying with interslice intervals as per Simpson’s method of discs. LVEF was 
calculated as LVEF=((EDV-ESV)/EDV) x 100% (Figure 3.2).22 
 
 
 
 
 
 
  
 
 
Figure 3.2. Tracing LV endocardial and epicardial contours and calculating 
LV volumes and LVEF using CMR Argus analysis software. 
 
 
3.4.2  Right ventricular systolic function protocol 
 
The right ventricle was imaged in the short axis orientation using steady-state free 
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precession sequences in a similar manner to the LV structure and function protocol. This is 
one of the two RV imaging protocols endorsed by the Society of Cardiac Magnetic 
Resonance Imaging.237  Short-axis RV endocardial contours were traced manually in end-
diastole (start of R-wave) and in end-systole (smallest cavity area). Trabeculations were 
included in the ventricular volume.  In the basal slice, both in end-diastole and end-systole, 
if the pulmonary valve was visible, only the portion of the right ventricular outflow tract 
below the level of the pulmonary valve was included. For the inflow part of the RV, the 
blood volume was excluded if the surrounding wall was thin and not trabeculated as it was 
considered to be in the right atrium. The end-diastolic and end-systolic cavity surface areas 
were then summed and end-diastolic (EDV) and end-systolic (ESV) volumes calculated by 
multiplying with interslice intervals as per Simpson’s method of discs. RVEF was 
calculated as RVEF = ((EDV-ESV)/EDV) x 100% (Figure 3.3). 
 
 
 
 
 
 
Figure 3.3. Tracing right ventricular endocardial contours and calculating RV 
volumes and RVEF using CMR Argus analysis software. 
 
3.4.3  Left ventricular diastolic function protocol  
 
 
VEC-CMR was used to measure early (E) and late (A) transmitral diastolic flow velocities, 
and E/A ratio calculated. The VEC-CMR protocol was then modified and used to record 
peak myocardial tissue velocities from the basal segments of all six walls of the left 
ventricle (Em). LVEDP was estimated from the VEC-CMR E/Em ratio in a manner 
analogous to the pulsed-wave tissue Doppler technique used in echocardiography. This 
method is described in detail in chapter 6: LV diastolic function. 
 
 
3.5 THREE DIMENSIONAL ECHOCARDIOGRAPHY IMAGING PROTOCOLS 
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3.4. 
3DE imaging was performed from the apical window with the patient in the left lateral 
decubitus position using a commercial ultrasound system (iE33 intelligent 
echocardiography, Philips Medical Systems, Andover, MA). Pyramidal 3D volume datasets 
were obtained in the apical view using a matrix array transducer.  Gain and compression 
controls were adjusted, and fundamental imaging was used to improve image quality.  
Views were optimized to include the entire LV cavity and walls using 2D biplane, then 
several full volume 3D data sets with a wide field of view were acquired using medium line 
density. The temporal resolution was approximately 20 frames per second. Acquisition of 
the 3D volume dataset was steered electronically without transducer movement. Datasets 
were recorded over several cardiac cycles in held expiration taking care to avoid stitching 
artefact. 
The 3D full volume images were manipulated with commercial software equipped with the 
3DE system (3D QLAB software, Philips Inc.). Each volumetric dataset was displayed in a 
quadrant screen consisting of the pyramidal view and three planar cross sections; 4-
chamber long axis, 2-chamber long axis and a short axis view. The three planar images 
were manipulated using multiplanar reconstruction to select anatomically correct 4- and 2-
chamber views with the largest long axis dimensions (see Figure 3.4A). End diastole was 
marked on the cine-loop as the frame of mitral valve closure and end systole was the frame 
preceding mitral valve opening. LV volumes were then calculated using 3D full volume 
algorithms on the 3DE system (3DQ Advanced, QLAB, Philips Inc.) A semi-automated 
border tracking system was used to create a full-volume 3D endocardial contour from five 
user defined points; four points at the junction of the mitral annulus with the basal septum 
and lateral wall in the 4-chamber view and the basal anterior and inferior wall in the 2-
chamber view, and one point at the cardiac apex.  Border tracking was then manually 
manipulated where required, for optimisation in all three planes. An advanced parallel 
processing algorithm generated 3D wire-mesh endocardial volumes for end diastole and 
end systole and LVEF was automatically calculated (Figure 3.4B).147 
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Figure 3.4. Calculating LVEF using 3DQ-Advanced software. 
Advanced parallel processing enables rapid generation of a full 3D wire mesh 
endocardial volume with minimal operator intervention. Three-dimensional pattern 
matching tracks the mitral annulus and apex over time, providing an “active object” 
motion presentation of the dynamic 3D shape.  This allows 3D borders for the 
endocardial space in each frame to be combined into a smooth beating volume 
with accurate spatial and temporal motion detail. LVEF is then calculated by the 
software from 3D end-diastolic and end-systolic volumes. 
 
 
3.6  TWO-DIMENSIONAL ECHOCARDIOGRAPHY IMAGING PROTOCOLS  
  
All two-dimensional echocardiograms were performed using a Vivid 7 scanner (GE 
Medical Systems, Wauwatosa, WI). All patients were imaged in the left lateral decubitus 
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position with the patients’ left arm raised above the head, taking care to avoid apical 
foreshortening.  Images were acquired in paused respiration (in gentle end expiration 
whenever possible) to prevent excessive translational motion of the heart. Image resolution 
and endocardial border delineation were maximised by optimising the gain, depth and focus 
of each image. Second harmonic imaging was used consistently throughout all studies.  Full 
transthoracic imaging studies were performed on all patients.  For the assessment of global 
left ventricular systolic function, optimal images were acquired in the standard parasternal 
long axis (PSLAX), parasternal short axis (PSSAX), apical four chamber (A4C), apical two 
chamber (A2C) and apical long axis (ALAX) views of the heart as per ASE/EAE 
guidelines.38  For the assessment of LV diastolic function, transmitral E and A velocities 
were recorded using pulsed-wave spectral Doppler as per ASE/EAE guidelines described 
below. Mitral annular peak systolic tissue velocities were recorded and E/Em ratio 
calculated as described below. For the non-volumetric assessment of global RV systolic 
function, optimal images were acquired in the apical-4-chamber view of the heart, and 
tricuspid inflow and pulmonary outflow spectral Doppler traces recorded for all patients. 
 
3.6.1  Quantifying left ventricular systolic function by 2DE 
 
Calculating LVEF using Simpson’s Biplane Method of Discs (Modified Simpson’s Rule) 
 
In this study, LVEF was quantified by 2DE using Simpson’s Biplane method of discs as 
per ASE/EAE guidelines. When calculating left ventricular end diastolic volume (LV 
EDV), end diastole was defined as the frame after mitral valve closure. This is in keeping 
with the ASE/EAE joint guideline for chamber quantification.38  LV EDV was calculated 
by manually tracing the endocardial border, excluding the papillary muscles, in the apical 
four chamber and apical two chamber views.  The basal border of the left ventricle was 
delineated as a straight line, between the insertion of the mitral valve leaflets at the septal 
and lateral mitral annulus in the apical four chamber view and the insertion of the leaflets at 
the inferior and anterior mitral annulus in the apical two-chamber view (see Figure 3.5). 
End systole was defined as the frame preceding mitral valve opening,38 and the left 
ventricular end systolic volume (LV ESV) was calculated by tracing the endocardial border 
in the end systolic frame by the method described in Figure 1.12 and Equation 1.5. The 
automated software then calculated the LVEF as follows: LVEF (%) = (EDV-ESV)/EDV. 
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Figure 3.5. Calculating left ventricular ejection fraction using Simpson’s 
Biplane Method of Discs. The endocardial border of the left ventricle was traced 
as shown in (a) end diastole and (b) end systole in the apical four-chamber view. 
The same process was repeated in the apical two chamber view and the LVEF 
calculated. 
 
 
Quantifying LV systolic function using 2D speckle tracking strain imaging 
 
A regional longitudinal strain score was calculated for each of the AHA 16 segments of the 
LV, from the 3 apical views of the heart, using GE AFI functional imaging software as 
described in detail in chapter 4: LV systolic function Part 1. This information was then used 
to quantify global LV systolic function. 
 
Calculating LVEF from the modified regional wall motion scoring index 
 
A regional wall motion score was applied to each of the 16-AHA myocardial segments of 
the left ventricle based on a visual assessment of radial contractility as described in detail in 
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chapter 5: LV systolic function Part 2. The resultant regional wall motion score index was 
then converted into a LVEF-equivalent score. 
3.6.2   Quantifying right ventricular systolic function by 2DE 
 
Due to the complex geometry of the RV, its anatomical relationship to the LV and the 
limited imaging planes for the RV by transthoracic echocardiography, accurate volumetric 
assessment of RV systolic function is not possible by 2DE. 
 
Ten non-volumetric indices of RV systolic function were assessed using a combination of 
M-Mode, spectral Doppler, tissue Doppler and speckle tracking strain imaging techniques.  
These were 1) M-Mode tricuspid annular systolic plane excursion (TAPSE), 2) Tissue 
Doppler tricuspid annular systolic plane excursion (TDE-TAPSE), 3) RV myocardial 
performance index by spectral Doppler (RV MPI), 4) RV myocardial performance index by 
pulsed tissue Doppler (RV TDE MPI), 5) RV peak systolic myocardial tissue velocity 
measured using pulsed-wave tissue Doppler echocardiography (RV PWTDE S’), 6) RV 
peak systolic myocardial tissue velocity measured using colour tissue Doppler 
echocardiography (RV CTDE S’),  7) RV isovolumic acceleration (RV IVA),  8) RV 
fractional area change (RV FAC), 9) RV “global” strain (RVGS) and 10) RV free wall 
strain (RVFWS). 
 
M-Mode imaging used to assess TAPSE was recorded from the apical 4-chamber view of 
the heart with the pulse sample volume at the junction of the lateral tricuspid annulus and 
RV free wall. M-Mode recording were made taking care to ensure correct cursor alignment 
with minimal angulation and a sweep speed of 100cm/s. Pulsed-wave (PW) spectral 
Doppler recordings of tricuspid inflow and pulmonary outflow were made from the apical-4 
chamber view and parasternal short axis view respectively, ensuring correct Doppler 
angulation and a sweep speed of 100cm/s. These measures were subsequently used to 
calculate RV MPI. The PW TDE RV myocardial peak systolic tissue velocity (S’) was 
recorded from the apical 4-chamber view of the heart with the pulse sample volume at the 
junction of the lateral tricuspid annulus and RV free wall. PW TDE recordings were made 
taking care to ensure Doppler angulation of ≤20 degrees, with a sweep speed of 100cm/s. 
S’ was defined as the peak systolic deflection, after the isovolumic contraction spike, from 
the PW tissue velocity trace. This PW tissue velocity trace was also used to measure RV 
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TDE MPI. Colour tissue Doppler images of the right ventricle were acquired from the 
apical 4 chamber views with frame rates ≥100 frames/sec and pulse repetition frequencies 
between 500 Hz to 1 KHz.  Three consecutive beats were stored and analysed during post 
processing. A continuous-wave Doppler tracing of pulmonary outflow was recorded 
through the pulmonary valve from the parasternal short axis view to enable event timing 
during post-processing. Pulmonary valve opening and closure times were recorded by 
placing event-timing markers at the start and end of the pulmonary outflow spectral 
envelope (Figure 3.6A).   The recorded pulmonary valve opening and closure times were 
then superimposed on the tissue velocity/time graph during post processing (Figure 3.6B).  
 
 
 
Figure 3.6.  Measuring the event timing intervals. 
Event timing markers for pulmonary valve opening (PVO) and closure (PVC) are 
applied at the start and end of pulmonary outflow spectral Doppler trace. These 
event timing markers are superimposed onto the tissue velocity-time graph during 
post processing. 
 
 
Myocardial tissue velocity and tissue displacement parameters were then measured from 
the colour images during further post processing.  The tissue Doppler sample volume, also 
known as the ROI (region of interest) marker was placed at the junction of the basal right 
ventricular free wall with the lateral tricuspid annulus, and the ROI was manually tracked 
throughout the cardiac cycle. CTDE S’ and RV IVA indices were calculated from this 
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position on the subsequent colour tissue velocity imaging graph. TDE TAPSE was recorded 
from the same position on the subsequent colour tissue displacement graph. RV “global” 
strain and RV free wall strain were quantified by speckle tracking strain using GE AFI 
automated functional imaging software.  Detailed descriptions of each technique are 
discussed in chapter 7: RV systolic function. 
 
3.6.3  Quantifying left ventricular diastolic function by 2DE 
 
Mitral filling patterns and E:A ratio 
 
Mitral inflow patterns were recorded using pulsed-wave Doppler from the apical four-
chamber view, with the pulsed sample volume placed at the mitral leaflet tips as per 
ASE/EAE guidelines.14 Peak mitral E wave velocity was measured as the maximal modal 
velocity recorded during early diastole (see Figure 3.7). Peak mitral A wave velocity was 
measured as the maximal modal velocity recorded during late diastole as shown in Figure 
3.7. E:A ratio was then calculated. 
 
 
 
Figure 3.7 Calculating the E:A ratio. In this example the peak E wave and A 
wave velocities were identical at 1.48m/s giving a ratio of 1:1. 
 
Mitral annular peak early diastolic relaxation velocities 
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The mitral annular early diastolic relaxation velocity, Em, provides an index of left 
ventricular relaxation that is independent of preload.5,194,302  In addition to providing load-
independent information, Em can be used to differentiate between normal and 
pseudonormal filling patterns.42 
 
Mitral annular velocities were recorded from the apical window using pulsed-wave mode.  
The gain and filters were set low and the frame rate optimised.  The pulsed-wave sample 
volume was placed at the junction of the left ventricular wall and mitral valve annulus on 
the septal side of the mitral valve.  The resultant tissue Doppler velocity profile was then 
acquired with a sweep speed of 100mm/s. The process was then repeated at the lateral, 
anterior, inferior and posterior and anteroseptal sides of the mitral valve annulus. The peak 
Em velocity was measured from the pulsed-wave tissue Doppler profile as shown below in 
Figure 3.8. The Em value recorded from the septal and lateral sides of the mitral valve 
annulus are the positions most often quoted in the literature and are subsequently referred to 
as Em(S) and Em(L) respectively. As we wished to compare myocardial tissue early 
diastolic relaxation velocities with diastolic tissue velocity traces derived using VEC-CMR 
sequences, we measured mitral annular peak early diastolic relaxation velocities from all 
sides of the mitral annulus in the apical views. 
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Figure 3.8. Example of a pulsed-wave tissue Doppler velocity trace of the 
mitral annulus. The peak mitral annular early diastolic relaxation velocity (Em) 
was recorded as shown. In this example taken from the septal mitral annulus of a 
patient with dilated cardiomyopathy, Em = 5cm/s which is significantly reduced. 
Calculating the left ventricular end diastolic filling pressure 
 
The ratio of transmitral E wave velocity to mitral annular tissue velocity has been shown to 
correlate with both pulmonary capillary wedge pressure and left ventricular end diastolic 
filling pressure (LVEDP) in various patient cohorts.4,5,13,303   
 
 
 
The revised EAE guidelines for assessing LV diastolic function recommend estimating 
LVEDP from E/Em ratios where Em is measured from either the septal side of the mitral 
anulus Em(S), the lateral side of the mitral annulus Em(L), or where Em is the averaged 
recordings from both septal and lateral sides of the mitral annulus Em(S+Lav).14 We 
calculated E/Em(S) by dividing the peak E wave velocity by Em recorded at the septal 
mitral annulus (Figure 3.9).199 We then repeated this ratio calculation using E/Em(L) and 
E/Em(S+Lav). As 12 of our 19 study subjects with impaired LV systolic function had 
ischaemic heart disease with regional wall motion abnormalities, we also calculated the 
E/Em ratio by dividing the peak E wave velocity by Em averaged from recordings at all 6 
sides (septal, lateral, anterior, anteroseptal, inferior and posterior) of the mitral annulus 
(E/Em(6av).) This was to ensure the E/Em ratios were not significantly influenced by 
regional changes in diastolic relaxation. Finally, as the anteroseptal side of the mitral 
annulus is in continuity with the aortic annulus in the apical long axis view, we also 
calculated the E/Em ratio from the remaining 5 sides of the mitral annulus, with the 
exclusion of the anteroseptum (E/Em(5av)). 
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Figure 3.9 Estimating left ventricular end diastolic pressure from E/Em ratio. 
E, peak velocity of early mitral inflow; Em, peak mitral annular early diastolic relaxation velocity. 
 
 
3.7  STATISTICAL ANALYSES 
 
All data sets were assessed for normality using the Kolmogorov-Smirnov test when the 
sample size was <50 and the Shapiro-Wilk test when the sample size was ≥50. Parametric 
data is displayed as mean ± two standard deviations. Non-parametric data is displayed as 
median (first to third interquartile range). 
 
Bivariate correlations were performed using Pearson correlation coefficient for parametric 
data and Spearman correlation coefficient for non-parametric data. For normally distributed 
data sets, different echocardiographic indices of left and right ventricular function were 
compared against each other when indexed against cardiac magnetic resonance imaging as 
the reference standard, using step-wise regression analysis. If data was non-parametrically 
distributed it was transformed where possible and stepwise regression analysis was 
performed to compare different techniques as previously described. If it was not possible to 
transform non-parametric data, then bivariate correlations were performed. 
 
For functional imaging techniques where normative cut-off values have been previously 
published, these values were used to classify patients as having normal or impaired 
ventricular function. Several of the echocardiographic functional imaging techniques 
studied in this thesis have no published normative values. For these techniques, receiver 
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operator characteristics were studied to determine normative threshold values, by indexing 
them appropriately against either CMR LVEF or RVEF, as the reference standards. 
 
 A p value of <0.05 was considered statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
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LEFT VENTRICULAR SYSTOLIC 
FUNCTION - PART ONE 
 
“TWO-DIMENSIONAL SPECKLE TRACKING 
STRAIN FOR THE EVALUATION OF LEFT 
VENTRICULAR SYSTOLIC FUNCTION: A 
COMPARISON AGAINST CARDIAC MAGNETIC 
RESONANCE IMAGING, THREE-DIMENSIONAL 
ECHOCARDIOGRAPHY AND SIMPSON’S BIPLANE 
METHOD OF DISCS” 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: LV SYSTOLIC FUNCTION PART 1 
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4.1  INTRODUCTION 
 
The quantification of LVEF is important for therapeutic and prognostic reasons.303  The 
high spatial resolution of CMR imaging makes it the reference standard for LVEF 
calculation.22  3DE is also an effective methodology for assessment of LVEF. However due 
to limited availability and high costs of CMR and 3DE, 2DE remains the most widely 
utilized imaging modality for LV systolic function. Currently joint ASE and EAE 
guidelines recommend that Simpson’s biplane method of discs remains the preferred 2D 
method for calculating LVEF despite the recognised limitations of this technique.38   
 
In recent years there have been major advantages in 2DE software particularly in the field 
of strain imaging.305-310  Two dimensional speckle tracking strain imaging involves the use 
of a semi-automated endocardial border tracking system to quantify myocardial 
deformation based on the recognition and tracking of unique “speckle” patterns within the 
myocardium. This technique has several theoretical advantages over both volumetric 
assessments of LV function and tissue Doppler strain.  Lagrangian strain measures the 
percentage deformation of the myocardium throughout systole in relation to end diastole as 
the reference point, rather than volumetric changes within the ventricle and therefore 
theoretically should be less affected by cardiac loading conditions than volumetric 
methods.311 The 2D strain automated tracking results in faster analysis times and improves 
reproducibility compared to manual tracking used with tissue Doppler strain. Unlike tissue 
Doppler strain, 2D strain is an angle independent technique which improves accuracy and 
reproducibility and enables strain analysis of all 16 myocardial segments of the American 
Heart Association (AHA) model, thus potentially allowing quantification of global as well 
as regional strain data.306,312  Finally global longitudinal strain has recently been shown to 
confer important prognostic information.313  Stanton et al have recently demonstrated that 
individuals with a global longitudinal strain score ≥-12% had significantly worse survival 
than those with a global longitudinal strain score of ≤-12% (p<0.001).313 
4.2  STUDY AIMS 
 
The aim of this study was to establish a novel 2DE technique to quantify LV systolic 
function by utilising global longitudinal systolic strain data. Furthermore we sought to 
 107 
assess the accuracy and reproducibility of this technique compared to CMR, 3DE and 
biplane Simpson’s rule and whether global longitudinal strain can be used to calculate a 
LVEF equivalent score (LVEFES). 
 
4.3  METHODS 
 
4.3.1  Study Design 
 
Eighty-three patients exhibiting a broad spectrum of LVEF’s (Range 15-79%) were 
recruited from outpatient clinics, elective echocardiography and cardiac catheterisation 
lists.  All study subjects underwent standard 2DE (GE Vivid 7) and 2D speckle tracking 
strain imaging (GE Automated Functional Imaging). LVEF was calculated by 2DE using 
Simpson’s Rule in as previously described.38  A global longitudinal strain score (GSS) was 
calculated by 2D speckle tracking strain as described below. The GSS was correlated 
against Simpson’s rule in all patients to validate the technique. An initial sub-study cohort 
of 33 patients successfully underwent 3DE (Phillips iE33) and CMR (1.5T Siemens Sonata) 
(LVEF range by CMR: 24-73%).  LVEF was calculated by 3DE and CMR in these patients 
as previously described.  The three echocardiographic methods for quantifying LV function 
were then compared against each other using multivariate analysis to establish the 
echocardiographic technique with the closest correlation to CMR-derived LVEF and the 
highest reproducibility. 
 
Linear regression was used to convert the GSS into a measure of LVEF.  A second cohort 
of 20 patients (LVEF range: 12-72%) was then recruited from outpatient clinics, elective 
echocardiography and cardiac catheterisation lists and underwent 2DE and CMR. This 
second cohort of patients was used to validate the regression equation used to convert the 
GSS into a LVEFES.  
 
 
4.3.2  Patient Selection 
 
Patients were included in the study if they were in sinus rhythm and had no 
contraindications to CMR. Patients were excluded if they were in atrial fibrillation, had a 
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contraindication to CMR or had poor endocardial wall definition as defined by the inability 
to accurately visualize ≥2 AHA myocardial segments. Clinical characteristics of the study 
population are shown in Table 4.1. 
 
 
 
Gender (M:F) 
Mean age (yrs) 
Cardiac Diagnosis 
            -     Ischaemic heart disease* 
- Valvular heart disease 
- Dilated cardiomyopathy 
- Pulmonary hypertension 
- Atrial septal defect 
- Other 
- No cardiac diagnosis 
   
21:12 
60±15 
 
18 
3 
1 
4 
1 
1 
5 
 
 
Table 4.1.  Clinical characteristics of the study population (N=33). 
F, female; M, male 
*diagnosed either on coronary angiography, or clinical diagnosis of angina/previous 
myocardial infarction. 
 
 
4.3.3  Imaging Methods  
 
CMR, 2DE and 3DE were performed consecutively, within 2 hours of each other, to ensure 
similar cardiac loading conditions.  
 
Cardiac Magnetic Resonance Imaging 
   
The CMR LV systolic function acquisition protocol was performed as previously described 
in section 3.4.1. 
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3D Echocardiography Imaging 
 
The 3DE LV systolic function acquisition protocol was performed as previously described 
in section 3.5. 
 
2D Echocardiography Imaging 
 
2DE imaging was performed from the apical window with the patient in the left lateral 
decubitus position using a Vivid 7 scanner (GE Medical Systems, Wauwatosa, WI). Depth 
and frame rate were optimized and 2D images recorded of the apical 4-chamber (A4C), 
apical-2chamber (A2C) and apical long axis (ALAX) views of the left ventricle and stored 
for subsequent LV analysis. Harmonic imaging was used consistently throughout each 
study. Speckle tracking strain analysis was performed from standard apical views of the 
heart therefore image acquisition times for 2D speckle tracking strain imaging was the 
same as that of a standard echocardiogram. 
 
4.3.4  Image Analysis 
 
Cardiac Magnetic Resonance 
 
LV volumes were quantified and LVEF calculated by CMR using the method described in 
section 3.4.1. 
 
3D Echocardiography 
 
LV volumes were quantified and LVEF calculated by 3DE using the method described in 
section 3.5. 
 
2D Echocardiography 
 
LVEF was calculated from the A4C and A2C views using Simpson’s biplane method of 
discs as described in section 3.6.1. 38   
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Two-dimensional longitudinal strain was analysed using Automated Functional Imaging 
(AFI) software (GE Medical Systems, Wauwatosa, WI) from the apical four-chamber, 
apical two-chamber and apical long axis views after optimising gain, depth and filter 
settings to ensure optimal endocardial border definition and frame rates. The aortic valve 
closure time in relation to QRS onset was determined from the apical long axis view as 
shown in Figure 4.1. 
 
 
Figure 4.1.  Determining the correct aortic valve closure time using AFI strain 
software. The point of closure of the aortic valve is selected after frame-to-frame 
analysis of aortic valve motion in the apical long axis view (large circle). The aortic 
valve closure time is represented as a green line on the ECG (small circle).  
 
Once the aortic valve closure time has been selected, the endocardial and epicardial borders 
were selected manually. Points are positioned at the junction of the basal walls and mitral 
annulus, and at the apex. The endocardial border tracking system (shown in Figure 4.2) is 
re-positioned manually by selecting the appropriate coloured dots, until the operator was 
satisfied that each myocardial segment was being tracked correctly throughout that cardiac 
cycle. 
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Figure 4.2.  Semi-automated border tracking with AFI 2D Strain Imaging. 
The semi-automated endocardial border tracking system is positioned as shown. 
Once the operator is satisfied that each myocardial segment is being correctly 
tracked throughout the cardiac cycle, the positions are finalised by selecting the 
approve button shown below. 
 
The AFI strain software automatically divides the left ventricle into the standard AHA 
myocardial segments using the 16-segment model as shown in Figure 4.3. 
 
 
Figure 4.3. Segmental distribution of AFI 2D strain imaging. The left ventricular 
walls are automatically divided in to the standard AHA myocardial segments as 
shown. 
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Using the software “quad” function, a peak systolic strain score is automatically calculated 
for each myocardial segment as shown in the bottom left quadrant of Figure 4.4. The top 
right and bottom right quadrants of Figure 4.4 are a graphical representation and parametric 
representation of the same data. A global strain score for the apical image is shown in the 
upper left quadrant of Figure 4.4. 
 
 
 
Figure 4.4. Segmental and global strain results recorded from the apical 4-
chamber view.  A segmental strain score is automatically applied to each 
myocardial segment. A global strain score is also applied to each apical view 
imaged (circled). Note the abnormally low segmental and global strain recordings 
this heart failure patient in comparison to the scores recorded in the normal control 
subject shown in Figure 1.19. 
 
 
The global strain score for each apical view was recorded, and a global strain score for the 
entire left ventricle was calculated as the average of these three recordings as shown in 
Equation 4.1. 
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Equation 4.1. Calculating the Global Strain Score of the left ventricle: 
 
Global Strain Score (LV) = (GS(A4C) + GS(A2C) +GS(ALAX))/3 
 
(GS, global strain; A4C, apical four-chamber view; A2C, apical two-chamber view; 
ALAX, apical long axis view) 
 
The semi-automated border tracking system ensured rapid quantification of 2D strain 
(analysis time <2 minutes per view) thus enabling online calculation of GSS during each 
standard echocardiographic study. 
 
4.3.3   Reproducibility 
 
Interobserver variability in CMR-LVEF, 3DE-LVEF, biplane Simpson’s LVEF and GSS 
were assessed in 10 patients by two independent observers.  These measurements were 
repeated by one observer six months later. 
 
4.3.4   Statistical Analysis 
 
All data sets were tested for normality using the Shapiro-Wilk test when sample size was 
greater than fifty and the Kolmogorov-Smirnov test when it was not. GSS was compared to 
biplane Simpson’s LVEF using bivariate correlation (Spearman correlation coefficient). 
Each echocardiographic technique was correlated against CMR-derived LVEF using 
bivariate correlation (Pearson correlation coefficient). Intertechnique agreement was tested 
through Bland-Altman analyses. Stepwise regression analysis was then performed to 
establish which echocardiographic technique had the strongest correlation to CMR-derived 
LVEF. A regression equation was derived from the results and used to convert the GSS into 
an ejection fraction equivalent score (LVEFES). Inter- and intra-observer variability was 
expressed as the co-efficient of variation, mean bias, limits of agreement and standard 
deviation of the difference for each echocardiographic technique. A value of p<0.05 was 
considered statistically significant. 
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4.4   RESULTS 
 
Eight patients were excluded from the study due to poor endocardial wall definition. One 
patient was unable to complete the CMR scan due to claustrophobia and was excluded from 
the CMR/3DE study arm. Seventy-five patients successfully completed the 2DE validation 
study and thirty-three patients successfully completed the CMR/3DE arm of the study.  
 
4.4.1  Correlation of GSS with Simpson’s LVEF 
 
GSS was compared to LVEF calculated using biplane Simpson’s rule in 75 patients (EF 
range: 15-79%). GSS had a good correlation with biplane Simpson’ rule (p<0.001, 
r=0.768).  Correlation between the two different 2D echocardiographic methods are shown 
in Figure 4.5.  
 
 
Figure 4.5.  Correlation of 2D Speckle tracking strain (Global Strain Score -%) 
with 2DE Simpson’s Rule.  
LVEF, left ventricular ejection fraction; 2DE, two dimensional echocardiography 
 
 
4.4.2 Correlation of GSS, Simpson’s LVEF and 3DE-LVEF with CMR-LVEF 
 
Quantification of global LV systolic function by GSS, Simpson’s-LVEF and 3DE-LVEF 
methods were compared to CMR-LVEF as the reference standard in 33 patients (LVEF 
range: 24-73%). GSS had a moderately-strong correlation with CMR-LVEF (p<0.001, 
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r=0.700) compared to 3DE-LVEF which had a strong correlation with CMR-LVEF 
(p<0.001, r=0.839). GSS had a better correlation with CMR-LVEF then Simpson’s-LVEF 
(p<0.001, r=0.652). Correlation between imaging modalities are shown in Figure 4.6-4.8. 
 
 
 
Figure 4.6. Correlation of CMR-derived LVEF (%) with 3DE-LVEF (%). 
CMR, cardiac magnetic resonance; LVEF, left ventricular ejection fraction; 3DE, three-dimensional 
echocardiography. 
 
 
Figure 4.7. Correlation of CMR-derived LVEF (%) with 2DE Simpson’s Rule 
LVEF (%) 
CMR, cardiac magnetic resonance; LVEF, left ventricular ejection fraction; 2DE, two-dimensional 
echocardiography 
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Figure 4.8. Correlation of CMR-derived LVEF (%) with 2D Speckle tracking 
strain (Global Strain Score -%). 
CMR, cardiac magnetic resonance; LVEF, left ventricular ejection fraction 
 
 
Table 4.2 shows the results of stepwise regression analysis of the three echocardiographic 
imaging modalities against CMR. On stepwise regression analysis, a combined assessment 
using 3DE and GSS, correlated most strongly with CMR-LVEF. Of the 2DE methods, the 
GSS had a significantly stronger relationship to CMR-LVEF than biplane Simpson’s Rule 
(Table 4.3). 
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Stepwise Regression of CMR-derived LVEF vs. 3DE, GSS and Simpson’s Rule 
 
1) 3DE:        T=  5.38, p<0.001 
2) GSS:        T= -2.08, p<0.05 
 
 
      1) 3DE:     R = 0.839 
      1) + 2) 3DE + GSS:  R = 0.860 
 
 
Table 4.2. Stepwise regression analysis of 3DE, GSS and 2DE Simpson’s 
Rule against CMR as the reference standard for the quantification of global 
LV systolic function. 
CMR, cardiac magnetic resonance; GSS, global strain score; LV, left ventricular; 3DE, three-dimensional 
echocardiography; 2DE, two-dimensional echocardiography 
 
 
Stepwise Regression of CMR-derived LVEF vs. GSS and Simpson’s Rule 
 
1)    GSS:               T= -2.74, p<0.01 
2)    Simpson’s :     T=  1.80, p=NS 
 
 
      1)  GSS:     R = 0.735 
 
 
Table 4.3. Comparing 2DE imaging modalities: Stepwise regression analysis 
of GSS and 2DE Simpson’s Rule against CMR as the reference standard for 
the quantification of global LV systolic function. 
CMR, cardiac magnetic resonance; GSS, global strain score; LV, left ventricular; 2DE, two-dimensional 
echocardiography 
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4.4.3  Receiver operator characteristics 
 
The cut-off point for calculating sensitivity and specificity for GSS was determined from 
the ROC curve (Figure 4.9).  Using CMR-LVEF<55% (abnormal LV function was 
considered positive), a GSS of ≥ -17% predicted abnormal LV systolic function with a 
specificity of 84% and a sensitivity of 71%. 
 
 
Figure 4.9.  Receiver operator characteristic curve of global strain score. 
AUC, area under the curve 
 
 
 4.4.4  Calculation of left ventricular ejection fraction and validation of regression   
           equation 
 
From linear regression analysis, the GSS can be converted into a LVEFES using the 
regression equation: LVEFES= -2.28(GSS) + 15.46.  Applying this formula to our patient 
population we confirmed that a GSS less than –17% is associated with a normal LVEF 
(LVEF≥55%) by CMR.  This regression equation was validated in a separate cohort of 20 
patients who were also recruited from outpatient clinics, elective echocardiography and 
cardiac catheterization lists (validation cohort LVEF range:12-72% as measured by CMR).  
Correlation analysis showed similar agreement in the validation group (p=0.001, r=0.683) 
as in the test group (Figure 4.10). Of the patients diagnosed with impaired LV systolic 
function (LVEF<55%) by CMR, 86% were correctly classified by GSS LVEFES. By 
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comparison, 79% were correctly classified as having impaired LVEF by 3DE and only 64% 
were correctly classified using biplane Simpson’s rule. 
 
 
Figure 4.10. Correlation of CMR-derived LVEF (%) with GSS LVEFES (%) in 
the validation cohort of 20 patients. 
CMR, cardiac magnetic resonance; GSS, global strain score; LV, left ventricular ejection fraction equivalent 
score 
 
4.4.5  Acquisition and analysis times 
 
For a technique to have wide spread clinical application it must be easy and quick to 
perform.  As speckle strain analysis is derived from standard apical imaging views of the 
heart, additional image acquisition time over and above that of a standard transthoracic 
study was negligible. Analysis time for the GSS was in the region of 4 minutes. 
 
4.4.6  Reproducibility 
 
Intra- and inter-observer variability for CMR LVEF, 3DE-LVEF, biplane Simpson’s LVEF 
and GSS are expressed as the co-efficient of variation, and as the mean bias, limits of 
agreement and standard deviation of the difference (Table 4.4 and 4.5). The corresponding 
Bland-Altman plots are shown in Figure 4.11-4.14.  
 
 
 
 120 
 
Table 4.4. Intra-observer variability for measurements of global left 
ventricular systolic function. 
CMR, cardiac magnetic resonance; LVEF, left ventricular ejection fraction; 3DE, three 
dimensional echocardiography; SDD, standard deviation of the difference. 
 
 
 
 
Table 4.5. Inter-observer variability for measurements of global left 
ventricular systolic function. 
CMR, cardiac magnetic resonance; LVEF, left ventricular ejection fraction; RT3DE, real 
time three dimensional echocardiography; SDD, standard deviation of the difference. 
 
 
 
 
 
 
Imaging modality used to 
quantify LV function 
% Co-efficient of 
variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
CMR - LVEF (%) 
3DE - LVEF (%) 
Simpson’s LVEF (%) 
Global Strain Score (-%) 
 
2.79% 
4.72% 
3.19% 
2.22% 
 
-0.98 
 1.3 
 0.82 
 0.45 
 
-5.59 to 3.62 
-9.06 to 11.66 
-5.16 to 6.79 
-1.30 to 2.20 
 
2.30 
5.18 
2.99 
0.88 
Imaging modality used to 
quantify LV function 
% Co-efficient of 
variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
CMR - LVEF (%) 
3DE - LVEF (%) 
Simpson’s LVEF (%) 
Global Strain Score  (-%) 
 
3.60% 
5.26% 
6.91% 
3.15% 
 
 1.29 
-0.26 
-0.69 
 0.44 
 
-5.19 to 7.78 
-13.25 to 12.72 
-13.45 to 12.07 
-1.25 to 2.13 
 
3.24 
6.49 
6.38 
0.84 
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Figure 4.11. Bland-Altman Plot of (A) intra-observer and (B) inter-observer 
variation for measuring LV systolic function using cardiac magnetic 
resonance (LVEF %) 
 
 
Figure 4.12. Bland-Altman Plot of (A) intra-observer and (B) inter-observer 
variation for measuring LV systolic function using 3D echocardiography 
(LVEF %) 
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Figure 4.13. Bland-Altman Plot of (A) intra-observer and (B) inter-observer 
variation for measuring LV systolic function using 2DE Simpson’s Rule 
(LVEF %)’ 
 
Figure 4.14. Bland-Altman Plot of (A) intra-observer and (B) inter-observer 
variation for measuring LV systolic function using 2D Speckle tracking strain 
(Global Strain Score - %) 
 
Intra- and inter-observer variability for calculating the GSS was excellent (co-efficient of 
variation = 2.3% and 3.0% respectively). The average time taken for calculating the GSS 
was ≤ 4 minutes. 
 
4.5  DISCUSSION 
 
This study has shown that using 2D speckle tracking strain is a fast, accurate and 
reproducible method for quantifying global LV systolic function. 
 
At the outset of this study we sought to explore the use of speckle tracking strain imaging 
as a novel rapid 2D assessment of global LV function and compare its accuracy against 
other cardiac imaging modalities. The GSS is a novel, reproducible measure of LV function 
with good correlation when compared to with CMR-derived LVEF.  On stepwise 
regression analysis, the GSS had a significantly stronger relationship to CMR-LVEF than 
biplane Simpson’s rule. 
 
CMR has rapidly become the reference standard for assessing cardiac anatomy and 
function. The technique for quantifying LVEF by CMR is highly reproducible as 
demonstrated in table 4.4.and 4.5 above.  However, there remain major limitations to its 
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widespread use due to initial cost and inability of some individuals to enter an enclosed 
space.  Furthermore, patients with severe LV dysfunction may be unable to lie flat for the 
duration of the investigation, or may be contraindicated from undergoing CMR due to the 
increasing prevalence of cardiac resynchronisation therapy and internal cardioverter 
defibrillator devices in this cohort.  Three-dimensional echocardiography measurements 
compare favourably to CMR reference values in this study and others,144-147 however as yet 
3DE is not widely available outside specialist centres. Two-dimensional speckle tracking 
strain, by comparison, now comes as a standard function on most new 2D GE echo 
machines, and is widely available on echo machines by other manufacturers. Both CMR 
and 3DE protocols involve image acquisition and frame averaging over several heart beats. 
Image quality is thus detrimentally affected by respiratory motion artefact, irregular heart 
rhythms and frequent ventricular ectopy. Two-dimensional speckle tracking strain analysis 
is performed on images acquired over a single heart-beat with high temporal resolution, and 
thus in theory may be more accurate in patients with atrial fibrillation, although this 
remains to be determined. 
 
Standard 2DE is widely available, relatively inexpensive and well tolerated.  Its limitation 
is in the 10-15% of patients in whom satisfactory images cannot be obtained due to poor 
echocardiographic windows.  At present, the ASE/EAE recommend Simpson’s rule as the 
preferred 2D method to calculate LVEF.38  This technique requires both the presence of 
good endocardial definition and the absence of apical foreshortening during image 
acquisition. In echogenic subjects and with the introduction of second harmonic imaging in 
the absence of contrast enhancement, inter-observer errors are still significant.  Thomson et 
al showed that the inter-observer variability in calculating the left ventricular end diastolic 
volume (LV EDV), left ventricular end systolic volume (LV ESV) and LVEF can be as 
high as 13%, 17% and 18% respectively.142  Even with the use of both second harmonic 
imaging and contrast enhancement (which is neither practical or feasible for routine use in a 
busy technician-led echocardiography laboratory), inter-observer variability for LV EDV, 
LV ESV and LVEF are 8%, 15% and 6% respectively.142  By contrast, intra- and inter-
observer variability of GSS in this study was 2.3% and 3.2% respectively.  Not only does 
GSS correlate more closely than biplane Simpson’s rule to CMR based quantification of 
LV systolic function, it is more reproducible too. Furthermore it is quick and easy to use, 
and due to the automated nature of the border tracking can be used by echocardiographers 
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of varying experience. The results of our study compliment the results of a recently 
published study by Brown et al314 further strengthening the growing body of evidence that 
2D speckle tracking strain may be a useful alternative for the quantification of global as 
well as regional LV systolic function. 
 
As echocardiography reports are interpreted by imaging specialists, general cardiologists, 
general physicians and trainees alike, it is important that the method used for quantifying 
LV function is easily recognised across all medical specialties. LVEF ubiquitously is the 
convention by which LV function is quantified. Strain imaging however, measures 
myocardial deformation not volumetric changes. We believe it is important that the GSS 
should be converted into a LVEFES that is easily interpreted by all. The GSS, derived 
using GE AFI Strain software may be used to calculate a LVEFES using the equation: 
LVEFES = -2.28(GSS) + 15.46 
 
4.5.1  Study limitations 
 
This study was designed to examine the feasibility of using 2D strain for quantifying global 
LV systolic function. In this study we derived GSS using GE Vivid 7 AFI speckle tracking 
strain software. We cannot comment on the accuracy of 2D strain for quantifying LV 
systolic function using software from other manufacturers. From the results of our study, 
we derived a regression equation to enable us to convert the GSS into a more user-friendly 
and recognisable LVEFES. Preliminary validation of this formula was performed by 
correlating GSS LVEFES against CMR-derived LVEF in a second independent cohort of 
20 patients with encouraging results. However, subgroup analysis in patient subgroups with 
mild, moderate and severe LV dysfunction was not possible due to the small number of 
study patients and this warrants further investigation before use of the GSS for calculating 
LVEF should be introduced into clinical practice.  
 
4.5.2  Conclusion 
 
In centres where CMR and 3DE are not available, the GSS may provide a superior 2DE 
alternative to biplane Simpson’s rule for quantifying global LV systolic function. 
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4.5.3  Future work 
 
Future work should involve repeating this study in a prospective and blinded manner in a 
much larger cohort of patients exhibiting a wide range of LVEF. This would enable 
meaningful sub-group analysis of study subjects with mild, moderate and severe LV 
systolic impairment.  We believe our regression equation should also be tested in a larger 
cohort of patients. Finally, inter-technique concordance needs to be established between 2D 
speckle tracking strain software packages produced by different manufacturers. 
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CHAPTER 5: LV SYSTOLIC FUNCTION PART 2 
 
5.1  INTRODUCTION 
 
The accurate quantification of LVEF is important for the reasons previously discussed. To 
have a wide clinical application, in addition to being accurate and reproducible, the 
technique used to quantify LVEF has to be easy to perform, relatively quick and widely 
available. Currently, high cost and limited availability prohibit the routine application of 
both CMR and 3DE as the first line imaging modality for assessing resting LV systolic 
function in clinical practice. The 2DE biplane Simpson’s rule although widely available, 
has limitations which have already been discussed extensively in chapters 1 and 4. In 
chapter 4, we therefore investigated the use of 2D speckle tracking strain as an alternative 
method for quantifying LVEF with an encouraging result.  Although this 2DE technology 
now comes routinely as part of the software package on several new echo machines, and is 
more accessible than 3DE or CMR, it is not available on older machines, and several 
cardiac imaging centres, especially in less affluent countries, may not have access to this 
technology. Furthermore, speckle tracking strain software varies between manufacturers, 
and until more validation studies are performed, it is unclear whether the strain value 
measured using a GE echo machine will be the same as that measured using an echo 
machine produced by Philips, Toshiba or other manufacturers. 
 
For this reason we decided to investigate the use of the method recommended by the ASE 
and EAE for assessing regional LV systolic function, to see if we could use it to quantify 
global LV systolic function and calculate LVEF. The ASE/EAE guidelines recommend 
using the American Heart Association (AHA) 16-segment model for the assessment of 
regional LV function.38  A regional wall score is applied to each myocardial segment 
classifying it as follows: 1=normal contraction, 2=hypokinetic (reduced contraction), 
3=akinetic (no contraction) and 4=dyskinetic (paradoxical motion during systole). The 
regional wall motion score is applied by visually assessing radial contraction of each AHA 
myocardial segment within the LV, and therefore does not require the use of specialist 
software. One limitation of this scoring system is that it does not differentiate between the 
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contractile differences of mildly hypokinetic and severely hypokinetic myocardial 
segments. 
 
5.2  STUDY AIMS  
 
The aim of this study was to validate the accuracy of a simple novel 2DE technique to 
quantify global LV systolic function by using a modified regional wall motion scoring 
system and comparing it against biplane Simpson’s Rule and also CMR as the reference 
standard. 
 
5.3  METHODS 
 
5.3.1  Study Design 
 
One hundred and ten patients exhibiting a broad spectrum of LVEF’s (Range 7-74%) were 
recruited from outpatient clinics, elective echocardiography and cardiac catheterisation 
lists.  
 
All study subjects underwent standard 2DE (GE Vivid 7). Due to limited access to MRI 
facilities, it was not possible to perform CMR scans on all 110 study subjects. Fifty-twoone 
of 110 study subjects were randomised to undergo CMR within one hour of 
echocardiography.successfully underwent CMR. LVEF was calculated by 2DE using 
Simpson’s rule and CMR in the standard way as previously described. A regional wall 
motion score (RWMS) was applied to each of 16-AHA myocardial segments based on the 
consensus opinion of two BSE accredited cardiologists experienced in echocardiography 
and blinded to the other scan results.  The modified Regional Wall Motion Score Index 
(RWMSI) was then used to calculate a global LVEF as described below. The two 
echocardiographic methods for quantifying LV function were then compared against each 
other.  LVEF calculated by using the RWMSI (RWMSI-LVEF) and by using Simpson’s 
Rule (Simpson’s-LVEF) was then correlated against CMR as the reference standard for the 
subgroup of 51 patients who successfully underwent CMR. There was a broad range of 
LVEF (12-73%) assessed in this cohort. Subgroup analyses were performed to assess 
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intertechnique agreement of both the RWMSI and Simpson’s rule compared to CMR in 
patients with normal (LVEF≥55%) and impaired (LVEF <55%) LV systolic function.  
 
5.3.2  Patient Selection 
 
Patients with normal LV systolic function, globally impaired LV systolic function and 
regional wall motion abnormalities were included in the study. Patients were excluded if 
they had a contraindication to CMR or had poor endocardial wall definition as defined by 
the inability to accurately visualize ≥2 AHA myocardial segments. Clinical characteristics 
of the study population are described in Table 5.1. 
 
 
Gender (M:F) 
Mean age (yrs) 
Clinical Diagnosis 
            -   Ischaemic heart disease* 
- Valvular heart disease 
- Dilated cardiomyopathy 
- Pulmonary hypertension 
- Restrictive cardiomyopathy 
- Atrial septal defect 
- Coronary artery spasm 
- No cardiac diagnosis 
   
29:22 
59 
 
31 
3 
3 
3 
1 
1 
1 
8 
 
 
Table 5.1. Clinical characteristics of study subjects who completed both CMR 
and 2D echocardiography protocols  (n=51) 
F, female; M, male 
* diagnosed either on coronary angiography, or clinical diagnosis of angina/previous 
myocardial infarction. 
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5.3.3 Imaging Methods 
 
CMR and 2DE were performed consecutively, within 30 minutes of each other, to ensure 
similar cardiac loading conditions.  
 
Cardiac Magnetic Resonance Imaging   
 
The CMR LV systolic function acquisition protocol was performed as previously described 
in section 3.4.1. 
 
2D Echocardiography Imaging 
 
2DE imaging was performed from the parasternal and apical windows with the patient in 
the left lateral decubitus position using a Vivid 7 scanner, (GE Medical Systems, 
Wauwatosa, WI). Depth and frame rate were optimized and 2D images recorded of the 
parasternal long axis (PSLAX), parasternal short axis (PSSAX), apical 4-chamber (A4C), 
apical 2-chamber (A2C) and apical long axis (ALAX) views of the left ventricle and stored 
for subsequent LV analysis. Harmonic imaging was used consistently throughout each 
study. Echo contrast agents were not used. 
 
5.3.4   Image Analysis 
 
Cardiac Magnetic Resonance 
 
LV volumes were quantified and LVEF calculated by CMR using the method described in 
section 3.4.1. 
 
2D Echocardiography 
 
LVEF was calculated from the A4C and A2C views using Simpson’s biplane method of 
discs as described in section 3.6.1.    
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Regional Wall Motion Score Index 
 
A modified regional wall motion score (RWMS) was applied to each of 16-AHA 
myocardial segments, based on the consensus opinion of two British Society of 
Echocardiography accredited cardiologists blinded to other scan results (Figure 5.1). The 
RWMS was applied as follows: Hyperkinesis = 3; Normal regional contraction = 2; Mild-
moderate Hypokinesis = 1.25; Moderate-Severe Hypokinesis = 0.75; Akinesis = 0, 
Dyskinesis = -1. This modified RWMS includes analysis of hyperkinetic and dyskinetic 
myocardial segments and differentiates between degrees of hypokinesis. Normal regional 
contraction was defined by the presence of normal wall thickening in the radial plane of the 
LV. In cases of partial segment contractility, when half a myocardial segment exhibited 
akinesis (0) and the other half normal contractility (2) the combined scores were averaged 
to give an overall score (1) for that segment.  LVEF was then calculated using the 
following equation:  
 
Equation 5.1. The Regional Wall Motion Scoring Index for calculating LVEF: 
 
LVEF(%) = Σ(16segRWMS)/16 x30. 
 
 
Figure 5.1. Calculating LVEF using the Regional Wall Motion Scoring Index. 
A regional wall motion score (RWMS) is applied to each of the 16-American Heart 
Association myocardial segments. RWMS: Hyperkinesis = 3; Normal regional 
contraction = 2; Mild-moderate Hypokinesis = 1.25; Moderate-severe Hypokinesis 
= 0.75; Akinesis = 0; Dyskinesis = -1.  LVEF is then calculated by: LVEF (%) = 
Formatted: Body Text 3, Left
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Σ(16segRWMS)/16 x 30. In this example, the RWMS=18, therefore LVEF=18/16 x 
30 = 34%. 
 
5.3.5.  Reproducibility 
 
Interobserver and intraobserver variability in Simpson’s-LVEF and RWMS-LVEF was 
assessed in 10 patients exhibiting a range of LVEFs (LVEF range: 12-68% by CMR 
analysis).  LVEF was assessed using RWMSI and Biplane Simpson’s rule by two 
independent observers.  These measurements were repeated by one observer six months 
later. 
 
5.3.6.  Statistical Analysis 
 
Values are expressed as mean ± standard deviation (SD).  All data sets were tested for 
normality using the Shapiro-Wilk test when sample size was greater than fifty and the 
Kolmogorov-Smirnov test when it was not. Each echocardiographic technique was 
correlated against CMR-LVEF using a bivariate correlation (Pearson correlation coefficient 
for parametric data and Spearman correlation coefficient for non-parametric data). For 
parametric data, linear regression analysis was used to directly compare RWMSI-LVEF to 
Simpson’s-LVEF when indexed against CMR-LVEF as the reference standard. Subgroup 
analysis was performed to assess the accuracy of RWMSI-LVEF and Simpson’s-LVEF 
indexed against CMR-LVEF in patients with normal (LVEF≥55%) and impaired 
(LVEF<55%) LV systolic function.  Bland-Altman analysis was used to determine the bias 
and limits of agreement between the corresponding measurements. Results are expressed as 
mean bias±1.96SD.  The significance of intertechnique biases was tested using the paired 
samples T-test for parametrically distributed data and Wilcoxon signed ranks test for non-
parametrically distributed data.  A value of p<0.05 was considered significant. 
 
5.4.  RESULTS 
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Eight patients were excluded from the study due to poor endocardial wall definition and 
one patient failed to complete the CMR protocol due to claustrophobia. 102 patients 
successfully underwent 2DE and 51 of 52102 completed the CMR sub-studyprotocol.  
 
5.4.1 Correlation and intertechnique agreement of RWMSI-LVEF with Simpson’s-
LVEF 
 
LVEF derived using the RWMSI was compared to LVEF calculated using 2D Simpson’s 
rule in 102 patients (EF range: 7-74%). RWMSI-LVEF correlated strongly with 2D 
Simpson’s rule (p<0.001, r=0.915).  Mean calculated LVEF was significantly lower using 
RWMSI compared to Simpson’s Rule (mean bias: 4.06±12.94; Z= -5.25, p<0.001) (Figure 
5.2). 
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Figure 5.2. (A) Correlation of RWMSI-LVEF with Simpson’s Rule in 102 subjects (LVEF 
range: = 7-74%). (B) Bland-Altman analysis between RWMSI and Simpson’s Rule; solid 
horizontal line denotes the mean difference between RWMSI and Simpson’s Rule 
measurements, broken horizontal lines represent the limits of agreement (2SD around the 
mean intertechnique difference). Bottom right of Bland-Altman plot: mean bias±1.96SD, 
the mean bias is significant if p<0.05. 
 LVEF, left ventricular ejection fraction; RWMSI, regional wall motion score index; SD, standard deviation. 
 
 
 
5.4.2 Correlation and intertechnique agreement of RWMSI-LVEF and Simpson’s-
LVEF with CMR-LVEF 
 
RWMSI-LVEF and Simpson’s-LVEF were compared to CMR-LVEF in 51 patients (EF 
range: 12-73%). Over a wide range of LVEF, RWMSI-LVEF showed a good correlation 
with CMR-LVEF (r=0.916, p<0.001); Simpson’s-LVEF showed a moderate correlation 
with CMR-LVEF (r=0.647, p<0.001).  RWMSI-LVEF significantly underestimated LVEF 
compared to CMR (mean bias: 2.47±11.37; Z=-3.281, p=0.001) and Simpson’s-LVEF 
significantly overestimated LVEF compared to CMR (mean bias; -3.46±16.74; Z=-2.83, 
p=0.005). Correlation between imaging modalities and corresponding Bland-Altman 
analysis of intertechnique agreement are shown in Figure 5.3. 
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Figure 5.3.  Correlation of CMR-LVEF with (A) RWMSI and (B) Simpson’s Rule in 
51 subjects (LVEF range: 12-73%). (C) Bland-Altman analysis between CMR and 
RWMSI; solid horizontal line denotes the mean difference between RWMSI and 
CMR measurements, broken horizontal lines represent the limits of agreement 
(2SD around the mean intertechnique difference). Bottom right of Bland-Altman 
plot: mean bias±1.96SD, the mean bias is significant if p<0.05. (D) Bland-Altman 
analysis between CMR-LVEF and Simpson’s Rule in the same format as in Figure 
5.3C. LVEF, left ventricular ejection fraction; RWMSI, regional wall motion score index; SD, 
standard deviation. 
 
 
5.4.3 Correlation and intertechnique agreement of RWMSI-LVEF and Simpson’s-
LVEF with CMR-LVEF in patients with normal LV systolic function 
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Twenty-seven patients who successfully underwent CMR had normal LV systolic function 
(LVEF≥55%).  Although a good correlation was noted between RWMSI-LVEF and CMR-
LVEF (r=0.785, p<0.001), RWMSI significantly underestimated LVEF in patients with 
normal LV systolic function (mean bias: 2.39±7.41; Z=-3.20, p=0.001).  There was no 
significant difference in mean LVEF calculated using Simpson’s rule and CMR in patients 
with normal LV systolic function (mean bias; -1.10±15.86 with 95%CI: -4.30 to 2.11, 
p=NS), however correlation between these two techniques in patients with normal LV 
function was surprisingly poor (r=0.124, p=NS) (Figure 5.4). 
 
 
 
Figure 5.4.  Correlation of CMR-LVEF with (A) RWMSI and (B) Simpson’s Rule in 
subjects with normal LV function (LVEF≥55%, n=27). Lower panels denote Bland-
Altman analysis between CMR-LVEF and (C) RWMSI and (D) Simpson’s Rule in 
the corresponding study subjects in the same format as in Figure 5.3. 
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5.4.4 Correlation and intertechnique agreement of RWMSI-LVEF and Simpson’s-
LVEF with CMR-LVEF in patients with impaired LV systolic function 
 
Twenty-four of the 51 patients who underwent CMR had impaired LV systolic function 
(LVEF<55%). RWMSI-LVEF showed a good correlation with CMR-LVEF (r=0.866, 
p<0.001) in patients with impaired LV systolic function, this being comparable to the 
correlation of Simpson’s-LVEF with CMR-LVEF (r=0.826, p<0.001).  On linear regression 
analysis, RWMSI-LVEF had a significantly stronger correlation with CMR-LVEF (T=3.14, 
p=0.005) than Simpson’s LVEF (T=1.84, p=NS). In patients with impaired LV systolic 
function there was no significant difference between LVEF calculated using the RWMSI 
and using CMR (mean bias: 2.58±14.80 with 95%CI: -0.60 to 5.77, p=NS).  Simpson’s rule 
significantly overestimated LVEF compared to CMR with a mean difference of  
-6.12±16.44 with 95%CI: -9.66 to –2.58 (p=0.002) (Figure 5.5). 
 
 
 
Figure 5.5.  Correlation of CMR-LVEF with (A) RWMSI and (B) Simpson’s Rule in 
subjects with impaired LV function (LVEF<55%, n=24). Lower panels denote 
Bland-Altman analysis between CMR-LVEF and (C) RWMSI and (D) Simpson’s 
Rule in the corresponding study subjects in the same format as in Figure 5.3. 
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5.4.5  Reproducibility 
 
Intra- and inter-observer variability for RWMSI-LVEF and Simpson’s-LVEF are expressed 
as the co-efficient of variation, and as the mean bias, limits of agreement and standard 
deviation of the difference as shown in Tables 5.2 and 5.3.  The corresponding Bland-
Altman plots are shown in Figure 5.6 A-D. 
 
Intra-observer mean of RWMSI-LVEF was 40.42% with difference between the means of 
1.68±10.88%. Inter-observer mean of RWMSI-LVEF was 40.48% with difference between 
the means of 1.64±12.32%. Intra-observer mean of Simpson’s-LVEF was 51.20% with 
difference between the means of –0.34±12.33%. Inter-observer mean of Simpson’s-LVEF 
was 52.52% with difference between the means of -2.91±9.86.   
 
 
 
Table 5.2. Intra-observer and Inter-observer variability for measurements of 
LVEF using the Regional Wall Motion Scoring Index  
SDD, standard deviation of the difference 
 
 
RWMSI-LVEF % Co-efficient of 
variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
Intra-observer 
 
8.33% 
 
1.68 
 
-9.43 to 12.79 
 
5.55 
Inter-observer 11.22% 1.64 -10.93 to 14.21 6.29 
Simpsons-LVEF % Co-efficient of 
variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
Intra-observer 
 
7.00% 
 
-0.34 
 
-12.92 to 12.24 
 
6.29 
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Table 5.3 Intra-observer and Inter-observer variability for measurements of 
LVEF using Biplane Simpson’s Rule  
SDD, standard deviation of the difference 
 
 
 
 
Figure 5.6.  Bland-Altman analysis of (A) intra-observer and (B) inter-observer 
variation for measuring LVEF using RWMSI, and (C) intra-observer and (D) inter-
observer variation for measuring LVEF using Biplane Simpson’s Rule. 
 
 
5.5  DISCUSSION 
 
Cardiac magnetic resonance imaging has rapidly become the reference standard for 
assessing cardiac anatomy and function. The technique for quantifying LVEF by CMR is 
highly reproducible as previously reported by our research group.22  However, there remain 
major limitations to its widespread use due to initial cost and inability of some individuals 
to enter an enclosed space.  Furthermore, patients with severe LV dysfunction may be 
Inter-observer 8.45% -2.91 -12.97 to 7.16 5.03 
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unable to lie flat for the duration of the investigation, or may be contraindicated from 
undergoing CMR due to the increasing prevalence of cardiac resynchronisation therapy and 
internal cardioverter defibrillator devices in this cohort. 3DE measurements compare 
favourably to CMR reference values,144-147 however as yet 3DE is not widely available 
outside specialist centres. 2DE, on the other hand, is widely available, relatively 
inexpensive and well tolerated.  
 
At present, the ASE/EAE recommend Simpson’s Rule as the preferred 2DE method by 
which to calculate LVEF despite its recognised limitations.38  Calculation of LVEF by the 
regional wall motion scoring index is a simple method for quantifying left ventricular 
systolic function that encompasses information from all 16 AHA myocardial segments of 
the left ventricle. It has the potential therefore to be of value in quantifying global LV 
systolic function in patients with impaired LV function due to the presence of regional wall 
motion abnormalities in addition to patients with global cardiomyopathies. Furthermore, 
quantification using this method does not require the presence of specialist software, and 
therefore can be performed in any cardiac centre on any 2D echocardiogram by an 
experienced operator. 
 
We are not the first research group to use a wall motion score to estimate LVEF.  In 2001, 
McGowan and colleagues used a 9-myocardial segment wall motion score index to quantify 
LVEF in patients with systolic heart failure secondary to ischaemic heart disease.315  They 
demonstrated moderate agreement with radionuclide ventriculography and moderate 
reproducibility, and concluded that while a 9-segment wall motion score index was a valid 
and widely applicable method for assessing LV systolic function, it may not be sensitive 
enough to detect small changes in LV systolic function that may occur in chronic heart 
failure. By comparison, we have used a more sensitive 16-segment wall motion score 
indexed based on the gold standard American Heart Association classification of regional 
myocardial function.38  Furthermore, McGowan’s wall motion score index was validated 
against radionuclide ventriculography, with a temporal delay of up to four weeks between 
the echocardiogram and nuclear study. By comparison, in our study we have validated our 
RWMSI-LVEF against CMR-LVEF, the internationally recognised reference standard. In 
our study echocardiograms and CMR scans were performed on the same day, within one 
hour of each other in all patients to ensure similar cardiac loading conditions. In our study, 
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RWMS-LVEF showed acceptable reproducibility, comparable to that of biplane Simpson’s 
rule. Importantly, LVEF calculated using the RWMSI had a strong correlation to CMR 
(p<0.001, R= 0.914).  Biplane Simpson’s rule LVEF had a moderate correlation to CMR 
(p<0.001, R=0.647) when tested over a wide range of LVEFs (range 12-73%). 
 
On sub-group analysis when compared to CMR, Simpson’s rule did not correlate with 
CMR in patients with normal LV systolic function. Although at first this result may seem 
surprising, on review of the literature, previous comparisons of Simpson’s biplane method 
of discs performed by TTE and volumetric assessment of LVEF performed by CMR have 
demonstrated large and systematic differences in absolute measurements; Gardner et al150 
reported important differences in CMR volumes and LVEF and echocardiographic volumes 
and LVEF on indirect comparisons of normal volunteers and Chuang et al151 have 
demonstrated that intermodality comparison of cardiac volumes and LVEF are significantly 
better between volumetric CMR analysis and volumetric echocardiography (3D 
echocardiography) than between volumetric CMR and biplane echocardiography 
(Simpson’s rule).  They have also reported wide limits of agreement when comparing 
volumetric CMR with biplane echocardiography for calculating LVEF.151  These results 
suggest that LVEF measurements by the two techniques are not interchangeable.  By 
comparison, the RWMSI had a significantly better correlation with CMR-LVEF in patients 
with normal LV systolic function compared to Simpson’s rule, despite a tendency to 
underestimate absolute LVEF in this cohort (mean RWMSI-LVEF vs. mean CMR-LVEF:  
59.37%±2.99 vs. 61.75%±4.82, p=0.001).   
 
In patients with LV dysfunction, although both echocardiographic techniques correlated 
well with CMR-LVEF, RWMSI-LVEF had a significantly better correlation with CMR-
LVEF than Simpson’s-LVEF on step-wise regression analysis.  Importantly, RWMSI-
LVEF had good intertechnique agreement with CMR in patients with impaired LV systolic 
function. Simpson’s rule significantly overestimated LVEF in the cohort of patients with 
LV systolic dysfunction. Bellenger et al have previously studied LVEF and cardiac 
volumes calculated using CMR, 2DE Simpson’s rule and radionuclide ventriculography in 
patients with heart failure and also concluded that biplane echocardiography tends to yield 
a higher ejection fraction than CMR; a similar finding to this study.149  This is a clinically 
important finding. A LVEF≤35% is a prerequisite for heart failure patients to be considered 
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for certain device therapies such as cardiac resynchronization therapy and internal cardiac 
defibrillators.136,139,316  If Simpson’s rule is significantly overestimating LVEF in patients 
with impaired LV function, patients who would benefit from these devices, may potentially 
be being excluded.  RWMSI did not significantly overestimate or underestimate LVEF in 
this cohort. 
 
The results of our study suggest that the novel RWMSI-LVEF may be a simple and reliable 
alternative to biplane Simpson’s rule for quantifying LV systolic function. Furthermore 
RWMSI-LVEF appears to have superior intertechnique agreement with CMR-LVEF 
compared to biplane Simpson’s rule. 
 
5.5.1. Study Limitations 
 
This study was designed to examine the feasibility of using the RWMSI to calculate LVEF 
and to examine its accuracy compared to CMR and biplane Simpson’s echocardiography. 
Subgroup analysis in patient subgroups with mild, moderate and severe LV dysfunction 
was not possible due to the small number of study patients and this warrants further 
investigation.  
 
5.5.2. Conclusion 
 
We have compared the use of the 16-segment RWMSI to biplane Simpson’s rule for the 
quantification of global LV systolic function in patients exhibiting a wide range of LVEF, 
when indexed against CMR as the reference standard. RWMSI-LVEF correlates strongly 
with CMR and has good inter-technique agreement. The RWMSI is a simple and widely 
available method for quantifying left ventricular systolic function using 2DE. In centres 
where CMR and 3DE are not readily available, the use by experienced individuals, of the 
RWMSI for calculation of LVEF may offer a simple and reliable 2D echocardiographic 
alternative to biplane Simpson’s rule. 
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CHAPTER 6: LV DIASTOLIC FUNCTION 
 
6.1  INTRODUCTION 
 
Diastolic function is a complex multi-stage active process that remains difficult to measure 
non-invasively in quantitative terms.  The need for accurate diagnosis and quantification of 
diastolic dysfunction is been designated of “paramount clinical importance” by the 
European Association of Echocardiography and American Society of Echocardiography.14 
Furthermore, in patients with known systolic heart failure due to dilated cardiomyopathy, 
the presence and severity of diastolic function correlates better with functional class and 
prognosis than LVEF.177-180,317-331 
 
Elevated LV filling pressures are the main physiologic consequences of diastolic 
dysfunction. These are measured invasively during cardiac catheter studies.  In patients 
with normal or near normal LV systolic function (LVEF≥50%) traditional non-invasive 
indices of diastolic function including transmitral E wave velocity, E/A ratio, mitral 
deceleration time, isovolumic relaxation time and pulmonary vein S:D ratio correlate 
poorly with LV filling pressures recorded during catheter studies.13,191,192  The peak 
transmitral E wave velocity is dependent on and varied directly with changes in the left 
atrial pressure and inversely with the time constant of LV relaxation.  As abnormal diastolic 
relaxation and high LV filling pressures commonly co-exist in patients with diastolic heart 
failure it is therefore unsurprising that peak transmitral E wave velocity correlated poorly 
with left atrial and left ventricular filling pressures. By dividing the peak transmitral E 
wave velocity by the early diastolic myocardial tissue relaxation velocity (Em), we are in 
effectively correcting the transmitral E wave velocity for the influence of myocardial 
relaxation, thus improving the relationship with the LV diastolic filling pressure. Therefore 
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“E” corrected by “Em” (E/Em) gives an estimate of the LV diastolic filling pressure. This is 
the basis upon which tissue Doppler echo E/Em has been used to non-invasively estimate 
LVEDP. 
 
The excellent spatial resolution of CMR makes it the gold standard for anatomical imaging 
of the cardiac chambers. The use of CMR for functional cardiac imaging is also increasing. 
One of the major advantages of CMR over cardiac CT and nuclear techniques, is that is can 
provide both accurate anatomical and functional imaging data during a single scan.  CMR 
can be used to assess myocardial viability, using delayed enhancement gadolinium 
scanning, and inducible myocardial ischaemia using adenosine stress-perfusion and 
dobutamine stress MRI protocols. CMR is now widely recognised as the reference standard 
for quantifying LV systolic function. For CMR to fulfil its potential as the one-stop 
imaging modality for both anatomical and functional imaging of the heart, accurate and 
reproducible quantitative methods for assessing LV diastolic function by CMR need to be 
developed. 
 
Research studies have demonstrated a relatively good correlation between CMR and 
echocardiography for recording mitral inflow patterns using VEC-CMR sequences, 
however, like echocardiography, these measures are load-dependent and only semi-
quantitative.223-225  Small single centre studies have explored the potential of using grid-
tagged myocardial deformation CMR imaging sequences to assess diastolic relaxation.215-
219  This has increased our understanding of left ventricular torsion and the contribution of 
diastolic “untwisting” and LV suction to LV filling in early diastole.220  CMR myocardial 
deformation imaging however has limited ability to assess late diastolic events due to the 
degradation of the grid-tags in end-diastole.221  Although useful for research purposes, 
CMR myocardial deformation imaging analysis is time consuming and analysis software is 
not widely available, limiting the clinical application of this technique at this time.  At the 
time of writing there is no standard CMR method for diagnosing and quantifying left 
ventricular diastolic dysfunction in clinical practice. 
 
Over the last 10 years, the use Doppler echocardiography has expanded substantially once 
it was discovered myocardial tissue velocities could be recorded from heart muscle with 
high temporal resolution, by applying standard autocorrelation processing but reversing low 
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amplitude and high velocity filters.  Tissue Doppler echocardiography is now used 
routinely in clinical practice to identify diastolic dysfunction non-invasively and estimate 
left ventricular end diastolic filling pressure (LVEDP) using the ratio E/Em where E is the 
peak early diastolic filling velocity of the LV and Em is the peak early diastolic myocardial 
tissue velocity recorded at the level of the mitral annulus. Based on this principle, we 
explored the clinical utility of using modified VEC-CMR sequences to measure early 
diastolic tissue velocities within the LV myocardium, and to use them, along with recorded 
early diastolic mitral inflow velocities, to estimate LVEDP by calculating a VEC-CMR 
E/Em ratio. 
 
6.2 STUDY AIMS  
 
The first aim of this study was to use VEC-CMR sequences to record early diastolic mitral 
inflow velocities (E), and early diastolic myocardial tissue velocities (Em), and compare 
them to E and Em velocities recorded by Doppler and tissue Doppler echocardiography in 
patients exhibiting a range of pathologies.  The second aim was to use the E and Em values 
to calculate the E/Em ratio by CMR and to establish if this technique correlated with 1) 
E/Em ratio recorded by echocardiography and 2) LVEDP as measured invasively by fluid-
filled catheter as the reference standard, in a heterogeneous patient cohort as seen in clinical 
practice. 
 
6.3 METHODS 
 
6.3.1 Study Design 
 
Ethical approval for this study was granted on the basis that patients enrolled into the study 
must have a clinical indication for undergoing invasive heart catheter studies. Forty-five 
patients exhibiting a broad spectrum of LVEF’s (Range: 18.5-71.6%) were recruited from 
elective cardiac catheterisation lists.  
 
All study subjects underwent standard 2DE (GE Vivid 7), CMR (1.5T Siemens Sonata) and 
left heart catheterisation within 3 hours of each other in the fasted state to ensure similar 
loading conditions. LVEDP was measured during left heart catheterisation as previously 
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described. Mitral E and A velocities were recorded for all patients by both Doppler 
echocardiography and VEC-CMR and E/A ratio calculated. VEC-CMR derived E, A and 
E/A ratios were compared to corresponding echocardiography values. Myocardial tissue 
Em velocities were recorded from all six LV walls by TDE and VEC-CMR. VEC-CMR 
Em velocities were compared to corresponding echocardiography values. VEC-CMR E/Em 
ratios were calculated and compared to Doppler E/Em and to invasively measured LVEDP 
as the gold standard.  
 
6.3.2 Patient Selection 
 
Patients in sinus rhythm with normal LV systolic function, globally impaired LV systolic 
function and regional wall motion abnormalities were included in the study. Patients were 
excluded if they had a contraindication to CMR, had significant mitral valve disease, 
moderate-severe mitral annular calcification, prosthetic mitral valve or known pericardial 
disease. Clinical characteristics of the study population are described in Table 6.1. 
 
 
 
Gender (M:F) 
Mean age (yrs) 
Clinical Diagnosis 
            -   Ischaemic heart disease 
- Valvular heart disease 
- Dilated cardiomyopathy 
- Pulmonary hypertension 
- Restrictive cardiomyopathy 
- Atrial septal defect 
- Other 
- No cardiac diagnosis 
   
22:19 
63±10 
 
25 
2 
2 
4 
1 
1 
2 
4 
 
 
Table 6.1. Clinical characteristics of study subjects (n=41) 
F, female; M, male 
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6.3.3  Imaging Methods 
 
Left heart catheterisation, CMR and 2DE were performed consecutively, within 3 hours of 
each other, to ensure similar cardiac loading conditions.  
 
Left heart catheterisation 
 
LVEDP was recorded during left heart catheterisation as previously described in section 
3.3. 
 
Cardiac Magnetic Resonance Imaging   
 
The CMR LV diastolic function acquisition protocol was performed as described below:  
 
Cardiac magnetic resonance imaging sequences – Phase encoded velocity imaging for 
the assessment of left ventricular diastolic function: Image acquisition 
 
Transmitral flow was measured using a retrospectively electrocardiographically triggered 
FLASH phase-contrast MRI technique with a velocity sensitivity of 130cm/s. The centre of 
the slice was positioned in the middle of the mitral valve at the level of the valve tips during 
early diastole with the imaging plane perpendicular to mitral flow, using both two-chamber 
and four chamber images.  In order to cover late diastolic filling, acquisition was performed 
throughout the cardiac cycle with a retrospective period of 1.2 (scan parameters: slice 
thickness, 5mm; in-plane resolution, 1.6 x 1.5mm; temporal resolution, 16-18msec; TR/TE 
= 30/3.2ms; 240 x 256 image matrix and 300 flip angle).194  Myocardial tissue velocities 
were measured by repeating this phase-contrast MR sequence with velocity encoding of 
30cm/s and a different image slice position.  The image slice position was positioned at 
two-thirds of the long axis, planned on early diastolic two-, three- and four-chamber 
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images, perpendicular to the interventricular septum.  Care was taken during sequence 
acquisition to ensure aliasing artefact did not occur.  If aliasing did occur, the velocity 
sensitivity was adjusted appropriately and the sequence acquisition was repeated. 
 
CMR Phase encoded velocity analysis for the quantification of LV diastolic function: 
Image analysis 
 
Offline analysis was performed by tracing a standardised circular region of interest (ROI) 
on the modulus images and transferring this ROI to the paired phase images, using the 
LEONARDO analytical software package (Siemens, Erlangen, Germany). For assessment 
of transmitral flow, tracings were performed manually on the images acquired with a 
velocity encoding of 130cm/s along the borders of the mitral valve from opening to closing 
(Figure 6.1).  From the reconstructed velocity versus time curves of LV filling, peak 
velocity in early diastole (E) and peak velocity associated with atrial contraction (A) were 
determined (Figure 6.2).  From these peak velocities the E/A ratio was calculated.   
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Figure 6.1. Analysis of peak mitral inflow velocity (E) using VEC-CMR. 
(A) VEC-CMR short axis imaging plane for transmitral inflow velocity measurement 
(dotted line) is at the level of the mitral leaflet tips. Resultant magnitude image (B) 
and velocity map (C) of mitral inflow. Transmitral velocities from within the region of 
interest (solid circle) are recorded and the information is used to create a peak 
velocity versus time curve (as shown subsequently in Figure 6.2) 
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Figure 6.2. Calculating E/A ratio from reconstructed velocity versus time 
curve. 
 
 
Early peak diastolic myocardial tissue relaxation velocities (Em) were recorded using a 
standardised ROI of 40 pixels placed in the centre of the inferoseptal, anteroseptal, lateral, 
anterior, posterior and inferior regions of LV myocardium in the LV short axis, at sites 
approximating to the LV wall positions from which the corresponding early peak tissue 
relaxation velocities were recorded by tissue Doppler echocardiography (Figure 6.3).  
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Figure 6.3. Analysis of peak early diastolic myocardial tissue relaxation 
velocities (Em) using VEC-CMR. 
(A) VEC-CMR short axis imaging plane for early diastolic myocardial tissue 
relaxation velocity measurements (dotted line) is at the level of the basal third of 
the LV. Image (B) is a schematic diagram delimiting the six LV basal AHA-
myocardial segments. Em velocities were then recorded from the middle of each of 
the six basal LV myocardial segments (solid circles) as shown in the resultant 
magnitude image (C) and velocity map (D). Em velocity information recorded from 
within each of the six regions of interest (solid circles) was then used to create six 
individual peak early myocardial tissue relaxation velocity versus time curves (as 
shown subsequently in Figure 6.4) 
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From the reconstructed velocity versus time curves of LV filling, early peak basal 
myocardial relaxation velocities of the left ventricle were calculated from the basal LV 
septum (EmS), anteropsetum (EmAS), anterior wall (EmA), lateral wall (EmL), posterior 
wall (EmP) and inferior wall (EmI) (Figure 6.4). 
 
 
 
Figure 6.4. Calculating Em from reconstructed velocity versus time curves.              
  
 
Doppler Echocardiography Imaging 
 
Mitral inflow Doppler velocities and myocardial tissue velocities were recorded as 
previously described in section 3.6.3. 
 
6.3.4. Image Analysis 
 
Cardiac Magnetic Resonance 
 
E, A and Em values were recorded from reconstructed VEC-CMR velocity-time graphs as 
previously described. LVEDP was then estimated by recording the ratios of 1) peak mitral 
inflow velocity: early myocardial relaxation velocity of the septum (E/Em(S)) 2) peak 
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mitral inflow velocity: early myocardial relaxation velocity of the lateral wall (E/Em(L)) 
and 3) peak mitral inflow velocity: average of the early myocardial relaxation velocities of 
the septum and lateral wall (E/Em(S+Lav).  These are the three E/Em ratios recommended 
for use by the EAE & ASE in their guidelines for the non-invasive assessment of diastolic 
function.14  Our study cohort included patients with regional wall motion abnormalities, for 
this reason we also estimated LVEDP by recording 4) peak mitral inflow velocity: average 
of the early myocardial relaxation velocities of the left ventricle (averaged from all six 
basal readings) (E/Em 6av). As the basal anteroseptum is in very close proximity with the 
aortic valve, we were unsure if this may adversely influence the accuracy of Em recordings 
made at the level of the basal anteroseptum by VEC-CMR and TDE. For this reason, our 
fifth and final estimation of LVEDP was performed by recording 5) peak mitral inflow 
velocity: average of the early myocardial relaxation velocities of the left ventricle (averaged 
from 5 basal readings, excluding the anteroseptum) (E/Em 5av) (see Figure 6.5).   
 
2D Echocardiography 
 
E, A and Em values were recorded from Doppler velocity-time graphs as previously 
described. E/Em ratios were then calculated as follows: E/Em(S), E/Em(L), E/Em(S+Lav), 
E/Em(5av) and E/Em(6av) in a manner analogous to the VEC-CMR E/Em ratios above 
(Figure 6.5) . 
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Figure 6.5. Calculating E/Em as a non-invasive estimate of LVEDP using (A) 
VEC-CMR  (B) tissue Doppler echocardiography 
 
 
 6.3.5. Reproducibility 
 
Inter-observer and intra-observer variability for E, A, Em(S) and Em(L) were assessed in 
10 patients by two independent observers. These measurements were repeated by one 
observer six months later. 
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6.3.6. Statistical Analysis 
 
Values are expressed as mean ± standard deviation (SD).  All data sets were tested for 
normality using the Kolmogorov-Smirnov test. Each VEC-CMR measure  (E, A, Em(S), 
Em(L), Em(AS), Em(A), Em(I) and Em(P)) was correlated against the equivalent 
echocardiographic measure using a bivariate correlation (Pearson correlation coefficient for 
parametric data and Spearman correlation coefficient for non-parametric data). E/Em(S), 
E/Em(L), E/Em(S+Lav), E/Em(5av) and E/Em(6av) ratios were then calculated by VEC-
CMR and echocardiographic techniques, and correlated against LVEDP as the gold 
standard. For parametric data, linear regression analysis was used to directly compare 
different combinations of E/Em ratio indexed against LVEDP as the reference standard. 
Subgroup analysis was performed to assess the accuracy of VEC-CMR E/Em and echo 
E/Em indexed against LVEDP in patients with normal (LVEF≥55%) and impaired 
(LVEF<55%) LV systolic function.  Receiver operator characteristics were examined. 
Bland-Altman analysis was used to determine the bias and limits of agreement between the 
corresponding measurements. Results are expressed as mean bias±1.96SD.  The 
significance of intertechnique biases was tested using the paired samples T-test for 
parametrically distributed data and Wilcoxon signed ranks test for non-parametrically 
distributed data.  A value of p<0.05 was considered significant. 
 
6.4. RESULTS 
 
Four patients were excluded from the study; two patients had incorrectly zeroed catheter 
traces; the clinician performing the LHC failed to perform an LV pressure recording prior 
to coronary angiography in one patient; and one patient failed to complete the CMR 
protocol due to claustrophobia. Forty-one patients successfully completed this study.  
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6.4.1  Correlation and intertechnique agreement of mitral E velocities, mitral A      
          velocities and E/A ratio recorded using VEC-CMR, with spectral Doppler   
          echocardiography mitral E and A velocities and E/A ratios. 
 
VEC-CMR derived mitral E velocities and mitral A velocities were compared to the 
corresponding mitral E and A velocities recorded by Doppler echocardiography (n=41). 
The resultant E/A ratios calculated from the VEC-CMR and Doppler echocardiography 
velocity traces were also compared. VEC-CMR mitral E velocity had a moderate 
correlation with Doppler echocardiography mitral E velocity (p<0.001, r=0.657).  Mean 
calculated mitral E velocity was significantly lower using VEC-CMR compared to Doppler 
echocardiography (mean bias: 10.98±15.79; Z=-3.94, p<0.001). VEC-CMR mitral A 
velocity correlated strongly with Doppler echocardiography mitral A velocity (p<0.001, 
r=0.701).  Mean calculated mitral A velocity was significantly lower using VEC-CMR 
compared to Doppler echocardiography (mean bias:17.27±15.83; Z=-3.91, p<0.001). VEC-
CMR E/A ratio had a weak correlation with Doppler echocardiography E/A ratio (p=0.003, 
r=0.481).  Mean calculated E/A ratio was significantly higher using VEC-CMR compared 
to Doppler echocardiography (mean bias: -0.17±0.41; Z=2.35, p<0.016) (Figure 6.6 A-F).  
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(A)                                                              (B) 
    
(C)                                                                (D) 
      
(E)                                                               (F) 
     
 
Figure 6.6. (A) Correlation of VEC-CMR mitral E velocity with Doppler echocardiography mitral E 
velocity in 41 subjects (LVEF range:18.5-71.0%). (B) Bland-Altman analysis between VEC-CMR 
mitral E velocity and Doppler echocardiography mitral E velocity; solid horizontal line denotes the 
mean difference between VEC-CMR and Doppler echocardiography measurements, broken 
horizontal lines represent the limits of agreement (2SD around the mean intertechnique difference). 
Bottom right of Bland-Altman plot: mean bias±1.96SD, the mean bias is significant if p<0.05. (C) 
Correlation of VEC-CMR mitral A velocity with Doppler echocardiography mitral A velocity (D) 
Bland-Altman analysis between VEC-CMR mitral A velocity and Doppler echocardiography mitral A 
velocity in the same format as in (B) above. (E) Correlation of VEC-CMR E/A ratio with Doppler 
echocardiography E/A ratio (F) Bland-Altman analysis between VEC-CMR E/A ratio and Doppler 
echocardiography E/A ratio in the same format as in (B) above. SD, standard deviation. 
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6.4.2  Correlation and intertechnique agreement of VEC-CMR early diastolic tissue 
          myocardial tissue relaxation velocities (Em) with pulsed-wave tissue Doppler   
          echocardiography Em velocities, recorded from the basal segment/mitral   
          annular junction of all six LV walls, in patients exhibiting a range of LVEF. 
 
The Em velocity was recorded from the basal segment of each LV wall by VEC-CMR as 
previously described for all study subjects (n=41). The Em velocities recorded from the 
anterior (EmA), lateral (EmL), posterior (EmP), inferior (EmI), septal (EmS) and 
anteroseptal (EmAS) LV walls were then compared to the Em velocities recorded from the 
basal LV wall/mitral annular junction in the corresponding anterior, lateral, posterior, 
inferior, septal and anteroseptal positions as measured by pulsed-wave tissue Doppler 
echocardiography (PWTDE) as previously described. Correlation and intertechnique 
agreement for each Em velocity is shown below (Figures 6.7-6.12).  
 
 
(A)                                                          (B) 
   
 
Fig 6.7. (A) Correlation of VEC-CMR Em(A) with PWTDE Em(A) (B) Bland-Altman 
analysis between VEC-CMR Em(A) and PWTDE Em(A) in the same format as in 
Figure 6.6. Em(A), early diastolic tissue relaxation velocity recorded from the basal anterior left 
ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler echocardiography; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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(A)                                                            (B) 
   
 
Fig 6.8. (A) Correlation of VEC-CMR Em(L) with PWTDE Em(L) (B) Bland-Altman 
analysis between VEC-CMR Em(L) and PWTDE Em(L) in the same format as in 
Figure 6.6. Em(L), early diastolic tissue relaxation velocity recorded from the basal anterior left 
ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler echocardiography; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging.  
 
 
 
 
(A)                                                             (B) 
    
 
Fig.6.9. (A) Correlation of VEC-CMR Em(P) with PWTDE Em(P) (B) Bland-Altman 
analysis between VEC-CMR Em(P) and PWTDE Em(P) in the same format as in 
Figure 6.6. Em(P), early diastolic tissue relaxation velocity recorded from the basal anterior left 
ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler echocardiography; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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(A)                                                             (B) 
    
 
Fig 6.10. (A) Correlation of VEC-CMR Em(I) with PWTDE Em(I) (B) Bland-Altman 
analysis between VEC-CMR Em(I) and PWTDE Em(I) in the same format as in 
Figure 6.6. Em(I), early diastolic tissue relaxation velocity recorded from the basal septal left 
ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler echocardiography; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
 
 
 
 
(A)                                                             (B) 
    
 
Fig 6.11. (A) Correlation of VEC-CMR Em(S) with PWTDE Em(S) (B) Bland-
Altman analysis between VEC-CMR Em(S) and PWTDE Em(S) in the same format 
as in Figure 6.6. Em(S), early diastolic tissue relaxation velocity recorded from the basal anterior 
left ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler echocardiography; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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(A)                                                               (B) 
      
 
Fig 6.12. (A) Correlation of VEC-CMR Em(AS) with PWTDE Em(AS) (B) Bland-
Altman analysis between VEC-CMR Em(AS) and PWTDE Em(AS) in the same 
format as in Figure 6.6. Em(AS), early diastolic tissue relaxation velocity recorded from the 
basal anteroseptal left ventricular wall/mitral annular junction; PWTDE, pulsed-wave tissue Doppler 
echocardiography; VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
 
 
None of the Em velocities recorded from the 6 basal LV wall segments by VEC-CMR had 
any correlation with the PWTDE mitral annular Em velocities in patients over a broad 
spectrum of LVEF. 
 
6.4.3.  Correlation of VEC-CMR E/Em ratio with invasive measurements of left   
           ventricular end diastolic filling pressure in patients exhibiting a range of LVEF.  
 
For all 41 study subjects, E/Em ratio was calculated using firstly the Em velocity recorded 
from the basal septum (E/Em(S)) and then the basal lateral wall (E/Em(L)). The E/Em ratio 
was then calculated from the mean of the septal and lateral velocities (E/Em(S+Lav)). 
These three variations in calculating E/Em are the methods recommended by the ASE/EAE 
for assessing diastolic function using PWTDE to calculate E/Em.  We included patients 
with ischaemic heart disease in our study, as is common to the patient population assessed 
by echocardiography and CMR in clinical practice, and felt that a single measure of Em, 
may reflect regional rather than global changes in early diastolic myocardial tissue 
relaxation in patients with regional wall motion abnormalities. For this reason, we recorded 
Em from all six wall of the LV, and calculated E/Em from the mean of all 6 early diastolic 
tissue velocities (E/Em(6av)).  Of note, on the anteroseptal side of the mitral annulus, the 
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mitral annulus is in fibrous continuity with the aortic annulus. We hypothesised that 
measurement from this position may be influenced by the anatomical relationship with the 
aortic valve, and so our final variation in calculating E/Em was made by dividing the peak 
mitral E velocity with the mean of the 5 basally recorded early diastolic tissue velocities, 
excluding the anteroseptal LV wall (E/Em(5av)).  Each of these variations in calculated 
E/Em ratio was compared to invasively recorded LVEDP, to establish which ratio, if any, 
best reflected LV diastolic filling pressure, and was therefore the most accurate in 
diagnosing and quantifying LV diastolic dysfunction in a heterogeneous population (Figure 
6.13). 
 
As demonstrated in Figure 6.13, in a heterogeneous population of patients exhibiting a wide 
range of LVEF’s, only VEC-MRI E/Em(S) had any correlation with invasive LVEDP. 
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(A)                                                              (B) 
     
 
                                  (C) 
   
 
(D)                                                              (E) 
    
 
Figure 6.13.  Correlation of LVEDP with (A) VEC-CMR E/Em(S), (B) VEC-CMR 
E/Em(L), (C) VEC-CMR E/Em(S+Lav), (D) VEC-CMR E/Em(5av) and (E) VEC-
CMR E/Em(6av) in N=41 patients (LVEF range: 18.5-71.6%). E, peak mitral inflow 
velocity; Em, early diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic filling 
pressure; VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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6.4.4. Correlation of VEC-CMR E/Em ratio with PWTDE E/Em ratio in patients  
          exhibiting a range of LVEF.  
 
E/Em ratios recorded using VEC-CMR and PWTDE methods were calculated as previously 
described in section 6.4.3. VEC-CMR E/Em ratios then were compared to corresponding 
echo E/Em ratios in all patients (N=41) as shown in Figure 6.14. 
 
As shown in Figure 6.14, in a heterogeneous population of patents with a broad spectrum of 
LVEF, E/Em by CMR had no correlation with Em by echo when Em was measured at the 
septal or lateral side of the mitral annulus. When Em was averaged from readings recorded 
from 5 or 6 LV walls however, a weak-moderate correlation was present between echo and 
CMR methods. 
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(A)                                                             (B) 
      
 
 (C) 
 
 
(D)                                                              (E) 
       
Figure 6.14. .  Correlation between echo and CMR-derived E/Em ratios in N=41 
patients: (A) Echo vs. VEC-CMR E/Em(S), (B) echo vs. VEC-CMR E/Em(L), (C) 
echo vs. VEC-CMR E/Em(S+Lav), (D) echo vs. VEC-CMR E/Em(5av) and (E) echo 
vs. VEC-CMR E/Em(6av) in N=41 patients (LVEF range: 18.5-71.6%). E, peak mitral 
inflow velocity; Em, early diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic 
filling pressure; VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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SUBGROUP ANALYSES: DIASTOLIC MEASUREMENTS IN PATIENTS WITH 
PRESERVED EJECTION FRACTION (LVEF≥55%) 
 
6.4.5.  Correlation and intertechnique agreement of mitral E velocities, mitral A   
           velocities and E/A ratio recorded using VEC-CMR, with spectral Doppler  
           echocardiography mitral E and A velocities and E/A ratios in patients with  
           normal LV systolic function 
 
In study subjects with normal LV systolic function, there was a moderate correlation 
between VEC-CMR mitral E velocity and echo mitral E velocity. A weak-moderate 
correlation was noted between CMR and echo methods for calculating mitral A velocity 
and E/A ratio (Figure 6.15). 
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(A)                                                             (B) 
      
(C)                                                             (D) 
      
(E)                                                             (F) 
      
 
Figure 6.15. (A) Correlation of VEC-CMR mitral E velocity with Doppler echocardiography mitral E 
velocity in 22 subjects (LVEF ≥55). (B) Bland-Altman analysis between VEC-CMR mitral E velocity 
and Doppler echocardiography mitral E velocity; solid horizontal line denotes the mean difference 
between VEC-CMR and Doppler echocardiography measurements, broken horizontal lines 
represent the limits of agreement (2SD around the mean intertechnique difference). Bottom right of 
Bland-Altman plot: mean bias±1.96SD, the mean bias is significant if p<0.05. (C) Correlation of 
VEC-CMR mitral A velocity with Doppler echocardiography mitral A velocity (D) Bland-Altman 
analysis between VEC-CMR mitral A velocity and Doppler echocardiography mitral A velocity in the 
same format as in (B) above. (E) Correlation of VEC-CMR E/A ratio with Doppler echocardiography 
E/A ratio (F) Bland-Altman analysis between VEC-CMR E/A ratio and Doppler echocardiography 
E/A ratio in the same format as in (B) above. SD, standard deviation. 
 
 169 
6.4.6.  Correlation of VEC-CMR E/Em ratio with invasive measurements of left   
          ventricular end diastolic filling pressure in patients with normal LV systolic  
          function. 
 
E/Em(S), E/Em(L) and E/Em(S+Lav) all correlated with LVEDP in patients with normal 
LV systolic function. There was a trend to significance between E/Em(5av) and LVEDP 
and E/Em(6av) and LVEDP (Figure 6.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 170 
(A)                                                               (B) 
       
                                     (C) 
    
(D)                                                               (E) 
    
 
Figure 6.16.  Correlation of LVEDP with (A) VEC-CMR E/Em(S), (B) VEC-CMR 
E/Em(L), (C) VEC-CMR E/Em(S+Lav), (D) VEC-CMR E/Em(5av) and (E) VEC-
CMR E/Em(6av) in N=22 patients (LVEF≥55%). E, peak mitral inflow velocity; Em, early 
diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic filling pressure; VEC–CMR, 
velocity encoded cardiac magnetic resonance imaging 
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6.4.7.  Correlation of VEC-CMR E/Em ratio with PWTDE E/Em ratio in patients  
           with normal LV systolic function. 
 
In individuals with normal LV systolic function, with the exception of E/Em(L), all VEC-
CMR E/Em indices had a moderate correlation with E/Em measured using pulsed-wave 
tissue Doppler echocardiography (Figure 6.17). 
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(A)                                                             (B) 
       
 
    (C) 
 
 
(D)                                                             (E) 
     
 
Figure 6.17. Correlation between echo and CMR-derived E/Em ratios in patients 
with preserved LVEF (LVEF≥55; N=22): (A) Echo vs. VEC-CMR E/Em(S), (B) echo 
vs. VEC-CMR E/Em(L), (C) echo vs. VEC-CMR E/Em(S+Lav), (D) echo vs. VEC-
CMR E/Em(5av) and (E) echo vs. VEC-CMR E/Em(6av). E, peak mitral inflow velocity; 
Em, early diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic filling pressure; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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6.4.8. Regression analysis for comparing variations in VEC-CMR E/Em ratio 
calculation compared to LVEDP in patients with normal LV systolic function. 
 
VEC-CMR E/Em(S), E/Em(L), E/Em(S+Lav), E/Em(5av) and E/Em(6av) were compared 
to each other, indexed against LVEDP, in all 22 patients with normal LVEFs. This was to 
establish if any one VEC-CMR E/Em index had a superior correlation with LVEDP when 
compared to the remaining VEC-CMR E/Em indices. On regression analysis, no single 
index of VEC-CMR E/Em had a significantly stronger correlation with LVEDP when 
compared to the other remaining indices in patients with normal LV systolic function. 
 
Calculating VEC-CMR E/Em(5av) and E/Em(6av) involves recording Em velocities from 5 
and 6 different regions of interest within the basal left ventricular myocardium respectively, 
across 30 phases. This is time consuming and is a limitation of the technique. Calculating 
VEC-CMR E/Em(S), E/Em(L) and E/Em(S+Lav) ratios involve analysing less LV 
myocardial regions of interest improving analysis times and therefore the potential clinical 
applicability of the technique. E/Em(5av) only exhibited a correlation with LVEDP that 
was of borderline significance, and E/Em(6av) did not significantly correlate with LVEDP. 
As calculating VEC-CMR E/Em(5av) and E/Em(6av) confers no statistical advantage over 
E/Em(S), E/Em(L) and E/Em(S+Lav), VEC-CMR E/Em(5av) and E/Em(6av) are excluded 
from further analysis in sections 6.4.14  and 6.4.15. 
 
SUBGROUP ANALYSES: DIASTOLIC MEASUREMENTS IN PATIENTS WITH 
IMPAIRED EJECTION FRACTION (LVEF<55%) 
 
6.4.9 Correlation and intertechnique agreement of mitral E velocities, mitral A 
velocities and E/A ratio recorded using VEC-CMR, with spectral Doppler 
echocardiography mitral E and A velocities and E/A ratios in patients with 
impaired LV systolic function. 
 
A moderately strong correlation was present between VEC-MR and Doppler 
echocardiography methods for measuring mitral E velocity, mitral A velocity and E/A ratio 
in patients with impaired LV systolic function (Figure 6.18). 
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 (A)                                                            (B) 
      
 (C)                                                            (D) 
      
 (E)                                                            (F) 
      
 
Figure 6.18. (A) Correlation of VEC-CMR mitral E velocity with Doppler echocardiography mitral E 
velocity in 19 subjects (LVEF <55%). (B) Bland-Altman analysis between VEC-CMR mitral E 
velocity and Doppler echocardiography mitral E velocity; solid horizontal line denotes the mean 
difference between VEC-CMR and Doppler echocardiography measurements, broken horizontal 
lines represent the limits of agreement (2SD around the mean intertechnique difference). Bottom 
right of Bland-Altman plot: mean bias±1.96SD, the mean bias is significant if p<0.05. (C) Correlation 
of VEC-CMR mitral A velocity with Doppler echocardiography mitral A velocity (D) Bland-Altman 
analysis between VEC-CMR mitral A velocity and Doppler echocardiography mitral A velocity in the 
same format as in (B) above. (E) Correlation of VEC-CMR E/A ratio with Doppler echocardiography 
E/A ratio (F) Bland-Altman analysis between VEC-CMR E/A ratio and Doppler echocardiography 
E/A ratio in the same format as in (B) above. SD, standard deviation. 
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6.4.10  Correlation of VEC-CMR E/Em ratio with invasive measurements of left   
           ventricular end diastolic filling pressure in patients with impaired LV systolic   
           function. 
 
A weak-moderate correlation between E/Em(S+Lav) and invasively recorded LVEDP was 
present in the study cohort with impaired LV systolic function. The remaining VEC-CMR 
indices had no significant correlation with LVEDP (Figure 6.19). 
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(A)                                                              (B) 
    
 
 (C) 
 
 
(D)                                                              (E) 
    
 
Figure 6.19.  Correlation of LVEDP with (A) VEC-CMR E/Em(S), (B) VEC-CMR 
E/Em(L), (C) VEC-CMR E/Em(S+Lav), (D) VEC-CMR E/Em(5av) and (E) VEC-
CMR E/Em(6av) in N=19 patients (LVEF<55%). E, peak mitral inflow velocity; Em, early 
diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic filling pressure; VEC–CMR, 
velocity encoded cardiac magnetic resonance imaging 
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6.4.11 Correlation and intertechnique agreement of VEC-CMR E/Em ratio with  
            PWTDE E/Em ratio in patients with impaired LV systolic function. 
 
There was no significant correlation between VEC-CMR and echo indices of E/Em in 
patients with impaired LV systolic function (Figure 6.20). 
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(A)                                                             (B) 
      
 
  (C) 
 
 
(D)                                                               (E) 
       
 
Figure 6.20. Correlation between echo and CMR-derived E/Em ratios in patients 
with preserved LVEF (LVEF<55; N=19): (A) Echo vs. VEC-CMR E/Em(S), (B) echo 
vs. VEC-CMR E/Em(L), (C) echo vs. VEC-CMR E/Em(S+Lav), (D) echo vs. VEC-
CMR E/Em(5av) and (E) echo vs. VEC-CMR E/Em(6av). E, peak mitral inflow velocity; 
Em, early diastolic tissue relaxation velocity; LVEDP, left ventricular end-diastolic filling pressure; 
VEC–CMR, velocity encoded cardiac magnetic resonance imaging. 
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6.4.12  Receiver-operator characteristics for VEC-CMR E/Em ratios 
 
In the absence of mitral valve disease, LVEDP approximates mean left atrial pressure 
(LAP). The upper limit of normal for both LVEDP and LAP is 12mmHg, as shown in 
Table 1.10. Receiver-operator characteristics were studied for VEC-CMR E/Em(S), 
E/Em(L) and E/Em(S+Lav) ratios to establish cut-off values for normal and elevated LV 
filling pressures by CMR. In our study LVEDP≤12mmHg was defined as normal and 
LVEDP>12mmHg was indicative of elevated LV filling pressure. This chosen threshold 
valuve was the same as the threshold value used for invasive left heart catheter data in both 
the original echo Doppler-catheterisation study by Ommen et al,4 and subsequent echo 
Doppler-catheterisation study by Kasner et al.6  
 
On ROC analysis, E/Em(S)≥9.6 predicted elevated LV filling pressures with a specificity of 
90.10%, and E/Em(S)<4.4 predicted normal LV filling pressures with a specificity of 
89.50%, with E/Em(S) of 4.5-9.5 representing an overlap zone. 
 
E/Em(L)≥10.2 predicted elevated LV filling pressures with a specificity of 90.90%, and 
E/Em(L)<3.6 predicted normal LV filling pressures with a specificity of 94.70%, with 
E/Em(L) of 3.7-10.1 representing an overlap zone. 
 
E/Em(S+Lav)≥8.7 predicted elevated LV filling pressures with a specificity of 90.90%, and 
E/Em(S+Lav)<3.9 predicted normal LV filling pressures with a specificity of 94.70%, with 
E/Em(S+Lav) 4.0-8.6 representing an overlap zone. 
 
6.4.13  Diagnosing diastolic dysfunction by VEC-CMR in a heterogeneous patient  
cohort, based on a modification of the EAE/ASE 2010 guidelines 
 
Since the recruitment of our study cohort, the EAE and ASE have published new guidelines 
in the form of a step-wise algorithm for diagnosing diastolic dysfunction in patients with 
preserved (Figure 1.31) and impaired (Figure 1.32) systolic function.14  Current EAE/ASE 
recommendations for diagnosing diastolic dysfunction involves the non-invasive 
quantification and identification of elevated LAP.  The EAE/ASE guidelines for assessing 
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LV diastolic function have been written for patients undergoing spectral and tissue Doppler 
echocardiography. We have used velocity-encoded magnetic resonance to record mitral 
inflow velocity, E/A ratio and E/Em ratios. Our VEC-CMR protocol for assessing diastolic 
function is based on a similar principle (although vastly different imaging physics) to 
echocardiographic mitral E velocity, E/A and E/Em ratios, and this method requires the use 
of different normative cut-off values specific to CMR. We have therefore modified the 
EAE/ASE guidelines, as described below, for use by VEC-CMR by calculating new 
normative values specific to the CMR protocol used. 
 
Current EAE/ASE guidelines use a mitral E velocity cut-off value of 50cm/s. The inter-
technique bias between mitral E velocity calculated by echo and by CMR was 10.98cm/s. 
Therefore, we determined an equivalent VEC-CMR mitral E velocity cut-off value of 
39cm/s. 
 
Current EAE/ASE guidelines use E/A cut-off values of 1 and 2. The inter-technique bias 
between E/A ratios calculated by echo and by CMR was -0.17. Therefore we determined 
VEC-CMR E/A equivalent threshold values of 1.17 and 2.17. 
 
Our VEC-CMR E/Em normative cut-off values were determined by ROC analysis as 
previously described in section 6.4.11.  
 
Based on the above modifications, we re-analysed our VEC-CMR data, creating a modified 
version of current EAE/ASE guidelines for diagnosing diastolic dysfunction that was 
specific to VEC-CMR (see Figures 6.21 and 6.22 below). 
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Modified EAE/ASE diagnostic algorithm for the estimation of left ventricular filling 
pressures in patients with normal LV systolic function: Modified for analysis of VEC-
CMR indices 
 
 
 
 
Figure 6.21.   Simplified EAE/ASE diagnostic algorithm for the estimation of 
left ventricular filling pressures in patients with normal LVEFs: Modified for 
use in patients undergoing VEC-CMR. 
 
 
Diastolic dysfunction was assessed in the 22 patients with normal LV systolic function 
(LVEF≥55%) using a version of the EAE/ASE diagnostic algorithm, modified by us for use 
in VEC-CMR scanning (Figure 6.21). Ten patients had E/Em ratio’s in the indeterminate 
range and were excluded from the analysis. The presence or absence of elevated diastolic 
filling pressures could be assessed in the remaining 12 patients (55%) using the above 
algorithm. Five of the 6 patients with elevated LVEDP, and all of patients with normal 
LVEDP were accurately diagnosed using the above algorithm (Fishers exact test: p=0.015).   
The sensitivity, specificity, positive and negative predictive values were 83.30%, 100.00%, 
100.00% and 85.71% respectively. 
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Modified EAE/ASE diagnostic algorithm for the estimation of left ventricular filling 
pressures in patients with impaired LV systolic function: Modified for analysis of VEC-
CMR indices 
 
 
 
 
Figure 6.22.  Simplified EAE/ASE diagnostic algorithm for the estimation of 
left ventricular filling pressures in patients with impaired LVEFs: Modified for 
use in patients undergoing VEC-CMR.  
 
 
Diastolic dysfunction was assessed in the 19 patients with impaired LV systolic function 
(LVEF<55%) using a version of the EAE/ASE diagnostic algorithm, modified by us for use 
in VEC-CMR scanning (Figure 6.22). Fourteen patients had E/Em ratio’s in the 
indeterminate range and were excluded from the analysis. The presence or absence of 
elevated diastolic filling pressures could only be assessed in 5 patients (26%) using the 
above algorithm. One of the 2 patients with elevated LVEDP, and one of the 3 patients with 
normal LVEDP were accurately diagnosed using the above algorithm (Fishers exact test: 
p=NS).   The sensitivity, specificity, positive and negative predictive values were 50.00%, 
33.33%, 33.33% and 50% respectively. 
 
 
 
 183 
6.4.14 Reproducibility 
 
Intra- and inter-observer variability for CMR measures of mitral E velocity, mitral A 
velocity, E/A ratio, Em(S), Em(L), E/Em(S), E/Em(L) and E/Em(L+Sav) are expressed as 
the co-efficient of variation, and as the mean bias, limits of agreement and standard 
deviation of the difference as shown in Tables 6.2 and 6.3. Reproducibility of transmitral 
Doppler echocardiography is well documented with intra- and inter-observer correlations 
≥0.89 for transmitral flow velocities.332 Reproducibility of mitral annular tissue velocities 
are excellent with an intra-class correlation co-efficient of 0.9.333 
 
 
 
Table 6.2. Intra-observer variability for CMR measurements of LV diastolic 
function. .  A, peak late transmitral inflow velocity associated with atrial contraction; E, peak 
early transmitral inflow velocity; Em, early peak myocardial tissue relaxation velocity; L, basal LV 
lateral wall; S, basal septum. 
 
 
 
 
Index of LV 
diastolic function 
% Co-efficient of 
variation 
Mean bias Limits of 
agreement 
SDD 
 
CMR PARAMETERS 
1) Mitral E velocity 
2) Mitral A velocity 
3) E/A ratio 
4) Em(S) 
5) Em(L) 
6) E/Em(S) 
7) E/Em(L) 
8) E/Em(S+Lav) 
 
 
 
2.57 
0.78 
3.16 
4.37 
8.84 
6.57 
11.19 
8.20 
 
 
-1.32 
0.23 
-0.05 
0.46 
0.86 
-0.45 
-0.32 
-0.41 
 
 
-9.67 to 7.03 
-1.42 to 1.92 
-0.34 to 0.24 
-1.02 to 1.93 
-3.24 to 4.95 
-1.82 to 1.19 
-2.07 to 1.42 
-1.39 to 0.57 
 
 
4.17 
0.83 
0.15 
0.74 
2.05 
0.69 
0.87 
0.49 
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Table 6.3.  Inter-observer variability for CMR measurements of LV diastolic 
function.  A, peak late transmitral inflow velocity associated with atrial contraction; E, peak early 
transmitral inflow velocity; Em, early peak myocardial tissue relaxation velocity; L, basal LV lateral 
wall; S, basal septum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index of LV 
diastolic function 
% Co-efficient of 
variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
CMR PARAMETERS 
1) Mitral E velocity 
2) Mitral A velocity 
3) E/A ratio 
4) Em(S) 
5) Em(L) 
6) E/Em(S) 
7) E/Em(L) 
8) E/Em(S+Lav) 
 
 
1.26 
3.27 
3.66 
9.92 
10.94 
9.22 
11.74 
8.75 
 
 
 
0.27 
1.01 
-0.03 
0.96 
1.37 
-0.68 
-0.39 
-0.57 
 
 
 
-3.65 to 4.19 
-4.08 to 6.11 
-0.25 to 0.18 
-2.29 to 4.21 
-3.68 to 6.42 
-3.06 to 1.70 
-2.05 to 1.26 
-1.81 to 0.67 
 
 
1.96 
2.55 
0.11 
1.63 
2.52 
1.19 
0.83 
0.62 
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(A) 
 
(B) 
 
 
 
Figure 6.23. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring mitral E velocity using cardiac magnetic 
resonance imaging (cm/s). 
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(A) 
 
 
(B) 
 
 
Figure 6.24. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring mitral A velocity using cardiac magnetic 
resonance imaging (cm/s). 
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(A) 
 
 
(B) 
 
 
 
Figure 6.25. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring mitral E/A ratio using cardiac magnetic 
resonance imaging.  
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(A) 
 
 
(B) 
 
 
 
Figure 6.26. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring peak myocardial tissue velocity of the basal 
LV septum (EmS) by cardiac magnetic resonance imaging (cm/s). 
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(A) 
 
 
(B) 
 
 
 
Figure 6.27. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring peak myocardial tissue velocity of the basal 
LV lateral wall (EmL) by cardiac magnetic resonance imaging (cm/s).  
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(A) 
 
 
(B) 
 
 
 
Figure 6.28. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring E/EmS ratio by cardiac magnetic resonance 
imaging. 
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(A) 
 
 
(B) 
 
 
Figure 6.29. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring E/EmL by cardiac magnetic resonance 
imaging. 
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(A) 
 
 
(B) 
 
 
 
Figure 6.30. Bland-Altman Plot of (A) intra-observer variation and (B) inter- 
observer variation for measuring E/EmS+Lav ratio by cardiac magnetic 
resonance imaging. 
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6.5.  DISCUSSION 
  
The first objective of this study was to examine the feasibility of using a VEC-CMR 
imaging protocol to calculate E//Em ratio as a non-invasive estimate of left ventricular 
diastolic filling pressure.  The second objective was to examine the accuracy of this new 
technique in heterogeneous population of patients exhibiting a wide range of LVEF, by 
directly comparing VEC-CMR E/Em ratios against LVEDP recorded invasively during left 
heart catheter studies. The third objective of this study was to examine the relationship of 
E/Em ratios recorded using VEC-CMR with E/Em recorded using pulsed-wave tissue 
Doppler echocardiography. Since completion of our study recruitment, there have been 
several single centre studies questioning the accuracy of echo-derived E/Em for estimating 
LV filling pressures in certain patient cohorts.15-19  A recent study by Mullens et al found 
no correlation between E/Em and PCWP measured in patients with severely impaired 
LVEFs.16  As a result of increasing research in this area, and since completion of our study 
recruitment, the American Society of Echocardiography and European Association of 
Echocardiography have issued new guidelines for diagnosing diastolic dysfunction.14  
These guidelines include two new step-wise protocols for diagnosing elevated mean left 
atrial pressures (as a definitive marker of diastolic dysfunction) using E/Em and other 
echocardiographic parameters of diastolic function in patients with normal and impaired 
left ventricular systolic function respectively.  The guidelines recommend E/Em as the first 
line index for diagnosing diastolic dysfunction in patients with preserved LVEF. For 
patients with impaired LV systolic function, an assessment of diastology is recommended 
using peak transmitral E-wave velocity, E/A ratio and mitral deceleration times as first line 
indices for diagnosing diastolic dysfunction as shown in Figure 1.32. In response to these 
new guidelines, we have re-analysed our data, using our own modification of these 
protocols tailored specifically for use with diastolic indices measured using the cardiac 
magnetic resonance protocols described above. This guideline modification for use by 
VEC-CMR will require validation in a separate patient cohort before its use in clinical 
practice should be contemplated. 
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6.5.1.  Comparing VEC-CMR peak transmitral inflow velocities, myocardial tissue 
           velocities and E/A ratios with spectral and tissue Doppler echo recordings and  
           LV filling pressures 
 
Mitral inflow velocities (E and A) measured by VEC-CMR were lower than those 
measured by spectral Doppler echocardiography. This may be partly due to the lower 
temporal resolution of VEC-CMR (30 phases/cycle) when compared to Doppler 
echocardiography (frame rate >90/cycle). There was a moderately good inter-modality 
correlation between echo and CMR mitral E velocities, and between echo and CMR mitral 
A velocities, and a moderate inter-modality correlation in E/A ratios.  This finding is 
consistent with previously published data comparing CMR and echo mitral inflow patterns, 
and most likely reflects the similar sampling sites used by the two imaging modalities, at 
the level of the mitral valve leaflet tips.223-225  By comparison, early diastolic relaxation 
myocardial tissue velocities (VEC-CMR Em) measured using VEC-CMR were 
significantly higher than the early diastolic relaxation mitral annular tissue velocities 
measured using tissue Doppler echocardiography (PWTDE Em). There was no significant 
correlation between Em values recorded using VEC-CMR and those using pulsed-wave 
tissue Doppler echocardiography.  There may be several reasons for this.  Em tissue 
velocities were measured by echocardiography from apical long-axis views of the heart by 
using pulsed-wave TDE from the junction of the mitral annulus and basal LV myocardium, 
as is standard practice. Using this method a TVI velocity trace is recorded from a pulsed 
sample volume that remains in a static position throughout the cardiac cycle and the mitral 
annulus moves up and down through the pulse sampling volume in the long-axis. By 
comparison, myocardial tissue velocities were recorded by VEC-CMR using through-plane 
views of the heart.  Using this method, the base of the heart actually move in and out of 
plane if the velocity-encoded slice is selected at the level of the mitral annulus, and so data 
throughout the whole of the cardiac cycle cannot be recorded. For this reason, our VEC-
CMR slice selection was at approximately two thirds of the length of the LV long-axis, at 
the level of the upper basal LV myocardium, and not at the level of the mitral annulus.   
Furthermore using PWTDE, the sampled Em velocity is at the level of the junction of the 
mitral annulus with basal LV endocardium.  Using VEC-CMR, the Em region of interest 
was within the middle of the basal LV myocardium.  During image acquisition every 
attempt was made to ensure carefully selected on-axis apical views through the middle of 
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all 6 LV walls by echocardiography.  During VEC-CMR analysis of the 6 LV myocardial 
tissue velocities recorded for each study subject, care was taken to ensure the 6 regions of 
interest within the basal LV myocardium selected reflected as closely as possible the 6 LV 
wall positions (anteroseptum, anterior, lateral, posterior, inferior and septal) recorded from 
the 3 apical echocardiographic views of the heart. Selecting the 6 region of interest sites 
within the basal myocardium from VEC-CMR through-plane views relied on a visual 
judgement of the position and delineation of the six LV wall mid-points and boundaries as 
demonstrated previously in Figure 6.3, and there may therefore have been an unavoidable 
degree of variability between echo and CMR region of interest positions. Furthermore, the 
amplitudes of the recorded PWTDE measurements are dependent on the angle of insonation 
of the ultrasound beam from the transducer. Any Doppler angulation beyond zero degrees 
would therefore result in a reduction in the maximal recorded Em tissue velocity, as per the 
Doppler shift equation.  The measurement of peak myocardial tissue velocities using VEC-
CMR is not angle dependent. Although care was taken to minimise the Doppler angulation 
during echo scanning to <20 degrees, any deviation from zero degrees would result in an 
underestimate of echo-recorded Em velocities compared to CMR-recorded Em velocities. 
Our finding is consistent with that of another recently published study by Jung et al, who 
noted an increase in peak Em velocities recorded by CMR compared to echo-measured 
CMR velocities from various different but comparable regions of interest within the 
ventricular myocardium.20  
 
In this study, we noted no relationship between invasively recorded LVEDP and peak 
transmitral E wave velocity, recorded by either VEC-CMR or Doppler echocardiography. 
There was no relationship between invasively recorded LVEDP and E/A ratio, recorded by 
either VEC-CMR or Doppler echocardiography.  These findings are consistent with 
previously published data.13,191,192  
 
6.5.2.  Comparing VEC-CMR E/Em with echo E/Em and LV filling pressures 
 
Using VEC-CMR, E velocity was lower and Em velocity higher than measured using 
echocardiography and this combination resulted in calculated E/Em ratios being 
significantly lower when measured using VEC-CMR compared to Doppler 
echocardiography.  Over a wide range of LVEF’s, E/Em(S), E/Em(L) and E/Em(S+Lav) 
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ratios measured by VEC-CMR had no correlation with the equivalent E/Em ratios 
measured by echocardiography. When Em velocities were averaged from 5 or 6 LV walls, 
there was a weak-moderate correlation between CMR and echo techniques, and this may 
reflect a smoothing effect in site selection velocities.  In study subjects with preserved 
LVEF there was a moderate correlation between VEC-CMR E/Em and echo E/Em. There 
was no correlation in E/Em ratios between imaging modalities in patients with impaired LV 
systolic function. This may reflect the fact that the majority of our patients in this study had 
known or suspected coronary artery disease, and hence of the 19 patients with impaired 
ventricular function, 12 (63%) had regional wall motion abnormalities. Em velocities may 
be affected by changes in regional as well as global function. As the Em velocities recorded 
by PWTDE for each LV wall were at a more basal and subendocardial site than the 
corresponding VEC-CMR Em velocities in patients with ischaemic heart disease and 
regional wall motion abnormalities, this could account for the poor correlation between 
CMR and echo-E/Em ratios in patients with impaired LV systolic function and is a 
recognised limitation of this study. 
 
Our VEC-CMR Em velocities were recorded from the basal LV myocardium and not the 
mitral annulus. Although this may affect the absolute Em velocity recorded, it should not 
significantly affect the validity of the resultant E/Em ratio as a reflection of the diastolic 
filling pressure of the left ventricle. The early diastolic myocardial tissue relaxation 
velocity Em, measured by VEC-CMR, is used to correct the peak transmitral E wave 
velocity for the influence of the time constant of myocardial relaxation, such that VEC-
CMR E/Em should closely reflect changes in the LV diastolic filling pressure. When VEC-
CMR E/Em was compared directly to LVEDP in all patients (n=41) exhibiting a broad 
range of LVEF, only E/Em(S) had a weak correlation with LVEDP.  The remaining E/Em 
indices exhibited no significant correlation to LVEDP measurements. Similarly, the cohort 
of patient with impaired LV systolic function, only E/Em(S+Lav) had any correlation with 
invasively measured LV filling pressures. The remaining VEC-CMR E/Em ratios showed 
no correlation to LVEDP measurements. In both cases, the limited correlation, may have 
been influenced by the presence of regional ischaemia and regional wall motion 
abnormalities. Although, it can be argued that this is a limitation of the study, these results 
are also important and valid. Ischaemic cardiomyopathy is the most common cause of LV 
systolic dysfunction in clinical practice. Current echocardiographic guidelines suggest 
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averaging Em velocities recorded from the septal and lateral sides of the mitral annulus to 
minimise the influence of regional changes, but do not preclude the use of E/Em ratio in 
patients with regional wall motion abnormalities.14  If E/Em ratio by CMR correlates poorly 
with LVEDP in patients with impaired ventricular function and regional wall motion 
abnormalities, then this technique should not be used to estimate LVEDP in this patient 
cohort.  
 
By comparison, in our cohort of patients with preserved LVEF, VEC-CMR E/Em(S), 
E/Em(L) and E/Em(S+Lav) had a moderate correlation with LVEDP. Measuring Em 
averaged from 5 or 6 sites within the ventricular myocardium significantly increases 
analysis times when compared to measuring Em from the septal and lateral positions only, 
limiting the clinical application of this technique. Averaging Em from 5 or 6 sites within 
the LV myocardium did not improve the correlation with LVEDP when compared to 
E/Em(S), E/Em(L) and E/Em(S+Lav) (p=NS), and therefore we do not recommend doing 
so. 
 
Recent EAE/ASE guidelines now recommend two distinct diagnostic algorithms for the 
non-invasive estimation of LV filling pressures in patients with normal and depressed 
LVEFs respectively. For this reason we re-analysed our VEC-CMR data as categorical, 
rather than numerical variables, using simplified versions of the two EAE/ASE diagnostic 
algorithms, with modified normative cut-off values specific to VEC-CMR which we 
determined from receiver-operator characteristics. Using our specific CMR modification of 
the EAE/ASE guidelines for assessing diastolic function, we have demonstrated that VEC-
CMR E/Em has a high sensitivity and high specificity for correctly diagnosing both normal 
and elevated LV filling pressures in individuals with preserved LV systolic function, but 
not in those with significant LV systolic impairment. 
 
 6.5.3  Comparing VEC-CMR E/Em results in this study with current research 
 
We found the Em velocities recorded by CMR were significantly higher than those 
recorded using TDE techniques.  While the site selection differences of the Em region of 
interests within the ventricular myocardium between the two techniques may have in part 
accounted for this finding in our patient population, it is unlikely to be the only explanation. 
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Jung and colleagues have published two studies, in separate patient cohorts comparing Em 
velocities recorded by VEC-CMR and TDE at similar sites within the LV.  In the first 
study, standard VEC-CMR temporal resolution scanning was used (temporal resolution: 
62-ms VEC-CMR vs. 40ms- TDE) in a cohort of 29 healthy volunteers.334  In the second 
study, a high-temporal resolution magnetic resonance tissue phase mapping sequence 
(temporal resolution: 13.8ms) was used in 12 healthy volunteers and 2 individuals with left 
ventricular hypertrophy, and compared with similar site TDE Em measurements.20  Both 
studies found a marked inter-technique discordance in peak Em velocity measurements, 
with Em velocities acquired using VEC-CMR being significantly higher than those 
recorded using the pulsed-wave TDE method.20,334 
 
To our knowledge, there is only one other small single centre study by Paelinck and 
colleagues which examines the use of VEC-CMR for diagnosing diastolic dysfunction.  
This small pilot study explores the relationship of VEC-CMR E/Em with LV filling 
pressures in a cohort of 18 patients with left ventricular hypertrophy and preserved LV 
systolic function.194  This study differs from ours in several ways.  Firstly, they only 
include patients with preserved systolic function, whereas we have chosen to validate the 
technique in patients with both preserved and impaired LVEFs. Secondly, they measured 
mean pulmonary capillary wedge pressure (mPCWP) during right heart catheter as an 
estimate of left ventricular filling pressure, using mPCWP>15mmHg as indicative of 
elevated diastolic filling pressure. Although, mPCWP and LVEDP have been shown to 
have a close relationship (r=0.81) they are not the same.7  PCWP may not accurately reflect 
LVEDP in patients with pulmonary artery hypertension and significant mitral valve 
pathology. Although, this limitation may not be relevant in Paelinck’s homogeneous study 
population, it is in our deliberately heterogeneous patient cohort which included 4 patients 
with primary pulmonary hypertension, and one patient with pulmonary hypertension 
secondary to a secundum ASD.  We felt it was preferable and more accurate to measure 
LVEDP directly during left heart catheterisation, using LVEDP of 12mmHg as our 
normative threshold value for the reasons previously described.  Despite these differences 
in study design and methodology, the results of our subgroup analysis of study subjects 
with preserved LVEF broadly compliments that of the Paelinck study. Both studies show 
moderate correlation between invasive measures of LV diastolic filling and various VEC-
CMR E/Em ratios.  Both studies also show moderate correlation between echo and VEC-
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CMR E/Em ratios, with the exception of VEC-CMR E/Em recorded from the lateral LV 
wall, which did not correlate with echo E/Em(L) in either study. 
 
To our knowledge, our study is the first to examine the use of VEC-CMR E/Em ratios as a 
non-invasive estimate of LVEDP, and hence diastolic function, in individuals with systolic 
heart failure secondary to both ischaemic and non-ischaemic causes. We found that peak 
transmitral E wave velocity divided by the mean of the septal and lateral Em velocities had 
a moderate correlation with LVEDP in patients with impaired ventricular function, whereas 
E/Em(S) and E/Em(L) individually did not.  As 63% of our cohort with impaired LV 
function had ischaemic heart disease, we also averaged Em from recordings taken from all 
six basal LV walls, to minimise the effect of regional dysfunction. This did not appear to 
make any difference, with E/Em(5av) and E/Em(6av) failing to correlate with measured 
LVEDP.  The reason for is unclear and warrants further investigation. Unfortunately, the 
small numbers of patients in this study prevents further meaningful subgroup analysis of 
those with depressed LVEFs. 
 
6.5.4  Study limitations 
 
This small pilot study was designed to establish if velocity encoded CMR tissue phase 
mapping sequences could be used to non-invasively estimate LV diastolic filling pressures 
in a manner analogous to echo E/Em. To be valid for use in clinical practice, we believed 
the technique had to be valid in a heterogenous population exhibiting a range of LVEF, as 
seen in our clinical practice. The results of our study compliment twhose of Paelinck, and 
suggest VEC-CMR E/Em may be clinically useful for diagnosing diastolic dysfunction in 
individuals with preserved LV systolic function. The accuracy of this technique in patients 
with impaired LVEF remains less clear. Unfortunately the small size and heterogeneous 
nature of our study cohort with impaired LVEF, precluded further meaningful subgroup 
analysis of this group, and warrants further study in the future. 
 
New EAE/ASE guidelines recommend two differing step-wise algorithms for diagnosing 
diastolic dysfunction on patients with a) preserved LVEF and b) impaired LVEF. In 
patients with preserved LVEF, low E/Em ratios are indicative of a normal LVEDP, and 
high E/Em ratios indicative of a high LVEDP.14  When we re-analysed our data using a 
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modification of the EAE/ASE step-wise algorithm for individuals with preserved LVEF, 
45% of our study cohort had E/Em ratios in the intermediate range. Where E/Em is of an 
intermediate value, LVEDP may be normal or elevated, and the EAE recommend that 
additional echo features, such as elevated LA volumes (>34ml/m2), need to be present to 
confirm the diagnosis of diastolic dysfunction in this intermediary cohort. Unfortunately 
these guidelines were published following the recruitment of our study cohort, and an LA 
volume stack was not part of our CMR protocol. The cohort of patients with preserved 
LVEF and intermediate E/Em, could not be analysed further to determine if diastolic 
function was present and this is a significant limitation of our study. Although CMR E/Em 
ratios were highly specific for accurately predicting normal or elevated LVEDP in the 55% 
of individuals in whom E/Em fell within the diagnostic range, we must conclude that 
overall CMR is likely to be a poor predictor of LVEDP in clinical practice due to the large 
number of subjects (45%) with E/Em ratios falling into the indeterminate range. 
 
Ideally we would have liked to recruit an unselected heterogenous patient population into 
this study.  However, due to the inherent risk of left heart catheterisation, we felt this was 
difficult to justify in ethical terms, and so patients undergoing invasive LVEDP recordings 
had to have a clinical indication for the left heart catheterisation study. For this reason, our 
study cohort may have a higher prevalence of coronary artery disease than that of a truly 
unselected population, and this may have biased our results.   
 
Left ventricular haemodynamics are best measured invasively using micro-manometer 
conductance catheters. Unfortunately expense and limited availability prevented the use of 
a micro-manometer catheter in this study and LVEDP was measured by the interventional 
cardiologist at the time of left heart catheterisation using a traditional fluid-filled catheter 
system. Although this method may not be as accurate and detailed as measuring pressure-
volume loops it is the reference standard by which LVEDP is quantified in routine clinical 
practice, and we would argue is superior to measuring PCWP which has been used as a 
surrogate marker of mLAP/LVEDP in several Doppler echo E/Em-invasive catheter 
comparison studies.5,16,335,336 
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6.5.5  Conclusion and future work 
 
VEC-CMR E/Em(S), E/Em(L) and E/Em(S+Lav) ratios have a moderate correlation with 
LVEDP in patients with preserved LVEF.  This finding suggests that velocity encoded 
magnetic resonance tissue phase mapping can be used to estimate left ventricular diastolic 
filling pressures and diagnose left ventricular diastolic dysfunction in patients with 
preserved LV systolic function. Using a modification of the EAE/ASE guidelines for 
diagnosing diastolic dysfunction in patients with preserved LVEF, modified specifically for 
use by VEC-CMR derived velocity indices, VEC-CMR E/Em was both sensitive and 
specific for correctly diagnosing and excluding elevated diastolic filling pressures. 
However, a significant number of patients had VEC-CMR E/Em values which fell within 
the indeterminate zone, limiting the clinical application of the technique, and this cohort 
requires further review. Further work could include secondary measures in this cohort, such 
as the assessment of left atrial volume by CMR. A larger prospective study of patients with 
1) normal LVEF and symptoms consistent with heart failure and 2) normal LVEF and no 
symptoms of heart failure is now required. Invasive LV filling pressure needs to be 
recorded in this study and the CMR imaging protocol should include an atrial short axis 
stack of steady state free precession imaging in addition to the VEC-CMR protocol 
described above. 
 
The accuracy of VEC-CMR E/Em in estimating LV diastolic filling pressures in patients 
with impaired ventricular function remains unclear. Further work is required. A future 
study of VEC-CMR E/Em velocity ratios indexed against LVEDP in patients with impaired 
LV systolic function secondary to dilated cardiomyopathy (in the absence of regional wall 
motion abnormalities) would provide useful insight into both the accuracy and the 
prognostic implications of an elevated VEC-CMR E/Em ratio in this patient cohort. 
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WITH CARDIAC MAGNETIC RESONANCE 
IMAGING” 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7: RV SYSTOLIC FUNCTION 
 
7.1  BACKGROUND 
 
The right ventricle was historically viewed as a passive conduit connecting the venous 
circulation to the pulmonary circulation. Until relatively recently the RV was considered 
less important than the LV in maintaining normal cardiovascular haemodynamics, and 
therefore study of the RV has been largely neglected in favour of research into left 
ventricular physiology. It is not until recent years that the true importance of this 
“forgotten” ventricle in cardiovascular pathophysiology is finally being appreciated.  It is 
now well recognised that right ventricular systolic function is of clinical and prognostic 
importance in a variety of cardiac diseases.82,337-340  Despite this knowledge, systematic 
quantitative assessment of right ventricular function is not uniformly performed during 
echocardiographic imaging studies, and a visual assessment of RV function remains the 
standard by which RV systolic function is assessed in many centres. This is due in part to 
the complex geometry of the right ventricle, rendering volumetric assessments of RV 
function by 2DE inaccurate, and also to the paucity of ultrasound studies providing normal 
values of right heart function.  Furthermore, the myofibre architecture of the RV lacks the 
middle contrictor fibre layer seen within the LV, and therefore relies more heavily on its 
long axis contractility to maintain RVEF.63  Due to the geometric complexity of the RV and 
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the predominance of RV long axis contractility, there has been recent interest in assessing 
RV systolic function by non-volumetric methods in particular TDE, myocardial 
deformation imaging and methods quantifying measures of tricuspid annular motion. In 
response to increasing echocardiographic study in this area, the American Society of 
Echocardiography published in 2010 revised guidelines, endorsed by both the European 
Association of Echocardiography and the Canadian Society of Echocardiography, for the 
echocardiographic assessment of the right heart in adults.37   The guidelines review ten non-
volumetric methods for quantifying RV systolic function, and for selected methods, suggest 
normal reference ranges based on data pooled from several studies.  The guidelines 
conclude that visual assessment of RV systolic function should be combined with at least 
one quantitative index of RV function – either tricuspid annular plane systolic excursion 
(TAPSE), RV myocardial performance index (RV MPI), pulsed-wave tissue Doppler peak 
systolic velocity of the lateral tricuspid annulus (RV PWTDE S’) or fractional area change 
(FAC).  The guidelines also consider the use of RV isovolumic acceleration (RV IVA) and 
strain imaging, but do not at present recommend the clinical use of these techniques due to 
the current paucity of data and lack of reference ranges.37 
 
Standardizing assessment of RV function is important for both clinical and prognostic 
reasons and will improve service delivery of cardiac diagnostic imaging within and 
between centres. To our knowledge, there are no head-to-head studies comparing multiple 
different non-volumetric indices of RV function in a heterogeneous population of patients. 
At the time of writing it remains unclear which if any, of the available quantitative 2DE 
non-volumetric assessments of RV function is superior to the others when compared to 
CMR, is the most reproducible, has the highest potential clinical application and should 
therefore be the echocardiography method of choice for assessing RV function in the 
heterogenous population of patients seen in clinical practice.   
 
Although there is no “gold standard” for assessing RV systolic function, the superior spatial 
resolution of CMR, coupled with its ability to image the heart in any plane, makes it the 
widely accepted reference standard for quantifying right ventricular volumes and ejection 
fraction. 
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The aim of this study was to compare ten non-volumetric 2DE methods for quantifying RV 
systolic function, indexed against CMR-RVEF as the reference standard, in a heterogenous 
population patients exhibiting a wide range of RVEFs. Methods reviewed in the ASE 
guidelines include measurement of RV dP/dT and regional tissue Doppler strain. The use of 
RV dP/dT for quantifying RV function requires the presence of significant tricuspid 
regurgitation (TR) and therefore cannot be used in patients without TR. Furthermore dP/dT 
is load dependent and may be inaccurate in patients with severe TR due to the neglect of 
the inertial component of the Bernouilli equation and the rise in right atrial pressure. For a 
technique to have high clinical application, it needs to be accurate and applicable to all. For 
these reasons the ASE do not recommend RV dP/dT for routine use and we therefore chose 
to exclude this measurement from our study. From both our own experience and the 
experience of others, we know that measurement of regional strain using tissue Doppler 
techniques is susceptible to significant inaccuracy due to angle dependency, high signal-to-
noise ratio and wide limits of agreement caused by high inter-observer variation in manual 
region of interest site selection and manual temporal tracking.166,341-343  For these reasons 
tissue Doppler strain techniques are not recommended by the ASE, and are not included in 
our study.  The remaining eight non-volumetric indices of RV function described by the 
ASE/EAE/CSE guidelines are included in our study.37  In addition to these indices, we have 
chosen to include two differing assessments of RV strain measured using the more accurate 
speckle tracking technique, plus one novel tissue Doppler index of tricuspid annular plane 
systolic excursion developed by us, which we have not found previously described in the 
current literature. Each RV index is described in detail below. 
 
7.2   STUDY AIM 
 
The aim of this study was to compare ten non-volumetric 2DE methods for quantifying RV 
systolic function, indexed against CMR-RVEF as the reference standard, in a heterogenous 
population of patients exhibiting a wide range of RVEFs. 
 
7.3  METHODS 
 
7.3.1  Study Design 
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This study was approved by the Regional Ethics Committee and study subjects gave written 
informed consent. Sixty patients exhibiting a broad spectrum of RVEF’s (Range 24-73%) 
were prospectively studied. They were recruited from outpatient clinics, elective 
echocardiography and cardiac catheterisation lists.  
 
All study subjects underwent standard 2DE (GE Vivid 7) and CMR (1.5T Siemens Sonata) 
consecutively. RVEF was calculated by CMR as described below. Ten non-volumetric 
echocardiographic indices of global RV systolic function were assessed from 2DE as 
described below. The ten echocardiographic methods for quantifying RV function were 
then correlated against CMR-RVEF, and compared against each other.  Where normative 
cut-off values for the technique have previously been published by the ASE/EAE/CSE, 
these cut-off values were applied to ROC curves to determine the sensitivity and specificity 
of the specified RV index in our patient cohort.  For RV indices in which no normative 
threshold values have been determined, ROC analysis was performed to establish normal 
RV function cut-off values for each echocardiographic method.  As visual assessment of 
the right ventricle is the standard by which RV systolic function is still quantified in many 
centres, patients were also visually assessed as having normal, mild, moderate or severe RV 
dysfunction on echocardiography by a British Society of Echocardiography accredited 
operator blinded to the CMR results.   
 
7.3.2  Patient Selection 
 
A heterogeneous population of patients in sinus rhythm, exhibiting a broad spectrum of RV 
systolic function, was studied. Patients were excluded if they had a contraindication to 
CMR, had severe calcific tricuspid valve disease, moderate-severe tricuspid annular 
calcification, tricuspid annular ring or prosthesis, or if it was not possible to image the right 
heart clearly from the apical 4-chamber view. 
 
7.3.3  Imaging Methods.   
 
 CMR and 2DE were performed consecutively, within 30 minutes of each other, to ensure 
similar heart rates and cardiac loading conditions.  
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Cardiac Magnetic Resonance.  
 
The CMR RV systolic function acquisition protocol was performed as previously described 
in section 3.4.2. 
 
Two-dimensional Echocardiography. 
 
2DE imaging was performed using a Vivid 7 scanner, (GE Medical Systems, Wauwatosa, 
WI).  All patients were imaged in the left lateral decubitus position and depth and frame 
rate were optimised.  The right ventricle was imaged from the parasternal short axis, 
parasternal long axis and apical-4 chamber views of the heart. Study subjects were then 
imaged in the supine position and the right ventricle was further assessed from the 
subcostal view of the heart. A visual assessment of global right ventricular function was 
made from review of the above 2D images. Harmonic imaging was used consistently 
throughout each study.  
 
Tricuspid inflow and Pulmonary outflow spectral Doppler acquisition for assessing RV 
Myocardial Performance Index 
 
A pulsed-wave Doppler signal was recorded through the pulmonary valve from the 
parasternal short axis view taking care to ensure a Doppler angle of <20degrees.  If it was 
not possible to obtain a clear Doppler envelope from this view, then a spectral Doppler 
recording was made through the pulmonary valve in either the modified parasternal long 
axis RV outflow view or the subcostal short-axis view of the heart.  A pulsed-wave Doppler 
signal was then recorded through the tricuspid valve from the apical 4-chamber view of the 
heart. The spectral Doppler traces were stored for subsequent post-processing. 
  
Acquiring colour M-mode data sets for the assessment of Tricuspid Annular Plane Systolic 
Excursion  
 
Right ventricular M-Mode measurements were made from the apical-4 chamber view of the 
heart in paused expiration. The M-Mode cursor was placed at the junction of the lateral 
tricuspid annulus and right ventricular free wall one centimetre from the insertion point of 
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the tricuspid valve leaflet as per EAE guidelines.332  The subsequent time-motion mode 
recording was acquired with a sweep speed of 100mm/s to ensure consistency in temporal 
resolution. To further improve accuracy a colour tissue Doppler trace was superimposed on 
the M-Mode recording as shown in Figure 7.3, with the red-blue interface representing 
peak systolic tricuspid annular excursion during systole prior to the onset of diastolic 
relaxation of the RV.  Colour Doppler M-mode recordings were stored for subsequent post-
processing. 
 
Acquiring pulsed-wave tissue Doppler traces for assessing the tricuspid annular peak 
systolic tissue velocity and tissue Doppler-derived RV myocardial performance index. 
 
Tissue Doppler imaging now allows the recording of longitudinal myocardial tissue 
velocities and mitral and tricuspid annular velocities. The tricuspid annular peak systolic 
tissue velocity (PWTDE S’) is a measure of the longitudinal contractile function of the right 
ventricle.  A tissue Doppler velocity trace of the RV was measured by placing a pulsed-
wave sample volume at the junction of the right ventricular free wall and lateral tricuspid 
annulus one centimetre from the insertion point of the tricuspid valve leaflet, in the apical 
4-chamber view of the heart.332 To improve accuracy, care was taken to ensure a Doppler 
angle of <20 degrees, and translational motion of the heart was reduced by acquiring the 
image in paused expiration. The pulsed-wave tissue Doppler trace was then stored for 
subsequent analysis. The tissue Doppler myocardial performance index was also calculated 
from this velocity trace. 
 
Right ventricular TDI-Q acquisition for analysis of colour tissue Doppler systolic 
velocities, isovolumic acceleration and tissue Doppler tricuspid annular plane systolic 
excursion. 
 
Colour tissue Doppler images of the right ventricle were acquired from the apical 4-
chamber views with frame rates ≥100 frames/sec and pulse repetition frequencies between 
500 Hz to 1 KHz.  Three consecutive beats were stored and analysed during post 
processing. A continuous-wave Doppler tracing of pulmonary outflow was recorded 
through the pulmonary valve from the parasternal short axis view to enable calculation of 
event timings during post-processing.  
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Acquiring RV data sets for assessing RV Fractional Area Change 
 
The RV was imaged from the apical 4-chamber view of the heart in the zoomed mode 
taking care to optimise RV endocardial wall definition and avoid apical foreshortening.  
Subsequent RV data sets were stored. 
 
Acquiring RV data sets for assessing RV global strain and RV free wall strain using 2D 
speckle tracking software. 
 
The ventricles were imaged from the apical windows as previously described. Care was 
taken to optimise endocardial wall definition of the RV. Images of the RV were acquired 
from the apical 4-chamber view taking care to avoid apical foreshortening. An apical long 
axis view of the RV was acquired to enable event-timing markers to be added during post-
processing of the data sets. 
 
7.3.4  Image Analysis. 
 
Cardiac Magnetic Resonance 
 
RV volumes were quantified and RVEF calculated by CMR using the method described in 
section 3.4.2.  Normal RV systolic function was defined as a CMR-derived RVEF ≥47% as 
is standard practice. 
 
Two-dimensional Echocardiography 
 
1) Measuring RV fractional area change (FAC) 
 
The RV FAC was calculated from an optimised apical four-chamber view of the RV 
acquired as described above.  End-diastole was determined as the frame after mitral valve 
closure and the RV end diastolic area (RVEDA) was measured by tracing the RV 
endocardial border from the tricuspid annulus, along the RV free wall to the apex and back 
down the interventricular septum.37 A straight line then connects the medial and lateral 
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tricuspid annular points (see Figure 7.1).  Trabeculations, tricuspid leaflets and chords were 
included in the RV chamber. End-systole was defined as the frame displaying the smallest 
cavity area. RV end systolic area (RVESA) was measured using the same method as 
described for RVEDA.  The RV FAC was then calculated from the equation: RV 
FAC=(RVEDA-RVESA)/RVEDA x 100%.37  According to ASE/EAE/CSA guidelines, a 
FAC≥35% is indicative of normal RV systolic function.37 
 
 
 
 
 
                                 
FAC(%)= (RVEDA-RVESA)/RVEDA x 100% 
Figure 7.1. Calculating the RV fractional area change.  The endocardial border 
of the RV traced in the apical 4-chamber view, from the lateral tricuspid annulus, 
along the free wall to the apex, then down the interventricular septum to medial 
tricuspid annulus. The medial and lateral borders of the tricuspid annulus are then 
connected by a straight line.  This is performed in end-diastole, to calculate RV 
end-diastolic area, and then repeated in end-systole. The percentage fractional 
area change is calculated using the equation shown above. Trabeculation, 
tricuspid leaflets and chords are included in the RV chamber. FAC, fractional area 
change; RVEDA, right ventricular end-diastolic area; RVESA, right ventricular end-systolic area. 
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2) Measuring RV myocardial performance index (MPI) by spectral Doppler 
 
The MPI is a simple, relatively load independent measure of RV function based on the ratio 
of the sum of the isovolumic contraction and relaxation times of the right ventricle 
(IVCT+IVRT) divided by the right ventricular ejection time (RVET). The RV MPI was 
calculated from the acquired spectral Doppler envelopes of tricuspid inflow and pulmonary 
outflow using the equation:  MPI = (a-b)/b, where:   a-b = (IVCT+IVRT) and b = RVET as 
shown in Figure 7.2. Using this method, the upper normative limit of RV MPI=0.40.37 
 
 
 
 
 
 
 
 
 
 
Figure 7.2. Calculating the RV Myocardial Performance Index (MPI) by 
spectral Doppler. MPI is the ratio of the sum of the isovolumic contraction and 
relaxation times (IVCT+IVRT) divided by the right ventricular ejection time (RVET 
(b)) and is calculated by the equation MPI= (a-b)/b. 
 
 
 
3) Measuring  RV myocardial performance index (MPI) by pulsed-wave tissue Doppler  
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The RV MPI was also calculated from a pulsed-wave tissue Doppler velocity trace of the 
lateral tricuspid annulus/RV free wall, as shown in Figure 7.3. Using TDE, the MPI is 
calculated from a single Doppler trace, thus minimising error due to variation in the R-R 
interval between cardiac cycles.  Using this method, the upper normative limit of tissue 
Doppler myocardial performance index (RV TDE-MPI) is 0.55.37 
 
 
Figure 7.3. Calculating the RV Myocardial Performance Index (MPI) by tissue 
Doppler. MPI is the ratio of the sum of the isovolumic contraction and relaxation 
times (IVCT+IVRT) divided by the right ventricular ejection time (RVET (b)) and is 
calculated by the equation MPI=(a-b)/b. 
 
 
4) Measuring tricuspid annular plane systolic excursion with colour M-Mode (M-Mode 
TAPSE) 
 
The M-Mode TAPSE score was measured as the peak systolic displacement from the end-
diastolic reference point, and occurred at the red-blue colour M-Mode interface as shown in 
Figure 7.4. ASE/EAE/CSA guidelines recommend a M-Mode TAPSE score of ≤16mm as 
indicative of impaired RV systolic function.37 
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Figure 7.4.  Measuring the tricuspid annular plane systolic excursion score 
using colour M-Mode (M-Mode TAPSE) . A slope caliper is used to measure the 
degree of systolic excursion in the longitudinal plane of the heart. 
 
5) Measuring tricuspid annular peak systolic tissue velocity by pulsed-wave tissue Doppler 
(RV PWTDE S’) 
 
The tricuspid annular peak systolic tissue velocity (S’) was measured as the peak deflection 
in systole above the isoelectric line, and occurs after the isovolumic contraction spike as 
shown in Figure 7.5. ASE/EAE/CSA guidelines recommend a lower normative limit of 
10cm/s for PWTDE S’.37 
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Figure 7.5.Recording the tricuspid annular peak systolic tissue velocity using 
pulsed-wave tissue Doppler imaging (RV PWTDE S’). 
A pulsed-wave sample volume is placed at the junction of RV free wall and lateral 
tricuspid annulus and the resultant tissue Doppler velocity pattern recorded. The 
peak systolic tissue velocity (S’) is the peak deflection seen in systole above the 
isoelectric line, and occurs after the isovolumic contraction spike as shown. 
 
 
6) Measuring tricuspid annular systolic tissue velocity by colour tissue Doppler (CTDE S’) 
 
Pulmonary valve opening and closure times were recorded by placing event-timing markers 
at the start and end of the recorded pulmonary outflow spectral envelope.   The recorded 
pulmonary event timing markers were then superimposed on the tissue velocity/time graph 
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during post processing. Tissue velocity parameters were measured from the colour images 
during further post processing.  The tissue Doppler sample volume, also known as the ROI 
(region of interest) marker was placed at the junction of the basal right ventricular free wall 
with the lateral tricuspid annulus, and the ROI was manually tracked throughout the cardiac 
cycle.  Colour tissue Doppler velocity maps display the mean of the recorded systolic 
velocities within the ROI and so the peak systolic deflection measured is usually lower than 
the peak systolic velocity recorded by pulsed-wave tissue Doppler (Figure 7.6). 
 
 
 
Figure 7.6. Measuring the tricuspid annular peak systolic tissue velocity 
using colour tissue velocity echocardiography imaging (RV CTDE S’) 
Pulmonary valve opening and closure event timing markers are recorded from a 
spectral Doppler trace of pulmonary outflow recorded in the parasternal short axis 
view, and superimposed on the resultant colour TDE graph. The raw colour TDE 
data set is recorded from the apical 4-chamber view of the heart with high temporal 
resolution (≥100fr/sec). The region of interest (ROI) marker is positioned at the 
junction of the lateral tricuspid annulus and RV free wall ~1cm from the tricuspid 
valve leaflet insertion point and motion is manually tracked throughout the cardiac 
cycle. The resultant colour TDE velocity trace is shown in the right side of the 
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image. S’ is measured as the maximal systolic deflection present between 
pulmonary valve opening (PVO) and pulmonary valve closure (PVC). 
 
 
 
7) Measuring right ventricular myocardial acceleration during isovolumic contraction – 
“Isovolumic acceleration”(RV IVA)  
 
Event timing markers were superimposed on the colour TDE graph as previously described.  
A tissue velocity trace obtained at the junction of the lateral tricuspid annulus and basal 
right ventricular free wall was recorded as described above. The peak velocity of 
isovolumic contraction (IVV) and the isovolumic acceleration time (AT) were recorded 
from the isovolumic contraction deflection on the tissue velocity graph as shown in Figure 
7.7.   The IVA was calculated as the ratio of IVV:AT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7. Measuring myocardial acceleration during isovolumic contraction 
of the right ventricle (RV IVA).  
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The peak velocity of isovolumic contraction (IVV) and the isovolumic acceleration 
time (AT) are recorded as shown. IVA is then calculated as the ratio of IVV:AT. 
PVO, pulmonary valve opening; PVC, pulmonary valve closure. 
 
 
 
 
8) Measuring tricuspid annular peak systolic excursion by colour tissue Doppler (TDE 
TAPSE) 
 
Event timing markers were superimposed on the colour TDE graph as previously described.  
A ROI sample volume was placed at the junction of the lateral tricuspid annulus and basal 
right ventricular free wall as previously described. Tissue Doppler myocardial displacement 
was selected from the TDI-Q analysis software and the ROI was manually tracked 
throughout the cardiac cycle to create a myocardial displacement graph as shown in Figure 
7.8.  The tricuspid annular peak systolic displacement was recorded as the peak systolic 
deflection on the graph prior to pulmonary valve closure. 
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Figure 7.8.  Measuring tricuspid annular peak systolic excursion using colour 
tissue Doppler displacement imaging (TDE TAPSE). 
A ROI sample volume was placed at the junction of the lateral tricuspid annulus 
and basal right ventricular free wall and tracked manually throughout the cardiac 
cycle. The tricuspid annular peak systolic displacement was recorded as the peak 
systolic deflection on the graph prior to pulmonary valve closure. PVO, pulmonary 
valve opening; PVC, pulmonary valve closure. 
 
9) Measuring right ventricular global strain (RVGS) 
 
Event-timing markers were applied to the speckle tracking strain data sets as previously 
described to enable temporal analysis within the systolic component of the cardiac cycle. 
Right ventricular speckle tracking strain analysis was performed using GE Automated 
Functional Imaging software. The semi-automated endocardial border tracking system was 
applied to the right ventricle in the apical 4-chamber view of the heart by manually 
selecting the RV apex and the junctions between the basal RV free wall and lateral 
tricuspid annulus and basal interventricular septum and medial tricuspid annulus 
respectively. The endocardial border tracking system was re-positioned manually by 
selecting the appropriate coloured dots, until the operator was satisfied that each 
myocardial segment was being tracked correctly throughout that cardiac cycle. Once the 
operator was satisfied, the positions were finalised by selecting the approve button and a 
global 2D strain score was automatically generated from the quadrant analysis of the right 
ventricular free wall and septum as shown in Figure 7.9. 
 
 
Figure 7.9.  Right ventricular global strain (RVGS) recorded from the apical 4-
chamber view.   
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A regional strain score is automatically applied to each myocardial segment in the 
RV free wall and septum. A global strain score is automatically calculated from the 
segmental strain score and is displayed in the top left picture of the quadrant. In 
this example the longitudinal global strain score for the right ventricle is -26.6% 
 
 
 
10) Measuring right ventricular free wall strain (RVFWS). 
 
As the interventricular septum, for imaging purposes, is traditionally considered as part of 
the left ventricle, it is unclear how much it contributes towards right ventricular systolic 
contraction. For this reason right ventricular free wall strain was analysed by excluding the 
longitudinal regional strain scores generated by the interventricular septum.  The speckle 
tracking software was applied to the RV in the apical 4-chamber view as previously 
described. The right ventricular free wall strain (RVFWS) was calculated as the average of 
the basal, mid and apical regional longitudinal strain scores within the RV free wall as 
shown in Figure 7.10. 
 
 
Figure 7.10. Measuring right ventricular free wall strain (RVFWS) using 2D  
speckle tracking software. RVFWS is measured as the mean of the 2D strain 
recordings from the basal, mid and apical RV free wall segments. In this example 
RVFWS = -(21+24+22)/3= -22% 
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7.3.5  Acquisition and Analysis times. 
 
For an imaging technique to have widespread clinical application it must be quick and easy 
to perform. The acquisition and analysis times for each non-volumetric index of RV 
function were recorded. 
 
 
 
7.3.6  Visual assessment of RV systolic function 
 
A visual “eyeball” assessment of the right ventricle function is common practice in 2D 
echocardiography and remains the standard by which many centres report on RV systolic 
function.  For this reason, the echocardiograms of the study subjects were visually assessed 
by a British Society of Echocardiography accredited operator blinded to the CMR results, 
and RV systolic function was reported semi-quantitatively as normal, mild, moderate and 
severely impaired. Due to the small numbers in this study, patients with moderate and 
severe RV dysfunction were classified as one sub-group. For each RV quantitative index 
measured, the mean±2SD was calculated for each of the three sub-groups of patients with 
normal, mildly impaired and moderately-severely impaired RV systolic function. The mean 
value for each subgroup was compared to each adjacent subgroup, to ensure each 
echocardiographic technique had the ability to discriminate between differing subgroups of 
RV function. 
 
7.3.7 Reproducibility 
 
Interobserver and intraobserver variability for CMR-RVEF and for the ten 
echocardiographic indices of RV function were assessed in 10 patients exhibiting a range of 
RVEFs  (RVEF range: 26-68% by CMR analysis). All measurements of RV function were 
assessed by two independent BSE accredited observers.  These measurements were 
subsequently repeated by one observer at six months. 
 
7.3.8  Statistical Analysis.   
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Values are expressed as mean ± standard deviation (SD).  All data sets were tested for 
normality.  Each echocardiographic technique was correlated against CMR-RVEF using a 
bivariate correlation (Pearson correlation coefficient for parametric data and Spearman 
correlation coefficient for non-parametric data). For parametric data, linear regression 
analysis was used to directly compare the echocardiographic indices of RV function 
indexed against CMR-RVEF as the reference standard. A value of p<0.05 was considered 
significant. Receiver operator characteristic (ROC) curves were estimated for each method 
and the area under the curve was calculated.  
 
The reproducibility of CMR-RVEF and the ten non-volumetric 2DE indices of RV function 
were assessed by calculating the co-efficient of variation for intra- and inter-observer 
measurements.  Bland-Altman analysis was also used to determine the mean bias and limits 
of agreement for intra- and inter-observer measurements. Results are expressed as mean 
bias±1.96SD. A value of p<0.05 was considered significant. 
 
7.4  RESULTS 
 
7.4.1 Patient characteristics 
 
CMR and all 10 echocardiographic indices of RV function were successfully measured in 
50 of the 60 patients.  The remaining patients were excluded from the study. Clinical 
characteristics of the study population are described in Table 7.1. 
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Gender (M:F) 
Mean age (yrs) 
Clinical Diagnosis 
            -   Ischaemic heart disease* 
- Valvular heart disease 
- Dilated cardiomyopathy 
- Pulmonary hypertension 
- Atrial septal defect 
- Coronary artery spasm 
- Hypertensive heart disease 
- Type 2 Diabetes & Metabolic syndrome 
- No cardiac diagnosis 
   
37:13 
56±14 
 
17 
5 
1 
3 
1 
1 
2 
10 
11 
 
 
Table 7.1. Clinical characteristics of study subjects who completed both RV-
CMR and 2D echocardiography protocols  (n=50).  F, female; M, male 
* diagnosed either on coronary angiography, or clinical diagnosis of angina/previous myocardial 
infarction. 
 
 
7.4.2 Correlation of ten echocardiographic indices of RV function against CMR 
         RVEF 
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The ten echocardiographic indices of RV systolic function were correlated against CMR-
RVEF in all patients (N=50; RVEF range: 26-73%). RvfwS (p<0.001, r=-0.770) and RVGS 
(p<0.001, r=-0.750) correlated strongly with CMR-RVEF (Figure 7.11 and Figure 7.12). 
 
 
Figure 7.11. Correlation of RVFWS with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction RVFWS, right ventricular free wall strain. 
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Figure 7.12. Correlation of RVGS with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction RVGS, right ventricular global strain. 
 
RV FAC (p<0.001, r=0.582), M-Mode TAPSE (p<0.001, r=0.581), RV CTDE S’ (p<0.001, 
r=0.523), RV PWTDE S’ (p<0.001, r=0.509) and TDE TAPSE (p<0.001, r=0.488) all had a 
modest correlation with CMR-RVEF (Figures 7.13 to 7.17). 
 
 
Figure 7.13. Correlation of RV FAC with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; RV FAC, right ventricular fractional area change. 
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Figure 7.14. Correlation of M-Mode TAPSE Sm with CMR-RVEF in 50 subjects 
(RVEF range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular 
ejection fraction; TAPSE, tricuspid annular plane systolic excursion. 
 
 
Figure 7.15. Correlation of RV CTDE S’ with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; RV CTDE S’, right ventricular colour tissue Doppler systolic velocity. 
 
 226 
 
 
Figure 7.16. Correlation of RV PWTDE S’ with CMR-RVEF in 50 subjects 
(RVEF range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular 
ejection fraction; RV PWTDE S’, right ventricular pulsed-wave tissue Doppler systolic velocity. 
 
 
Figure 7.17. Correlation of TDE TAPSE with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; TDE TAPSE, tissue Doppler echocardiography-derived tricuspid annular plane systolic 
excursion. 
 
RV TDE-MPI (p=0.031, r=0.306) had a weak correlation with CMR-RVEF (Figure 7.18). 
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Figure 7.18. Correlation of RV TDE-MPI with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; RV MPI, right ventricular myocardial performance index. 
RV MPI (p=NS, r=-0.262) and RV IVA (p=NS, r=0.166) had no correlation with CMR-
RVEF (Figure 7.19 and 7.20) and were therefore excluded from further subgroup analysis. 
 
 
 
 228 
Figure 7.19. Correlation of RV MPI with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; RV MPI, right ventricular myocardial performance index. 
 
 
 
Figure 7.20. Correlation of RV IVA with CMR-RVEF in 50 subjects (RVEF 
range: 26-73%). CMR, cardiac magnetic resonance imaging; RVEF, right ventricular ejection 
fraction; RV IVA, right ventricular isovolumic acceleration. 
7.4.3 Receiver operator characteristics 
 
Eight echocardiographic indices of RV function (RVFWS, RVGS, RV FAC, M-Mode 
TAPSE, RV CTDE S’, RV PWTDE S’, TDE TAPSE and TDE-MPI) correlated with 
CMR-RVEF as detailed in section 7.4.2 above.  ROC analysis was performed to examine 
the accuracy of these indices in correctly identifying patients with normal (RVEF≥47%) 
and abnormal (RVEF<47%) RV systolic function as determined by CMR. 
 
For RV indices in which normative threshold values have already been published and 
endorsed in the ASE/EAE/CSE 2010 Guidelines for assessing the right heart in adults (ref), 
(i.e. FAC=35%, PWTDE S’=10cm/s, M-Mode TAPSE=16mm, TDE-MPI=0.55), the 
sensitivity and specificity of these normative threshold values were determined in our 
cohort of heterogenous patients. For the echo techniques used in which normative reference 
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values are as yet unclear (i.e. RVFWS, RVGS, CTDE S’ and TDE-TAPSE), optimum 
normative cut-off values were determined from ROC analysis. 
 
RV free wall strain 
 
Of the eight RV echocardiographic indices RVFWS exhibited the largest area under the 
curve (AUC: 0.853).  RVFWS ≥ -22.50% predicted RVEF<47% with a sensitivity of 
78.90% and a specificity of 80.6% (Figure 7.21). 
 
 
 
 
 
 
Figure 7.21. ROC curve of RVFWS indexed against CMR-RVEF.  
A normal cut-off valve of –22.50% identified RV systolic dysfunction with a 
sensitivity of 78.90% and a specificity of 80.6%. AUC, area under the curve; CMR, cardiac 
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magnetic resonance; RV, right ventricle; RVEF, right ventricular ejection fraction; RVfwS, right 
ventricular free wall strain. 
 
 
 
 
 
 
 
 
 
 
 
 
RV global strain 
 
RVGS≥ -18.05% predicted RVEF<47% with a sensitivity of 73.70% and a specificity of 
93.5% (AUC: 0.822) (Figure 7.22). 
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Figure 7.22. ROC curve of RVGS indexed against CMR-RVEF.  
A normal cut-off valve of –18.05% identified RV systolic dysfunction with a 
sensitivity of 73.70% and a specificity of 93.50%. AUC, area under the curve; CMR, 
cardiac magnetic resonance; RV, right ventricle; RVEF, right ventricular ejection fraction; RVGS, 
right ventricular global strain. 
 
 
 
 
 
 
M-Mode TAPSE 
 
The ASE guidelines for assessing RV function recommend the use of TAPSE (performed 
using the M-Mode method) and ASE, EAE and British Society of Echocardiography 
guidelines suggest a TAPSE score of >16mm as indicative of normal RV systolic function 
based on radionuclide and other comparison studies.37,244,245,287  Using this cut-off value, 
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M-Mode TAPSE<1.6cm was highly specific at predicting RVEF<47% by CMR 
(specificity=93.50%) but with a low sensitivity of 36.80% (AUC: 0.791) (Figure 7.23). 
 
An alternative threshold value of 18.5mm, improved sensitivity to 57.9%, but at the 
expense of specificity (specificity=83.9%). 
 
 
 
Figure 7.23. ROC curve of M-Mode TAPSE indexed against CMR-RVEF.  
A normal cut-off valve of 1.6cm identified RV systolic dysfunction with a sensitivity 
of 36.80% and a specificity of 93.50%. AUC, area under the curve; CMR, cardiac magnetic 
resonance; RV, right ventricle; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular 
plane systolic excursion. 
 
Tissue Doppler TAPSE 
 
TDE TAPSE<1.44cm predicted RVEF<47% with a sensitivity of 52.60% and a specificity 
of 90.30% (AUC: 0.730) (Figure 7.24). 
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Figure 7.24. ROC curve of TDE TAPSE indexed against CMR-RVEF.  
A normal cut-off valve of 1.4cm identified RV systolic dysfunction with a sensitivity 
of 52.60% and a specificity of 90.30%. AUC, area under the curve; CMR, cardiac magnetic 
resonance; RV, right ventricle; RVEF, right ventricular ejection fraction; TDE TAPSE, tissue Doppler 
echocardiography-derived tricuspid annular plane systolic excursion. 
 
 
 
 
 
 
Fractional area change 
 
The ASE guidelines for assessing RV function recommend the use of RV FAC using a 
threshold value of 35% as the lower normative limit.37  Using this cut-off value, RV FAC 
was highly specific at predicting RVEF<47% by CMR (specificity=93.50%) but with a low 
sensitivity of 47.4% (AUC: 0.734) (Figure 7.25). 
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An alternative threshold value of 44.5%, improved sensitivity to 78.9%, but at the expense 
of specificity (specificity=61.3%). 
 
 
 
Figure 7.25. ROC curve of RV FAC indexed against CMR-RVEF.  
A normal cut-off valve of 35% identified RV systolic dysfunction with a sensitivity of 
52.60% and a specificity of 90.30%. AUC, area under the curve; CMR, cardiac magnetic 
resonance; FAC, fractional area change RV, right ventricle; RVEF, right ventricular ejection fraction. 
 
 
 
PWTDE S’ 
 
The ASE guidelines for assessing RV function in adults recommend the use of RV PWTDE 
S’ and suggest a S’ of 10cm/s as the lower reference limit of normal based on pooled data 
from 43 studies of over 2000 normal controls.37,291  Using this cut-off value, RV PWTDE 
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S’<10cm/s only had a moderate specificity of 77.50% and a low sensitivity of 52.60% for 
predicting CMR-RVEF<47% (AUC: 0.734). 
 
An alternative threshold value of S’<8.5cm/s improved specificity to 90.30%, but at the 
expense of sensitivity (sensitivity=47.40%) (Figure 7.26). 
 
 
 
Figure 7.26. ROC curve of RV PWTDE S’ indexed against CMR-RVEF.  
A normal cut-off valve of 8.5cm/s identified RV systolic dysfunction with a 
sensitivity of 47.40% and a specificity of 90.30%. AUC, area under the curve; CMR, 
cardiac magnetic resonance; RV, right ventricle; RV PWTDE S’, right ventricular pulsed-wave tissue 
Doppler systolic velocity; RVEF, right ventricular ejection fraction. 
 
CTDE S’ 
 
RV CTDE S’<7.7cm/s predicted RVEF<47% with a sensitivity of 68.40% and a specificity 
of 83.90% (AUC: 0.730) (Figure 7.27). 
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Figure 7.27. ROC curve of RV CTDE S’ indexed against CMR-RVEF.  
A normal cut-off valve of 7.7cm/s identified RV systolic dysfunction with a 
sensitivity of 68.40% and a specificity of 83.90%. AUC, area under the curve; CMR, 
cardiac magnetic resonance; RV, right ventricle; RV CTDE S’, right ventricular colour tissue Doppler 
systolic velocity; RVEF, right ventricular ejection fraction. 
 
 
 
 
 
 
TDE MPI 
 
The ASE guidelines for assessing RV function in adults endorse the use of RV TDE-MPI 
for estimating RV function in complement, but not in isolation, with other quantitative and 
non-quantitative indices of RV function. The ASE recommend an upper normative 
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reference limit of 0.55 for RV TDE-MPI.37  Using this cut-off value, RV TDE-MPI >0.55 
had a poor sensitivity and specificity of 57.9% and 33.3% respectively for predicting CMR-
RVEF <47% (AUC: 0.621). 
 
 
 
 
Figure 7.28. ROC curve of RV TDE-MPI indexed against CMR-RVEF.  
A normal cut-off valve of 0.55 identified RV systolic dysfunction with a sensitivity of 
32.30% and a specificity of 57.90%. AUC, area under the curve; CMR, cardiac magnetic 
resonance; RV, right ventricle; RVEF, right ventricular ejection fraction; RV TDE-MPI, right 
ventricular tissue Doppler myocardial performance index. 
 
 
 
7.4.4 Regression analysis of echo RV indices indexed against CMR-RVEF 
 
On bivariate correlation, RV MPI and RV IVA failed to correlate with CMR-RVEF and 
were therefore excluded from regression analysis.  On regression analysis, in patients 
exhibiting a wide range of RV function (RVEF range: 26-73%, n=50), RVFWS had a 
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significantly stronger correlation with CMR-RVEF than all other RV echocardiographic 
parameters for quantifying RV systolic function (p=0.013, T=-2.61).  When RVFWS was 
excluded from the analysis, RVGS exhibited the strongest correlation to CMR-RVEF, 
when compared the remaining echocardiographic indices of RV function (p<0.001, T=-
3.99). When both RVFWS and RVGS were excluded from the analysis, RV FAC exhibited 
the strongest correlation to CMR-RVEF when compared to the remaining 
echocardiographic RV parameters (p=0.009, T=2.75). Upon exclusion of RVFWS, RVGS 
and RV FAC, no remaining echocardiographic index of RV systolic function exhibited a 
superior correlation over all other remaining indices, when compared to CMR-RVEF as the 
reference standard. 
 
7.4.5 Calculation of right ventricular ejection fraction 
 
From linear regression analysis, the RVFWS can be converted into a RVEF equivalent 
score (RVEFES) using the regression equation below: 
 
Equation 7.1           RVEFES= -1.16(RVFWS) + 24.55. 
 
7.4.6 Comparison of the ten echocardiographic indices of RV systolic function with 
visual assessment of RV systolic function. 
 
The echocardiograms of all 50 patients were visually assessed and RV systolic function 
was categorized as normal, mild, moderately or severely impaired.  Due to the small 
numbers of patients in this study, patients with moderately and severely impaired RV 
function were combined into one category.   The mean values for patients with normal, 
mild and moderately-severely impaired RV function were recorded for each 
echocardiographic index. The mean difference between each functional subgroup was 
compared with the adjacent subgroup to examine the power of each echocardiographic 
index of RV function to discriminate between different categories of RV 
function/dysfunction.  Results are shown in Table 7.2. 
 
Quantitative Index of Normal Mild  Moderate-severe 
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RV systolic function RV function RV dysfunction RV dysfunction 
 
CMR-RVEF (%) 
 
 
55.82±7.30 
 
45.65±2.20ς 
 
30.86±3.82ς 
RVFWS (-%) 
 
-25.56±4.41 -20.04±6.20φ -9.67±4.11φ 
RVGS (-%) 
 
-21.81±3.38 -18.91±4.77* -10.58±2.63φ 
RV FAC (%) 
 
47.87±10.14 37.79±9.28φ 25.72±9.08* 
RV CTDE S’  
(cm/s) 
9.28±1.71 8.04±1.87NS 
 
5.55±2.31* 
RV PWTDE S’ 
(cm/s) 
12.21±2.47 10.13±2.17* 6.50±1.51φ 
M-Mode TAPSE 
(cm) 
2.33±0.48 1.91±0.28φ 1.25±0.65* 
TDE TAPSE 
(cm) 
1.88±0.39 1.55±0.26φ 0.97±0.46φ 
RV MPI 
 
0.46±0.20 0.61±0.16NS 0.68±0.20NS 
RV TDE-MPI 
 
0.48±0.21 0.50±0.11 NS 0.89±0.42* 
RV IVA 
(cm/s-2) 
145.31±57.78 163.76±69.36NS 109.15±59.74NS 
Table 7.2.  Comparison of CMR-RVEF and ten echocardiographic indices of 
RV function with visual assessment of RV systolic function. Each category of 
RV dysfunction is compared to the category above (i.e. Mild RV dysfunction is compared 
to normal RV function; moderate-severe RV dysfunction is compared to mild RV 
dysfunction). NS = not significant; * = p<0.05; φ = p<0.01; ς = p<0.001 
CMR, RVFWS, RVGS, RV PWTDE S’, M-Mode TAPSE and TDE TAPSE were able to 
discriminate both visually mild RV dysfunction from visually normal RV function, and 
visually moderate-severe RV dysfunction from visually mild RV dysfunction.  RV CTDE 
S’ discriminated visually moderate-severe RV dysfunction from mild RV dysfunction, but 
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not mild RV impairment from visually normal RV function.  The difference between means 
between the normal and mildly impaired RV categories and between the mildly impaired 
and moderately-severely impaired categories were not significant for either RV MPI or RV 
IVA. 
 
7.4.7. Acquisition and analysis times 
 
The acquisition and analysis times for each index of RV function are shown in Table 7.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quantitative Index of RV 
systolic function 
Additional 
Acquisition time 
Analysis 
Time 
 
   
 241 
RVFWS (-%) 
 
15 secmin 2 min 
RVGS (-%) 
 
15 secmin 1 min 30 sec 
RV FAC (%) 
 
15 sec 1 min 30 sec 
RV CTDE S’  
(cm/s) 
35 sec 1min 25 sec 
 
RV PWTDE S’ 
(cm/s) 
15 sec 15 sec 
M-Mode TAPSE 
(cm) 
15 sec 15 sec 
TDE TAPSE 
(cm) 
35 sec 1min 6 sec 
RV MPI 
 
30 sec 51 sec 
RV TDE-MPI 
 
15 sec 45 sec 
RV IVA 
(cm/s-2) 
35 sec 2 min 
 
Table 7.3. The additional acquisition and analysis time for each index of RV 
function, performed during acquisition of a full standard transthoracic 
echocardiogram study. Min, minute; sec, second 
 
 
 
 
7.4.8. Reproducibility 
 
Intra- and inter-observer variability for CMR-RVEF and all ten echocardiographic indices 
of RV function are expressed as the co-efficient of variation, and as the mean bias, limits of 
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agreement and standard deviation of the difference (Table 7.4 and 7.5). The corresponding 
Bland-Altman plots are shown in Figures 7.29 to 7.39. 
 
 
 
Table 7.4. Intra-observer variability for measurements of right ventricular 
systolic function  
 
 
 
 
Imaging modality used  
to quantify RV function 
% Co-efficient 
of variation 
Mean 
bias 
Limits of 
agreement 
SDD 
CMR PARAMETER 
RVEF (%) 
ECHO PARAMETERS 
2DE :  
1) RV FAC (%) 
2) RV MPI  
3) M-Mode TAPSE (cm) 
TDE:  
4) RV PWTDE S’ (cm/s) 
5) RV CTDE S’ (cm/s) 
6) RV IVA (cm/s-2) 
7) TDE MPI 
8) TDE TAPSE (cm) 
9) RVGS (-%) 
10) RVFWS (-%) 
 
5.90% 
 
 
13.13% 
8.38% 
4.22% 
 
2.23% 
2.40% 
13.96% 
 9.63% 
1.32% 
-2.31% 
-3.89% 
 
0.19 
 
 
-3.15 
-0.02 
-0.00 
 
-0.32 
-0.08 
12.50 
 0.05 
-0.07 
-0.09 
0.12 
 
-8.70 to 9.07 
 
 
-17.09 to 10.79 
-0.15 to 0.11 
-0.17 to 0.17 
 
-1.35 to 0.72 
-0.86 to 0.71 
-72.71 to 97.71 
-0.11 to 0.21 
-0.86 to 0.72 
-2.18 to 2.00 
-3.77 to 4.00 
 
4.44 
 
 
6.97 
0.06 
0.09 
 
0.52 
0.39 
42.61 
0.08 
0.39 
1.05 
1.94 
Imaging modality used  
to quantify RV function 
% Co-efficient 
of variation 
Mean 
bias 
Limits of 
agreement 
SDD 
 
CMR PARAMETER 
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Table 7.5. Inter-observer variability for measurements of right ventricular 
systolic function. 
 
 
 
 
 
 
 
 
 
 
 
(A) 
RVEF (%) 
ECHO PARAMETERS 
2DE :  
1) RV FAC (%) 
2) RV MPI  
3) M-Mode TAPSE (cm) 
TDE:  
4) RV PWTDE S’ (cm/s) 
5) RV CTDE S’ (cm/s) 
6) RV IVA (cm/s-2) 
7) TDE MPI 
8) TDE TAPSE (cm) 
9) RVGS (-%) 
10) RVFWS (-%) 
8.44% 
 
 
17.42% 
18.95% 
7.91% 
 
1.29% 
2.69% 
18.52% 
18.98% 
4.12% 
-3.12% 
-3.03% 
1.78 
 
 
-1.33 
 0.11 
 0.03 
 
-0.14 
0.09 
8.05 
-0.14 
0.30 
0.40 
0.43 
-11.35 to 13.71 
 
 
-20.69 to 18.03 
-0.32 to 0.54 
-0.32 to 0.38 
 
-0.99 to 0.70 
-0.69 to 0.88 
-94.37 to 110.48 
-0.54 to 0.26 
-1.62 to 2.23 
-1.65 to 2.46 
-2.36 to 3.22 
 6.27 
 
 
 9.68 
 0.21 
 0.18 
 
 0.42 
 0.39 
51.21 
-0.20 
 0.96 
 1.03 
 1.40 
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(B) 
 
 
Figure 7.29.Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using cardiac 
magnetic resonance imaging (RVEF %) 
 
 
 
 
    (A) 
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   (B) 
 
 
Figure 7.30. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using RV myocardial 
performance index derived by spectral Doppler (MPI) 
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   (B) 
 
 
Figure 7.31. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using colour M-Mode 
tricuspid annular plane systolic excursion (MM TAPSE) (cm) 
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  (B) 
 
 
Figure 7.32. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using tricuspid 
annular peak systolic velocity measured using pulsed wave tissue Doppler 
(PWTDE S’) (cm/s) 
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    (B) 
 
 
Figure 7.33. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using tricuspid 
annular peak systolic velocity measured using colour tissue Doppler  
(CTDE S’) (cm/s) 
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    (B) 
 
 
Figure 7.34. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using isovolumic 
acceleration (IVA) (cm/s-2) 
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    (B) 
 
 
Figure 7.35. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using tricuspid 
annular peak systolic displacement measured using colour tissue Doppler 
(TDE TAPSE) (mm) 
 
 
   (A) 
-3
-2
-1
0
1
2
3
0 5 10 15 20 25
D
iff
er
en
ce
 b
et
w
ee
n 
tw
o 
ob
se
rv
at
io
ns
 
Mean of two observations (Intra-observer) (mm) 
-3
-2
-1
0
1
2
3
0 5 10 15 20 25
D
iff
er
en
ce
 b
et
w
ee
n 
tw
o 
ob
se
rv
at
io
ns
 
Mean of two observations (Inter-observer) (mm) 
 251 
 
 
   (B) 
 
 
Figure 7.36. Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using RV Global strain 
score (RVGS) (-%) 
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   (B) 
 
 
Figure 7.37.  Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using RV free wall 
strain score (RVFWS) (-%) 
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(B) 
 
 
 
Figure 7.38.  Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using RV fractional 
area change (RVFAC) (%) 
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Figure 7.39.Bland-Altman Plot of (A) intra-observer variation and (B) inter-
observer variation for measuring RV systolic function using RV myocardial 
performance index derived by tissue Doppler (TDE MPI) 
 
 
 
7.5 DISCUSSION 
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This study has compared ten easily performed 2DE measures of RV function against each 
other in an unselected population when indexed against CMR as the reference standard. 
Our study demonstrates that RVFWS, assessed using 2D speckle tracking, has a stronger 
correlation with CMR-RVEF than all other indices of RV function and is highly 
reproducible. Due to the semi-automated nature of the speckle tracking software, data 
analysis times were short (<3minutes), ensuring this technique has a highly clinical 
application.  On ROC analysis, RVFWS had both a high sensitivity and specificity for 
detecting abnormal RV systolic function, with a normative cut-off value of –22.5%.  
Furthermore, RVFWS can be converted into a more user-friendly RVEF equivalent score 
using the regression equation: RVEFES = -1.16(RVFWS) + 24.55.  
 
We assessed both RVFWS and RVGS to establish the effect including the interventricular 
septum had on subsequent RV analysis. This study clearly demonstrated that assessing the 
average longitudinal strain value from the RV free wall had a stronger relationship to 
RVEF than a combined assessment of RV free wall and interventricular septum. Therefore 
when speckle tracking strain imaging is available, strain imaging of the RV free wall 
should be performed. RV FAC had a poorer correlation with CMR-RVEF when compared 
to speckle tracking strain imaging techniques, but a stronger correlation with CMR-RVEF 
than the remaining echocardiographic indices of RV function. The robustness of this 
technique however is limited by its moderate reproducibility. Using the normative cut-off 
value of ≤1.6cm recommended by the ASE/EAE/CSE guidelines, TAPSE had a high 
specificity, but moderately-low sensitivity for correctly identifying RV systolic 
dysfunction. M-Mode TAPSE had a moderately good correlation with CMR-RVEF and 
had acceptable reproducibility. RV CTDE S’, RV PWTDE S’ and TDE TAPSE were all 
highly reproducible techniques, but had only moderate correlation with CMR-RVEF. RV 
IVA and RV MPI did not correlate with RVEF.  This result may not be as surprising as it 
first seems. RVEF is a volumetric assessment of RV systolic function.  The RV relies 
heavily on longitudinal contraction during systole to maintain ejection fraction, so measures 
of RV longitudinal strain (RVfwS and RVGS) and measures of tricuspid annular motion 
(M-Mode TAPSE, TDE TAPSE, RV CTDE S’, RV PWTDE S’) should correlate with 
RVEF.  IVA is a non-invasive measure of myocardial contractility, and RV MPI is an index 
of global RV performance, combining systolic and diastolic functional components. 
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Although both are still indices of RV performance, they do measure different physiological 
events compared to RVEF.  However the high intra- and inter-observer variability of these 
two techniques limit their clinical application in an unselected population. Furthermore, 
when compared to visual assessment of RV systolic function, RV MPI and RV IVA were 
unable to discriminate between different categories of RV dysfunction. For these reasons, 
the result of this study does not support the use of RV MPI or RV IVA in routine clinical 
practice. 
 
The accurate evaluation of RV function by 2D-ultrasonography is difficult given its 
complex geometry, interrelationship with the left ventricle, anatomical location within the 
thorax and sensitivity to changes in pulmonary pressures. While volumetric calculation of 
ejection fraction has for many years been the ubiquitous measure of left ventricular systolic 
performance, 2DE estimation of RVEF is unreliable due to the heterogeneity of methods, 
numerous geometric assumptions and technical limitations of the echocardiographic 
imaging windows.  Due to its superior spatial resolution and unlimited ability to image the 
heart in any plane, CMR has become largely accepted as the reference standard for 
assessing the right heart.   However, there remain major limitations to its widespread use 
due to initial cost and inability of some individuals to enter an enclosed space.  RVEF 
quantification by 3DE has recently been made possible due to advances in 3DE software. 
However the limited normative data available is from small single centre studies, and 
suggests intermodality discordance between the techniques with 3DE underestimating RV 
volumes when compared to CMR.  This discordance is believed due to imprecise 
endocardial wall definition by 3DE secondary to the poor visualisation of anterior RV wall 
segments by 3DE, the abundant RV trabeculae and variations in the demarcation of the 
basal RV and RVOT boundaries.240  For these reasons the joint ASE/EAE/CSE guidelines 
do not yet endorse the use of 3DE RVEF in routine clinical practice until more validation 
studies are available. 
 
Recent international guidelines have reviewed the 2DE and TDE indices available for the 
quantitative assessment of RV systolic function.37  While the guidelines recommend the use 
of several quantitative indices of RV function in addition to qualitative RV assessment, 
they draw no conclusions as to which method is preferred above the others. We have sought 
to compare all of these indices of RV function in an unselected population of patients 
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exhibiting a wide range of RVEFs. We are not the first study to do so. Miller and 
colleagues have previously compared RV MPI, RV PWTDE S’ and M-Mode TAPSE and 
concluded that all three techniques were comparable based on a similar areas under the 
curve on ROC analysis. Unfortunately, these RV parameters were indexed against 2DE 
biplane Simpson’s RVEF as the reference standard. This is a technique the American 
Society of Echocardiography, European Association of Echocardiography, Canadian 
Society of Echocardiography and British Society of Echocardiography do not recommend 
due to multiple geometric assumptions and inherent inaccuracy.37  Furthermore, in this 
study a Simpson’s RVEF<50% was considered abnormal, whereas the joint ASE/EAE/CSE 
guidelines state the lower normative reference limit for RVEF from pooled studies is 
actually 44% with a 95% confidence interval of 38% to 50%.37   To our knowledge, our 
study is the first to directly compare ten different quantitative 2DE indices of RV function 
indexed against RVEF calculated by CMR, the internationally accepted reference standard.  
Current ASE/EAE/CSE guidelines review the use of 2D speckle tracking strain for 
quantifying RV function, but make no recommendations for routine clinical use due to the 
paucity of research data and lack of normative values. The results of our study suggest 
RVFWS is highly specific and sensitive at detecting RV dysfunction with a lower 
normative reference value of –22.5%. We have demonstrated that RVFWS is a technique 
that is accurate, reproducible and quick to perform, and therefore has the potential to be a 
routine clinical tool of the future for the quantifying RV systolic function. 
 
7.5.1  Study limitations 
 
In this study we assessed both intra- and inter-observer variation in data analysis for each of 
the 10 described echo indices of RV systolic function, based on pre-acquired 
echocardiographic data. Due to time constraints, limitations in both imaging sessions and 
patient availability, we were unable to repeat scans using an independent operator. We were 
therefore unable to assess inter-observer variation in data acquisition (the ‘repeatability’ of 
the methods) and we accept this as a significant limitation of our study. 
 
In this study we assessed RVFWS and RVGS using GE Vivid 7 AFI speckle tracking strain 
software. We cannot comment on the accuracy of 2D strain for quantifying RV systolic 
function using software from other manufacturers. From the results of our study, we 
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derived a regression equation to enable us to convert RVFWS into a more user-friendly and 
recognisable RVEFES. Validation of this formula is required in an independent cohort of 
patients before this regression equation should be considered for clinical use. 
 
 
 
7.5.2  Conclusion 
 
In patients exhibiting a wide range of RVEFs, RVFWS is a highly reproducible measure of 
RV systolic function that had a stronger correlation to CMR-derived RVEF, when 
compared to nine alternative echocardiographic indices of RV function. Using a normative 
cut-off value of –22.5%, RVFWS detects RV systolic dysfunction with a high sensitivity 
and specificity. 
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CHAPTER 8: DISCUSSION, CONCLUSIONS, FUTURE WORK 
 
 
8.1  GENERAL DISCUSSION 
 
Quantification of cardiac ventricular function is the most common request in cardiac 
imaging and one of the most fundamental assessments in the cardiac patient.  However, the 
accurate assessment of cardiac ventricular function is far from simple and remains a 
constant challenge for the non-invasive cardiac imaging specialist. Cardiac 
contraction/relaxation during each cardiac cycle is a complex multi-stage multi-planar and 
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multi-directional pressure-dependent active process which involves myofilament coupling, 
long-axis shortening, radial thickening and circumferential torsion and twist during systole 
and myofilament uncoupling, myocardial relaxation and ventricular compliance, 
circumferential “untwisting”, pressure-gradient induced ventricular suction and LV filling 
and atrial contraction during diastole.  Conventionally, the assessment of cardiac 
ventricular function is sub-classified into right and left, systolic and diastolic, regional and 
global function. Within each of these sub-classifications, the quantification of ventricular 
function may vary depending on both the imaging mode and imaging method used, and in 
some cases, may also vary depending on the experience of the operator.   To minimise 
error, improve accuracy and reliability, the governing bodies within the specialties of 
echocardiography and cardiac magnetic resonance imaging have set international 
guidelines and standards for the quantification of left ventricular systolic,38,237 left 
ventricular diastolic14 and right ventricular function.37,237 
 
The advance in non-invasive cardiac imaging technology over the past few years has been 
phenomenal. In a symbiotic relationship, the advance in non-invasive cardiac imaging 
technology has greatly improved our understanding of ventricular function, which in turn 
has enabled the development and refinement of further imaging software programmes. A 
classic example being the development of speckle-tracking myocardial deformation 
imaging.  As we become increasingly able to image the heart with high spatial and temporal 
resolution, we will likely reach a point whereby new imaging methods supersede the 
accuracy and reproducibility of current gold standard methods for quantifying ventricular 
function. Historically, this has already occurred on several occasions. The recording of 
haemodynamic and functional data during left heart catheterisation and left ventriculogram, 
was once the gold standard for assessing LV systolic function. This was superseded by the 
development of echocardiography, which in turn has been superseded by CMR 
quantification of LVEF. In clinical practice however, the cost, availability and safety 
profile of a “gold standard” investigation will be the determining factor in whether or not a 
patient receives this test, or a cheaper, more widely available and safer alternative. 
 
The primary research aims of this thesis were therefore both clinical and pragmatic. The 
primary aims of this thesis were specifically directed at validating new non-invasive 
imaging methods for quantifying global left ventricular systolic function, left ventricular 
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diastolic function and right ventricular systolic function against internationally accepted 
reference standards in a heterogenous population of patients, as seen in clinical practice. 
Furthermore in all sub-classifications of ventricular function studied, in addition to being 
validated against the current imaging reference standard, our new imaging methods were 
also compared to the most widely used alternative methods for assessing LV systolic, LV 
diastolic and RV systolic function in clinical practice. A further aim of this thesis was to 
therefore establish if our new methods were superior to current methods used in clinical 
practice, when compared to the imaging reference standard.  For example, CMR-derived 
LVEF is the widely accepted reference standard for quantifying left ventricular systolic 
function, with 3D echocardiography emerging as a close second. However, due to cost and 
limited availability of CMR and 3DE, 2DE Simpson’s biplane method of discs remains the 
widespread standard by which LVEF is quantified in clinical practice. For this reason, in 
chapter 4 and chapter 5 we validated our new imaging methods for quantifying LV systolic 
function against CMR-derived LVEF, but also compared them against 2DE Simpson’s 
biplane method of discs. Invasive measurement of intracardiac pressures during left heart 
catheterisation remains the reference standard for assessing LV diastolic filling pressures, 
however, due to both patient discomfort and the inherent risks of cardiac catheterisation, 
tissue Doppler echocardiography E/Em has become the non-invasive method used to 
estimate LV filling pressures in clinical practice. For this reason, in chapter 6 we validated 
our new VEC-CMR E/Em ratio against invasively recorded LVEDP and compared it to 
echo-derived E/Em ratios.  
 
Due to the complex nature of cardiac contractile function, and the intimate and 
interdependent relationship between cardiac systole and diastole, RV and LV function and 
changes in cardiac preload and afterload, no single two-dimensional quantitative measure 
of LV systolic function, LV diastolic function or RV systolic function can accurately 
capture all the changes that occur during that specified phase of the cardiac cycle. However, 
that was not the aim of this thesis.  Our aim was to establish new methods for quantifying 
global ventricular function that are more sensitive, accurate and reproducible than current 
widely employed imaging techniques, and to prove that these new methods correlate 
closely to current reference standards.  
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2D speckle tracking strain is a myocardial deformation imaging technique that is used to 
assess regional changes in ventricular function in clinical research. It has been found to be 
sensitive in detecting sub-clinical ventricular dysfunction in a variety of pathologies344-351 
and also is useful as an indicator of prognosis.313  We hypothesised that detailed Lagrangian 
strain analysis of all 16 AHA myocardial segments of the left ventricle could be averaged 
to establish a global strain score of the LV that would accurately reflect changes in LV 
systolic function. We have demonstrated that our GSS has a significantly stronger 
correlation and higher reproducibility than 2DE biplane Simpson’s rule for quantifying LV 
systolic function when compared to CMR-derived LVEF as the reference standard. During 
the recruitment period of our study we only had access to longitudinal strain speckle 
tracking software, although radial strain software is now commercially available. As our 
strain imaging software was able to record systolic deformation in only one contractile 
plane of the heart, it is perhaps unsurprising that our 3D volumetric assessment of LVEF 
using Philips iE33 3DE scanner, had a closer correlation with CMR LVEF than GSS. At 
the start of this year General Electric Incorporated completed the development of 4D-
speckle tracking software programme. This software aims to quantify myocardial 
deformation in 3 contractile planes of the heart in addition to quantification of regional 
volumetric change. Future work should therefore include validation of this 4D speckle 
software against CMR and strain software from other manufacturers. Until then, the results 
of our study suggest that GSS may be a more accurate and reproducible alternative to 
biplane Simpson’s rule for the quantification of LV systolic function by 2DE.  This finding 
requires confirmation in a larger diverse population before the GSS should be used in 
routine clinical practice. 
The cost of a 1.5T MRI scanner is in the region of one million pounds.  A Philips iE33 3DE 
scanner costs £98,711.352  Speckle tracking software costs £2,500.352  A standard CMR scan 
costs £380.352  By comparison the tariff for a standard 2D transthoracic echocardiogram is 
£57.352  In addition to its accuracy and reproducibility the clinical application of a technique 
also depends on its simplicity and its wide-spread availability.  Although speckle-tracking 
strain is a cheaper alternative to CMR for quantifying LV systolic function, many cardiac 
imaging departments world-wide may not be able to afford the cost of this specialist 
software. For this reason, in Chapter 5, we examined the use of a modified regional wall 
motion scoring index for calculating LVEF, and compared this to CMR-LVEF. Again, our 
findings suggest that the RWMSI-derived LVEF had a closer correlation and better inter-
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technique concordance with CMR-LVEF, when compared to biplane Simpson’s LVEF.  
The clear advance of this technique is that is it quick and easy to perform and does not 
require the use of specialist software.  It can therefore be used on any echo machine, in any 
echo laboratory world-wide, giving it huge potential clinical application. The disadvantage 
is that the technique is clearly subjective and has poorer reproducibility than GSS 
(interobserver variability: 11.2% vs. 3.2%). It must also be noted in this study that 
validation and reproducibility of our modified RWMSI equation was performed by 
experienced British Society of Echocardiography accredited imaging specialists.  We 
would not recommend use of this technique by trainees or inexperienced individuals due to 
its inherent subjectivity.  Within these limitations, our results suggest that use of the 
modified RWMSI, by experienced individuals, may be a superior alternative to biplane 
Simpson’s rule. Future work should include recruitment of larger patient numbers, to 
enable valid sub-group assessment of the accuracy and inter-technique concordance of the 
RWMSI in patients with mild, moderate and severely impaired LV systolic function 
compared to CMR-LVEF. 
 
Diastolic function is a complex multi-stage process that is difficult to quantify in absolute 
terms. In recent years the prevalence and importance of diastolic dysfunction has become 
increasingly recognised.  Diastolic dysfunction is now believed to account for up to 50% of 
clinical heart failure cases.168,169   The accurate diagnosis of diastolic dysfunction has been 
classified as being of “paramount clinical importance” by the EAE/ASE.14  The 
development of tissue Doppler echocardiography has resulted in a move away from load-
dependent semi-quantitative assessments of mitral inflow patterns, to more simple 
quantitative non-invasive estimates of LV filling pressures based on echo E/Em ratio.  In 
this area, CMR lags behind echo. At present there is no standard method for assessing 
diastolic function by CMR. In chapter 6 we sought to explore the clinical utility of using 
phase encoded velocity mapping CMR sequences to estimate LV filling pressure (and 
hence diastolic function), by comparing VEC-CMR E/Em with invasively recorded 
LVEDP, with mixed results. We found that VEC-CMR E/Em had a significant correlation 
with LVEDP in study subjects with preserved LVEF, but a weak correlation in those with 
impaired LV systolic function.  The reason for this is unclear, but our results compliment 
recent echo findings of E/Em in patients with systolic heart failure.16  Ours was a small 
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pilot study, designed to explore the feasibility and potential clinical utility of the technique, 
and our findings require further validation in a larger prospective study. 
 
Technically, there is no “gold standard” for quantifying RV systolic function, however, due 
to the high spatial resolution of CMR and the ability to image the heart in any plane, CMR 
is the widely accepted reference standard for quantifying RVEF.  The resolution of the RV 
by 3DE is generally poorer than that of the LV, and at present the EAE/ASE guidelines do 
not recommend the use of 3DE for quantifying RVEF in routine clinical practice.37  Due to 
the complex geometry of the RV, quantification of RVEF by 2DE is inaccurate and should 
not be used.37 The 2010 EAE/ASE guidelines review 10 non-volumetric alternative 
methods for quantifying RV systolic function by 2DE, and recommend at least one of these 
quantitative indices be measured in addition to a qualitative assessment of RV function, in 
every routine TTE performed.37  Due to a paucity of head-head comparison studies on the 
subject, the guidelines fail to make a clinical recommendation as to which 2D index of RV 
function is superior to the remaining methods and should therefore be the standardised 
method of choice in routine clinical practice. In chapter 7, we therefore attempt to answer 
this important clinical question by performing a direct comparison study of these 10 non-
volumetric indices of RV function, indexed against CMR RVEF as the reference standard. 
In our study we have demonstrated that longitudinal speckle tracking strain of the RV free 
wall had a significantly closer correlation with RVEF than all other non-volumetric echo 
indices of RV systolic function. Current EAE/ASE guidelines review the methodology 
behind strain imaging, but do not as yet endorse its use in routine clinical practice due to a 
paucity of normative data and reproducibility data.37  For this reason, we have determined 
normative threshold values for the technique by studying receiver-operator characteristics. 
We have also demonstrated that the technique is reproducible. Furthermore, due to the 
semi-automated nature of the software, the technique is easy to perform and the analysis 
time for calculating RV free wall strain is ~2 minutes. For these reasons, we believe this 
technique has a potentially far reaching clinical application.  What remains unclear at 
present, is if the normative cut-off values for RVFWS determined using GE speckle 
tracking software, will correspond to the same values for RVFWS which are calculated 
using speckle-tracking software produced by other manufacturers. Future work now should 
include a comparison study of RVFWS indices measured using speckle tracking software 
from various manufacturers. The same rule must also apply for our LV global strain score. 
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8.2  CONCLUSION 
 
Non-invasive cardiac imaging is a constantly evolving specialty, and regular review of 
current practice for the assessment of cardiac ventricular function is required as new multi-
modal imaging techniques become available. Due to the small patient numbers within our 
studies, the preliminary findings of this thesis clearly require validation in a larger, more 
diverse patient population before any of these techniques should be used in routine clinical 
practice. However, the results of this thesis suggest that when compared to CMR as the 
reference standard, speckle tracking strain imaging, using the methods described in detail 
above, may be the best 2D echocardiographic imaging method available for accurately 
assessing both left and right ventricular systolic function in a heterogenous population of 
patients as seen in clinical practice. When speckle tracking strain imaging is not available, 
the use of the modified regional wall motion scoring index, by experienced individuals, 
may provide a superior alternative to 2D biplane Simpson’s method of discs.  We have also 
demonstrated that phase encoded velocity mapping CMR E/Em ratios can be used to 
estimate LVEDP in individuals with preserved LVEF, but not impaired LV systolic 
function and this may therefore may provide a potential new method for assessing diastolic 
function by CMR. 
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ROYAL ADELAIDE HOSPITAL & WAKEFIELD HOSPITAL 
 
VOLUNTEER INFORMATION SHEET 
 
“Non-invasive indices for the assessment of load independent cardiac function: 
Comparison of Cardiac Magnetic Resonance Imaging (CMR) and Transthoracic 
Echocardiography (TTE) techniques versus invasive Left Ventricular End Diastolic 
Pressure (LVEDP) ” 
 
Principal Investigator:Dr Rae Duncan 
Co-investigators: Prof Stephen Worthley, Prof Gary Wittert, Dr Matthew 
Worthley, Prof Prashanthan Sanders, Dr Julie Bradley, Mr 
Angelo Carbone, Mr Greg Brown, Ms Diana Pilkington, Ms 
Kerry Brackenridge, Dr Darryl Leong 
 
YOUR PARTICIPATION IS VOLUNTARY 
 
You are invited to take part in a study looking at non-invasive ways of imaging (scanning) 
the heart, to measure the pressure in the main pumping chamber of the heart at the end of 
each heartbeat.  This pressure reading gives your doctor information on how well the heart 
is able to relax (diastolic function) after each heart muscle contraction (systolic function).  
The purpose of this sheet is to provide you with information so you can make an informed 
decision as to whether you wish to participate part in this study.  This is a research project 
and you do not have to be involved.  If you do not wish to participate, your medical care 
will not be affected in any way. 
 
BACKGROUND 
 
During each heartbeat, the heart contracts and then relaxes. Contraction of the heart is 
termed “systolic function” and relaxation of the heart is termed “diastolic function”. 
Abnormalities in either contraction (termed systolic dysfunction) and abnormalities in 
relaxation (termed diastolic dysfunction) of the heart can cause the signs and symptoms of 
heart failure. Systolic dysfunction can usually be detected easily, and sometimes before the 
development of symptoms, by performing a scan of the heart  - either an echo (ultrasound) 
scan or a cardiac MRI scan. Early detection results in early treatment and monitoring by 
doctors to prevent problems developing. By calculating the ejection fraction (the fraction of 
blood pumped out of the heart with each heartbeat), the systolic function of an individual’s 
heart can be monitored accurately over many years. Diastolic function is not so easy to 
measure. Diastolic function can be measured by measuring the pressure in the main 
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pumping chamber of the heart, the left ventricle, during the relaxation phase of the heart. 
The accepted “Gold Standard”, or best way of doing this, is by inserting a catheter (a long 
thin tube), via a blood vessel in the leg, into the ventricle, and to measure pressure and 
volume changes in the left ventricle throughout the cardiac cycle.  The pressure at end of 
the hearts relaxation period – the left ventricular end diastolic pressure (LVEDP) – is also 
measured this way.  These are standard clinical measurements which, can be recorded in 
individuals like yourself, during a cardiac catheter procedure. Because a cardiac catheter 
procedure involves taking X-ray pictures, doctors try to keep the number of times a catheter 
procedure is performed in any individual, to a minimum.  For this reason it is not practical 
or recommended that a cardiac catheter procedure be used to monitor the diastolic function 
of an individual over an extended time period of several years as this would involve several 
repeat procedures. Instead, echocardiography has been used to assess diastolic function, as 
it is non-invasive, quick and does not involve X-rays.  However, the standard methods for 
assessing diastolic function with echo are limited by the fact that they are not quantitative, 
and they are not as accurate or reproducible as the cardiac catheter “Gold Standard”.  There 
have been major advances in the quality of cardiac imaging recently both in the 
development of tissue Doppler echo techniques and in cardiac MRI scanning.  Both of 
these methods of heart scanning are non-invasive, safe, painless and do not involve any 
exposure to ionising radiation.  Both of these new imaging techniques, now give  the 
opportunity to measure diastolic function quantitatively and to calculate LVEDP non-
invasively.  We would like to validate these techniques by comparing the LVEDP and 
diastolic pressure-volume curves your doctor records during you cardiac catheter procedure 
with the figures we record during echo and cardiac MRI scanning. 
 
WHAT IS THE PURPOSE OF THE TRIAL? 
 
The overall aim of this project is to investigate the use of both echo and cardiac MRI 
protocols in calculating LVEDP, and to validate the results against LVEDP and/or left 
ventricular pressure-volume curves recorded during cardiac catheterisation.  We hope that 
if we can validate these techniques in this study, we may be able to use tissue Doppler echo 
or cardiac MRI routinely in the future to monitor diastolic dysfunction in patients who 
suffer from heart failure. 
 
WHAT WILL YOU HAVE TO DO? 
 
If you agree to participate in this study, we will ask and record relevant aspects of your 
medical history – this is simply to ensure that you are suitable for our study and you have 
no problems that would prevent you from entering the MRI scanner. We will invite you to 
attend Adelaide Cardiac Imaging (Wakefield Clinic, Wakefield Street, Adelaide) early on 
the morning of your catheter procedure.  We would like to perform an echo scan of your 
heart (which takes approximately 30-40 minutes) followed by an MRI scan (which takes 
approximately 60 minutes) prior to your catheter procedure (which takes approximately 20 
minutes). 
 
What is an Echo exam and what is involved? 
An echo is an ultrasound scan of the heart, and works on a similar principal to the 
ultrasound scan used to scan pregnant women. You will be asked to lie on a couch and a 
microphone like device (a transducer probe) will be placed on your chest.  The transducer 
transmits and receives sound waves that travel through the chest wall to the heart and 
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reflect back again.  The reflected sound waves are translated into moving images of the 
heart. An echo is non-invasive, painless, without radiation and carries no side effects.  
 
What is an MRI exam and what is involved? 
MRI is a test which uses a powerful magnet with special radiofrequency pulses to produce 
radiofrequency signals (echoes) from within the body.  These echoes produce a very 
detailed picture of the part of the body being studied (in this case the heart). The MRI 
scanner consists of a very short circular tunnel and a narrow table. During the scan you 
simply lie on your back on the table and your body goes through the tunnel of the scanner.   
The scan will take approximately 45-60 minutes to perform. MRI is also non-invasive, 
painless, without radiation and carries no significant side effects, however you will hear a 
loud knocking or buzzing sound at various intervals. Some patients can find an MRI scan 
distressing. You will be provided with earplugs and if you wish, we can offer you music to 
listen to during the scan.  
 
As part of this research study, all the scans are free.  We may also be able to assist in 
transport arrangements to Wakefield Hospital for those with difficulty. 
 
ADVERSE EFFECTS 
 
Both echo and MRI scans are safe. Overall, there is very little risk involved in this research 
study. Some individuals can find the MRI scanner a little claustrophobic or uncomfortable. 
 
CONFIDENTIALITY 
 
Your participation in this study is strictly confidential.  All information collected for 
research purposes is only available to the study investigators and will not be released to 
other medical or research staff without your consent.  If information from this study is 
published in any form, it will be done so in a way that does not allow you to be personally 
identified. 
 
CONTACT DETAILS 
 
Should you have any questions about this study please feel free to contact: 
 
Dr Rae Duncan (08) 8222 2473 
 
INDEPENDENT CONTACT 
 
If you wish to speak to someone not directly involved in the study about your rights as a 
volunteer, or about the conduct of the study, you may also contact the Chairman, Research 
Ethics Committee, on (08) 8405 3333. 
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ROYAL ADELAIDE HOSPITAL & WAKEFIELD HOSPITAL 
CONSENT FORM 
 
I, THE UNDERSIGNED HEREBY CONSENT TO MY INVOVLEMENT IN THE 
PROJECT TITLED: 
 
““Non-invasive indices for the assessment of load independent cardiac function: Comparison of 
Cardiac Magnetic Resonance Imaging (CMR) and Transthoracic Echocardiography (TTE) 
techniques versus invasive Left Ventricular End Diastolic Pressure (LVEDP) ” 
 
conducted by Dr Rae Duncan, Prof Stephen Worthley, Dr Matthew Worthley, Prof 
Prashanthan Sanders, Dr Julie Bradley, Mr Angelo Carbone, Mr Greg Brown, Mrs Diana 
Pilkington, Ms Kerry Brackenridge, Dr Darryl Leong. 
 
1. I understand the nature, purpose and contemplated effects of the research project.  It has been 
fully explained to my satisfaction and I have been given the opportunity to ask questions about 
the project.  I have also read the Information Sheet and I agree to take part in the study.  My 
consent is given voluntarily. 
 
2. I understand that I may not directly benefit from taking part in this study. 
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